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CLAIMS 
1) Circular recombinant plasmid DNA construct encoding a) a protein tag,  
b) a visual marker protein, and containing c) a multiple cloning site suitable for 
insertion of an additional gene, characterised in that the gene sequence encoding 
the protein tag and the visual marker protein are specifically designed and 
engineered at the DNA level for respectively a) immobilisation purposes and b) 
visualisation and quantification purposes at the protein level. 
2) 2) Construct according to claim 1, characterised in that the protein tag is chosen 
from the group containing lysine (lys), histidine (his), tyrosine (tyr), phenylalanine 
(phe), arginine (arg), glutamic acid (glu), aspartic acid (asp), glutamate, aspartate, 
asparagine (asn), glycine (gly), glutamine (gln), alanine (ala), valine (val), 
tryptophan (trp). 
3) Construct according to claim 1 or 2, characterised in that the protein tag is a 
histidine-tag such as a polyhistidine variant, in particular (6X) histidine. 
4) Construct according to any one of the preceding claims, characterised in that the 
visual marker protein is chosen from the group containing fluorescent or 
phosphorescent proteins. 
5) Construct according to claim 4, characterised in that the fluorescent protein is 
chosen from the group containing Green Fluorescent Protein (GFP), Red 
Fluorescent Protein (RFP), Yellow Fluorescent Protein (YFP) and Blue Fluorescent 
Protein (BFP) as well as their variants and/or mutants. 
6) Construct according to any one of the preceding claims, characterised in that the 
multiple cloning site contains restriction enzyme recognition sites. 
7) Construct according to claim 6, characterised in that the restriction enzyme 
recognition site is chosen from the group containing SacI, SalI, HindIII, EagI, NotI. 
8) Construct according to any one of the preceding claims, characterised in that it 
further contains a frame adapter of variable length between the visual marker and 
protein tag genes. 
  vi
9) Protein expressed by circular recombinant plasmid DNA construct according to any 
one of claims 1 to 8, characterised in that in the MCS adjacent to the visual marker, 
it further contains an additional target protein and in that the tag is suitable to 
interact directly with appropriate surface pendant groups of a support material. 
10) Protein according to claim 9 characterised in that it is a fusion protein. 
11) Use of the protein constructs of claim 9 or 10, in immobilisation and visualisation 
of proteins on compatible support material. 
12) Method for preparing and immobilising a protein on a support material, 
characterised in that it contains the steps of: 
a) Engineering at the DNA level, in series a protein tag suitable to interact 
directly with appropriate surface pendant groups of a support material, a 
fluorescent marker protein for visualisation and quantification purposes at 
the protein level and a multiple cloning site suitable for insertion of a target 
protein to be immobilised, 
b) Inserting the corresponding gene of the target protein to be immobilised into 
the multiple cloning site; 
c) Initiating protein expression. 
d) Optionally pre-treating the support material; 
e) Incubating the protein and support material together, wherein the protein is 
immobilised to the support via specific tag-surface interactions; 
f) Washing away the non-specific biomolecules; 
g) Optionally quantifying the fluorescence of the visual marker protein; 
h) Optionally desorbing the target protein. 
13) Method according to claim 12, characterised in that the support material is chosen 
from the group containing polymers, biopolymers, glass and composites containing 
silicone dioxides, metals and metal oxides, as well as any combination thereof on 
the microscopic, mesoscopic or macroscopic length scale.  
14) Method according to any one of claims 12 and 13, characterised in that the support 
material is chosen from the group containing polymers, silicon dioxides, aluminum 
oxides, titanium oxides, magnesium oxides, borates, metals and other metal oxides. 
  vii
15) Method according to any one of claims 13 and 14, characterised in that the 
polymers are chosen from the group containing polyolefins such as polystyrene, 
polyacrylates, polymethyacrylates, polybutylene, polyvinylalcohol and related 
derivatives, polyvinylchlorides, polyisoprene, polypropylene, polyphenols, 
polyamides, polyesters polysulfones, polyethersulfones, polyethersulfides, 
polyimines, polyethyleneglycols, polypropyleneglycols, polyimides, 
polycarbonates, polyurethanes,  
16) Method according to claim 15, characterised in that the polymer surface is 
chemically treated to bear various functional groups chosen between carboxyl 
groups, hydroxyl groups, amino groups, amide groups, ester groups, imide groups, 
imine groups, mercapto groups, nitro groups, sulfonate groups, phosphate groups, 
phosphonate groups, cyano groups, sulfone groups, aldehyde groups, epoxide 
groups, urethane groups, ketone groups, phenolic groups, aromatic groups, alkyl, 
alkenyl, alkynyl, acyl and aryl groups, silanol groups, silicon oxide groups, 
siloxane groups, metal hydroxide groups, metal oxide groups, and elemental 
metals. 
17) Method according to any one of claims 13 to 16, characterised in that the support 
material is carboxylated polystyrene. 
18) Immobilised protein construct obtained by the method according to any one of 
claims 13 to 17, characterised in that it is covalently or non-covalently bonded to 
the support material. 
19) Immobilised protein construct according to claim 18, characterised in that it is non-
covalent and yet freely accessible and leach-free like proteins immobilised in the 
covalent sense. 
20) Use of the immobilised protein constructs according to any one of claims 18 and 19 
in applications selected from analysis, diagnosis (like in enzyme based diagnostic 
kits), incubation, storage, sensing, arraying and orienting, catalysis, stabilisation, 
binding, signal transduction, chemical transformation, implant passivation and 
surface biocompatibilization, surface activation, purification, detoxification and 
scavenging. 
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ABSTRACT 
A two-component system was designed and developed to facilitate immobilization of 
any peptide such as enzyme or signal peptide onto appropriately modified surfaces. The 
system was based upon a specialty plasmid that codes a sequence for a poly(6)histidine tag, 
a GFP (green fluorescent protein) gene, and a multiple cloning site, to which the gene of 
the target peptide may be inserted, and an interactive surface that was tailored with 
negatively charged functional groups.  
 
The target plasmid bearing a poly(6)histidine coding region was engineered starting 
from pETM-11 plasmid, which is a vector optimized for expression purposes. In order to 
better preserve the traits of pETM-11, the non-essential gene of a protein called MAD was 
excised and replaced with a frame adaptor, as well as GFP gene of comparable size to 
MAD. This "frame adaptor" a frame-adjusting, small oligonucleotide sequence joining the 
histidine anchors and the fluorescent GFP linker prevented the frameshift problem that 
would be introduced after substituting the MAD gene with the GFP gene. In addition, it 
was designed to code for a highly flexible sequence of amino acids (Gly-Gly-Thr) to best 
preserve the solution-phase traits of the GFP gene. The finalized immobilization adapter 
protein construct, termed GFPimm, was expressed and isolated using either a Ni2+ 
polyhistidine tag affinity column or ion exchange chromatography. Following isolation, the 
protein is tested for binding performance using surface-modified polystyrene 96-well 
plates. In contrast to the typical mode used to bind polyhistidine tags, in which a 
coordination bond between Ni2+ and imidazole anchors the protein to a surface, the strategy 
proposed herein was to exploit the positive charges of histidine and negative charges on the 
surface to achieve salt bridging. For this purpose, a polystyrene surface was modified to 
bear negatively charged surface groups via incubation with a persulfate reagent, ammonium 
persulfate.  
 
It follows that the recombinant vector designed and constructed in this study is not 
only amenable to cloning and expression but also for realizing easy purifications, visual 
tagging of target proteins by fusion methodologies, and performing immobilizations in 
specialty applications. 
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ÖZET 
Uygun biçimde de<i;ikli<e u<rat=lm=; yüzeyler üzerine enzimler veya sinyal peptitleri 
gibi her türlü proteini sabitlemek amac=yla iki bile;enli bir sistem tasarland= ve olu;turuldu. 
Sistem, çoklu (6l=) histidine dizisi kodlayan bir k=s=m, GFP (ye;il parlayan protein) geni, 
sabitlenmesi hedeflenen proteinin geninin yerle;tirilebilece<i bir çoklu klonlama bölgesi 
içeren yüzey sabitlemeye özelle;mi; bir plazmid ve eksi yüke sahip i;levsel gruplar ta;=mak 
üzere de<i;ikli<e u<rat=lm=;, etkile;en bir yüzeyden olu;maktad=r. 
 
Çoklu (6) histidine kodlayan k=s=m içeren hedeflenen plazmid gen klonlama ve 
ekspresyonu için optimize edilmi; olan pETM-11 ekspresyon vektörü de<i;tirilerek elde 
edilmi;tir. pETM-11in optimize edilmi; özelliklerini daha iyi korumak için, 
uygulamam=zda gerekli olmayan MAD geni ç=kar=lm=;, yerine s=ras=yla çerçeve kaymas= 
engelleyici bir adaptör ve pGFPuv vektöründen elde edilen, MAD geniyle yakla;=k ayn= 
uzunlukta olan GFP geni yerle;tirilmi;tir. Sözü edilen çerçeve kaymas= engelleyici 
adaptör kodon çerçevesini do<ru diziye ayarlayan, histidin tutunucu dizisi ile parlayan 
GFP ba<lay=c=s=n= birle;tiren küçük nükleotid dizisi MAD geninin GFP geniyle 
de<i;tirilmesi sonucu olu;acak olan çerçeve kaymas= mutasyonunu engellemi;tir. Ek olarak 
bu adaptör, fiziksel olarak çok esnek bir amino asit dizisini (Gly-Gly-Thr) kodlamak ve 
böylece GFPnin solüsyon faz= karakteristi<ini mümkün oldu<unca korumak üzere 
tasarlanm=;t=r. Sonuçta elde edilen, GFPimm olarak adland=r=lan sabitleme adaptörü 
protein konstrakt, ekspresyondan sonra hem Ni2+ çoklu histidin ilgi kolonu hem de iyon 
de<i;tirme kromatografisi kullan=larak izole edildi. zolasyon sonras=nda proteinin yüzeye 
ba<lanma özellikleri, de<i;tirilmi; yüzeye sahip 96-kuyulu polistiren kaplar kullan=larak 
denendi. Bu çal=;mada, çoklu histidine gruplar=n= yüzeye ba<lamak için genelde kullan=lan 
Ni2+ ile imidazol aras=ndaki koordinasyon ba<=n=n yerine histidinin art= yükleri ile 
yüzeydeki eksi yükler aras=nda tuz ba<= olu;turma stratejisi uyguland=. Buna paralel olarak 
polistiren yüzey de persülfat kullan=larak eksi yüklü yüzey gruplar= ta;=mak üzere 
de<i;ikli<e u<rat=ld=.  
 
 Bu çal=;mada tasarlanan ve olu;turulan rekombinant vektörün sadece gen klonlama 
ve ekspresyonda de<il, ayn= zamanda kolay protein izolasyonu, hedef proteinlerin 
birle;tirme yöntemi kullan=larak görsel i;aretlemesi ve biyoteknoloji endüstrisinde 
kullan=labilecek özelle;mi; yüzey sabitleme uygulamalar=nda da i;levsel olaca<= 
dü;ünülmektedir. 
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1. INTRODUCTION 
Immobilization, as a strategy of general scope, has been incorporated into many 
established facets of biotechnology, particularly in situations where enzymes are used to 
mediate synthetic transformations in industry or facilitate diagnosis of some clinical cases 
by the help of certain kits used in medical examinations. For immobilizing the proteins the 
following technologies are currently being used: 
 
Adsorption technology has the advantage that the protein-surface interaction is non-
covalent and thus precludes any potentially disruptive chemical modifications associated 
with covalent immobilization, affording enzymes that often retain good, albeit perhaps 
altered biological activity, but with the common disadvantage of leaching of adsorbed 
enzymes from the surface and being lost in time. Another disadvantage, which is common 
in all non-site-specific immobilization methods described below is the low number of 
enzymes in the whole immobilized population having the correct orientation to leave the 
active site available. Although adsorption has the mentioned disadvantages, other major 
advantages include rapid and facile preparation of the material (Bickerstaff, 1997). 
Encapsulation technology, like the above said adsorption technology, features many 
advantages associated with non-covalent protein-surface interactions, particularly the very 
native-like properties of matrix-enclosed enzymes. In addition, enzymes are easily 
encapsulated and well retained by the support. A related disadvantage however may be 
poor substrate accessibility both due to encapsulation and being randomly oriented as 
described in adsorption technology, leading to slowed kinetics or lost apparent activity in 
the case of large substrates (Bickerstaff, 1997). 
Cross-linking technology features the advantages and disadvantages normally 
associated with covalent modification, one advantage being that protein is well retained on 
the support. A typical disadvantage of covalent modification is the possibility of loss of 
biological function as a result of chemical reaction or conditions imposed during the 
immobilization protocol. A potential advantage/disadvantage defined by context is the 
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alteration of biological function. In the case of cross-linking technology, another 
disadvantage is the waste of useful biocatalyst since clumps of enzymes are often bound 
together, intertwined with the support. Under such conditions, diffusional limitations may 
define the effective enzyme concentration to only those residing near the surface. 
Furthermore, the dynamic mobility of one enzyme may be impeded by virtue of being 
anchored to a neighbouring enzyme (Bickerstaff, 1997). 
Covalent bonding, like above mentioned cross-linking technology, features the 
advantage of binding enzyme irreversibly to a surface. The observation of poor or altered 
activity has introduced modifications to the original method, in which a linker strand 
separating enzyme and surface imposes a distance constraint, thus restoring much native-
like activity with possible exception to site-specific alterations normally associated with 
covalent modification of protein groups (edited by Gebelein, 1990). More often than non-
covalent methods, the conditions required to achieve covalent bonding may require harsh 
conditions that lead to enzyme instability and deactivation (Bickerstaff, 1997). 
Site specific immobilization using antibodies, uses the advantage of recombinant 
DNA technology for fusing the enzyme of interest to an antibody while the surface is 
coated with the specific anti-antibody. Mostly, biotin-streptavidin couple is used for this 
purpose. As an advantage over non-site-specific methods of immobilization described 
above, in this method the enzyme is properly oriented so that active site accessibility is 
higher (reviewed by Butterfield et al., 2001). Although this strategy overcomes undesired 
effects on enzymatic activity caused by the harsh chemical treatment and randomly oriented 
immobilization, it is rather tedious to form both a fusion protein and an anti-antibody 
coated surface since the strategy indeed is composed of more than one immobilization 
together with monoclonal antibody synthesis, just to immobilize one target protein. 
Although benefits of immobilization are case specific, some reported advantages 
include prevention of enzyme loss in continuous systems, increased thermal or pH stability, 
increased longevity, and under certain circumstances higher activity (Smith, 1996; 
Hermanson et al., 1992; edited by Cass et al., 1998). Immobilization as a practice has 
undergone substantial change in response to the demands of the industry. Once considered 
a relatively crude and non-specific method, modern immobilization protocols strive to 
realize optimum levels of homogeneity, orientation and loading efficiency of enzyme along 
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the surface of the support medium. To characterize immobilization efficiency, enzyme 
assays relating activity to concentration are typically employed and interpreted using the 
oversimplified approximation that the biomolecule is equally active on a surface as it is in 
solution. In reality, activity in solution-phase and on a surface may be very different. As 
might be anticipated, any substantial digression from the native state, such as an over-
modification of the protein environment, has strong influence on the apparent kinetic 
constants that relate to protein function. That being said, enzyme loading is arguably one 
parameter of paramount importance from which product quality quantity and purity of 
immobilization-based commercial syntheses are gauged. With due consideration to the risk 
of digressing from native-like activity upon immobilization, the task of achieving an 
accurate enzyme quantification on the basis of solution-phase literature values is wrought 
with potential errors and experiment-related difficulties.  
 Quantification of surface bound protein is a common problem in immobilization 
practices. Direct and indirect methods -such as activity measurements on surface and 
quantification of unbound protein in solution- are employed to quantify surface bound 
proteins (Bickerstaff, et al., 1997; Sardar et al., 1997). In direct methods, the activity of the 
biomolecule is (over-)assumed to be similar to solution phase in order to measure the 
surface-bound protein amount by an activity based assay. In indirect methods, unbound 
protein is subtracted from the protein in the initial load to quantify the bound protein. The 
indirect method requires very dilute protein surface-loading solutions in order to keep the 
amount in a range where the correlation between protein amount and the assayed parameter 
is linear. 
In extrapolating the potential problems of protein quantification to medical diagnostic 
kits, biocompatible blood materials, specialty cell culture surfaces bearing signal peptides, 
and any scenario where biopolymers are used to improve surface properties of specialty 
plastics, glasses or other negatively charged surfaces, it is noteworthy that many of these 
biopolymers bear no convenient means of selective immobilization and unlike enzymes, 
bear no means of convenient quantification, thus posing increased difficulties in estimating 
their immobilization efficiency. In order to facilitate protein immobilization and 
purification and to overcome several immobilization-related problems such as the activity 
loss due to harsh chemical treatments during immobilization and potentially misleading 
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assumption of unaltered biological activity when immobilized, we have designed a multi-
component immobilization/visual detection system that can be applied to proteins, peptides 
and enzymes in any facet of bio-surface engineering. The approach is ammenable to any 
protein and is novel in that proteins are expressed ready-made for immobilization, featuring 
good surface separation to mimic native-like conditions, and surface retention reminiscent 
of covalent methods, without necessitating the use of chemical reagents in the presence of 
the protein. The approach is based on five elements: 
 
  1. GFP: Fusion protein strategies incorporating the green fluorescent protein 
facilitate localization of proteins in situ. In the approach explained here, fusion protein 
strategy is specifically used to visualize and quantify the immobilized enzyme. 
  2. His-tag: Multiple histidine residues in series are used for selective purification of 
recombinant proteins. Unlike established purification methods based on His-tag 
interactions, here, no metal ion is required to enable the immobilization event. 
Immobilization is achieved through a direct interaction between the surface-pendent 
carboxyl groups and the imidazole moieties of a poly(6)histidine tag that has been 
engineered N-terminal to GFP. It follows that the technique can be extended to any peptide 
tag as long as the surface is designed to bear affinity for it. 
 3. Cleavable linker: A linker bearing chemical specificity cleavage upon addition of 
the appropriate external agent. The system includes a TEV (Tobacco Etch Virus) protease 
recognition site to permit easy release of immobilized peptide from the surface into the 
solution phase following proteolytic cleavage. 
 4. Multiple cloning site: A special sequence that has the property of being cut by 
sequence specific endonuclease enzymes. MCSs are typically used to insert and 
clone/express foreign target genes in a host organism. In our recombinant vector, the 
multiple cloning site of pETM-11 was used for inserting GFPuv gene into the modified 
pETM11 vector and resulting MCS downstream of the GFPuv gene was preserved in order 
to provide space for the gene of peptide to be immobilized. 
 5. Carboxylated polymer support media: Carboxylated surfaces are used in 
reversible/irreversible surface immobilization of positively charged species as well as for 
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hydrogen bonding species. Here, binding is achieved using persulfate-modified, 
carboxylated polymeric surfaces.   
 Similar studies, which bring GFP and immobilization together, were performed. 
Among these studies the ones that are closest to the one presented here involve the 
purification (immobilization) of GFP fusion proteins using poly-histidine tag (Wu et al., 
2002), immobilization of GFP using poly-amino acid tags and quantification of bound GFP 
(Nock et al., 1997). Despite the similarities with these studies, our approach is novel in the 
way that it defines a modular recombinant vector designed for and principally capable of 
immobilizing any protein provided that its gene is cloned. In addition to the achieving easy 
immobilization, immobilized enzyme can be quantified by an activity-independent assay 
based on fluorescence measurements. This is very important since in activity based 
quantification strategies; the enzyme is is bravely assumed to be as active as in solution and 
compared to the activity of same enzyme in solution as the standard. However binding the 
enzymes onto solid supports have a hard-to-ignore potential in alteration of activity.  
Another novelty of the strategy is the flexibility of the system. Each above-mentioned 
element of the designed vector can be replaced in order to use in modified case specific 
conditions. GFP can be changed with BFP, YFP, RFP or similar fluorescent peptides to 
independently quantify different immobilized peptides where more than one is involved. 
Poly-histidine tag can be replaced with other poly-amino acid tags such as negatively 
charged or ring containing amino acids in order to use with alternatively tailored surfaces. 
Frame adapter can be replaced with longer or different sequence containing alternatives. 
Multiple cloning site can be modified to have additional restriction enzyme recognition 
sites as well as endless possibilities for proteins for immobilization. 
In addition to realizing easy and accurate quantification of immobilized peptides, the 
approach also provides increased mobility and separation of the target protein from the 
surface through linkage via GFP and a flexible Gly-Gly-Thr frame adapter peptide. It is 
also noteworthy that the immobilization event is likely to occur at only one point, thereby 
minimizing the risk of adverse functional consequences. Although any enzyme gene was 
not inserted within MCS of pETM-GFP-Imm specialty vector for immobilization in this 
study, above-indicated factors should promote retention of native-like characteristics rather 
than altered, surface-bound kinetics, which may restrict enzyme action. A his-tag based 
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immobilization also promotes uniform orientation along the surface, a definite advantage in 
comparison to established immobilization technologies.  
In this study we aimed to construct a specialty recombinant plasmid coding for fusion 
proteins for immobilizing any peptide (e.g. signal peptides, enzymes) provided that their 
genes are cloned. In parallel to the plasmid construction, polystyrene surfaces were 
modified so that they will interact with the expressed proteins coded by the recombinant 
plasmid mentioned above. The use of immobilization specialized fusion proteins gives the 
opportunity to easily visualize and quantify immobilization efficiency using a fluorescence-
based method instead of an activity-based assay. In addition, targeted outcome of this 
project included the development of an enzyme-friendly immobilization system in which 
the enzymes are not subjected to harsh chemical immobilization methods that result in 
important loss of enzymatic activity. Instead the peptides and the surfaces would be 
independently prepared for immobilization process.  
Although the system is not characterized in the presence of an enzyme for the criteria 
of activity, specificity and stability; it follows that by using an optimal combination of the 
above strategies the drawbacks of classical enzyme and/or protein immobilization and 
efficiency detection methods can be overcome. 
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2. OVERVIEW: 
In this thesis a new application of well-known tools of molecular biology to solving a 
problem in the chemical industry is described. The strategy developed for immobilization 
and quantification of enzymes involves several technologies including construction of a 
recombinant vector, design and production of a modified surface, usage of an 
immobilization tag and the modified surface, and the use of a fluorescent probe for 
visualisation and quantification. This brief overview to different aspects of technologies 
involved aims to provide background information to the work presented in the later 
chapters. 
2.1 Uses of Enzymes by Mankind:  
A Brief History Until Their Modern Use as Fixed Machines in Production Lines 
Although a great number of synthesis reactions may be achieved only by using 
information from the field of chemistry, in some cases mankind  knowingly or not  has 
used an alternative source of information to perform certain chemical reactions: the genetic 
information coded in the DNA. This particular information is the one necessary to code for 
efficient and highly selective chemists of nature, namely the enzymes. Advantages and 
disadvantages of using these different materials and sources of information for synthesis 
reactions are given in Table 2.1. 
  8
Table 2. 1 Advantages and disadvantages of biological syntheses in comparison to chemical 
syntheses. 
Advantages 
- Production of complex molecules 
such as proteins and antibodies is not 
possible by chemical means. 
- Bioconversions give higher yields 
when considered with the product 
homogeneity 
- Operate at low temperature, near-
neutral pH. 
- Have much greater catalytic 
specificity. 
- Bioprocesses are extremely 
successful in obtaining necessarily 
one form of isomeric products.  
Disadvantages 
- Can be easily contaminated with 
unwanted microorganisms, etc. 
- Product is usually in a complex 
mixture requiring separation. 
- Involve providing, handling and 
disposing of large volumes of water. 
- Are generally slower than chemical 
processes. 
- Are expensive. 
- May necessitate advanced protocols 
for waste treatment. 
2.1.1 Use of Enzymes in Human Related Applications:  
On the Way to Modern Biotechnology 
Enzymes, without being recognized, have been used for centuries in applications such 
as cheese production, brewing and bread making. It is known that methods for the 
fermentation of milk products, meat and vegetables were described in earliest records 
dating back to 6000 B.C. by civilizations (e.g. Sumerians, Babylonians) of the Fertile 
Crescent in the Middle East (reviewed by Caplice et al., 1999; Smith, 1996). These are 
followed by the records about mold-fermented foods in China and beer brewing and bread 
making combined in Egypt (reviewed by Colwell, R.R., 2002). In more literary sources, 
such as the famous Greek epic poems The Odyssey and The Iliad (~700 B.C.), 
descriptions of processes involving the use of enzymes in cheese making can be found. 
These examples show that, well before rationalization of the process, enzymatic 
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conversions of raw materials were empirically being used for especially food related 
synthesis reactions. 
 
Industrial use and understanding of enzymes revolved independently around yeast 
and malt in the west, and around sake production and many food fermentations in the east. 
In 1896, presumably the first enzyme patenting and an important fermentation related 
technology transfer from East to West occurred by the marketing of takadiastase. This was 
a crude mixture of starch hydrolysing enzymes obtained by growing the fungus Aspergillus 
oryzae on wheat bran, which was well known and used for thousands of years in Asia. 
Approximately in the time, between 1857 and 1876, fermentative ability of bacteria was 
demonstrated by Pasteur (Smith, 1996). 
 
Leather processing, in particular the softening process (bating) in which structural 
components such as collagen that give rigidity and stability to the unmodified leather were 
removed was a hard-to-tolerate application since dog feces and pigeon droppings were 
used in large quantities. After Otto Röhm a distinguished German chemist has 
discovered in 1905 that active components of this process are in fact some protein 
degrading enzymes which can alternatively be found in some animal organs, pig and cow 
pancreases became more acceptable and reliable sources of these enzymes and leather 
processing became tolerable.   
In the 1940s, mass cultivation of microorganisms in contaminant-excluding sterile 
conditions was introduced to have products such as vaccines, antibiotics, polysaccharides. 
After the use of microbial enzyme resources around mid-1950s, enzyme technology was 
revolutionized. The main reasons for this jump were as follows: 
- The war industry that fed World War II improved the knowledge about large-scale 
cultivation of microorganisms together with enzyme and/or product harvesting (e.g. 
penicillin production). 
- The rapidly increasing knowledge on the properties and mechanisms of enzymes led 
their use in industry for their catalytic properties. 
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- Recombinant DNA technology provided new materials and methods that either 
increased production efficiency or changed previously impossible processes to 
routine practices. 
- Microorganisms were convenient sources of most potentially industry-related 
enzymes. 
 
As a result, enzymes found a wide range of applications such as  
- production of biological detergents (primarily proteases and amylases),  
- baking industry (e.g. amylases),  
- brewing industry (e.g. amylases, glucanases, proteases),  
- dairy industry (e.g. proteases such as rennin and chymosin, lipases and lactases), 
- starch industry (e.g. amylases, amyloglucosidases, glucoamylases, glucose 
isomerase), 
- textile industry (e.g. amylases), 
- leather industry (e.g. trypsin), 
- medical, pharmaceutical and diagnostic uses (e.g. ELISA tests) (Smith, 1996). 
 
Rationalization of empirical biotechnological applications by the discovery and 
effective use of enzymes in industry was followed by development of methods for 
extraction of them from producer microorganisms. Cell-free enzymes were recognized to 
have a number of advantages over the use of microorganism containing media (Smith, 
1996):  
- Avoiding conversion of a large amount of substrate into biomass as in the cases 
where microorganisms were used. 
- Prevention of wasteful side reactions caused by different metabolic events within 
the same microorganism. 
- Overcoming the possibility of incompatibility of condition optima for 
microorganism growth and product formation. 
- Ease of product purification when compared to microorganism containing bulk 
fermentation liquor. 
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In addition to the developments mentioned above, recombinant DNA technology and 
protein chemistry studies led to modification of economically important enzymes in order 
to 
- enhance the enzymatic activity, 
- improve the stability, 
- permit the enzyme to function in a non-optimum environment, 
- change pH and/or temperature optima, 
- alter specificity so that different substrates may be used, 
- enhance the efficiency of process. (Smith, 1996) 
 
Further improvement in strategy involves applications where immobilized enzymes 
are used, which is discussed in Section 2.1.2. 
2.1.2 Immobilization of Enzymes on Surfaces: 
 The discovery of the active factors of ancient industrial processes was followed by 
the alternative of using cell-free enzymes rather than whole-cells or enzyme containing 
complex media. Due to developments in protein purification area, an important progress 
towards enzyme use in industrial and synthesis related applications is achieved. 
In most solution-phase reactions, the enzyme used cannot be recovered, and is wasted 
at the end of the reaction. Immobilization on insoluble supports such as polymeric 
membranes or particles is carried out mainly in order not to lose the enzyme in synthesis 
reactions. Since enzymes are physically restricted in this method, it is possible to reuse the 
immobilized molecules without losing them into the solution. Some reported common 
advantages immobilization regardless of the technique used are (Smith, 1996; Hermanson 
et al., 1992; edited by Cass et al., 1998): 
- Permits reuse of biocatalysts used in the reaction, 
- Reactions may be run with a small amount of enzyme, 
- Ideal for continuous operation, 
- No product contamination with the enzyme used, 
- Permits better control of catalytic processes, 
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- Prevents autocatalysis in case the enzyme is a protease, 
- Improves stability of enzymes especially in extreme conditions, 
- Allows construction of multi-enzyme production lines, 
- Has high potential in industrial and medical use, 
- Since effluent is enzyme free, product purification from the enzyme containing 
media and disposal problems are overcome. 
 
Along with its advantages, the strategy also has disadvantages concerning the 
relatively rigid positioning of enzymes on supports. Even though the bulk properties of the 
support may not have inhibitory effects, the structural properties may be negatively affected 
by the surface properties of support material, as it is perfectly stated by Enrico Fermi in the 
expression:  God made the solid state. He left the surface to the Devil. (Cass et al., 1998) 
Because the disadvantages of enzyme immobilization studies are rather method 
specific, those will be discussed within the sections about each immobilization strategy. To 
highlight generally, the common point in those disadvantageous cases is the possibility of 
alteration of chemical and/or physical properties of active site of enzymes or its 
accessibility (Hermanson et al., 1992). 
In enzyme immobilization practices, the ideal support material and method of 
immobilization varies greatly with characteristics of the enzyme, nature of substrates and 
products and reaction conditions used in biocatalysis. Thus, selection of support material 
and the method of immobilization is not a standardized procedure; instead, it is done by 
considering the advantages/disadvantages of properties, limitations and characteristics of 
several combinations of methods and supports. Some criteria to consider in this selection 
are provided in Table 2.2 (edited by Bickerstaff, 1997): 
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Table 2. 2 Important criteria in selecting support and method of immobilization (edited by 
Bickerstaff, 1997). 
 
Considering the above criteria, which are widely branched within themselves, mainly 
four methods (based only on chemical and/or physical phenomena) are used for random 
immobilization of enzymes (edited by Bickerstaff, 1997). As schematically indicated in 
Figure 2.1, these are:  
1. adsorption,  
2. covalent binding, 
3. entrapment/encapsulation,  
4. crosslinking. 
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Figure 2. 1 Random immobilization methods using only chemical and/or physical 
phenomena (edited by Bickerstaff, 1997). 
 
In addition to these techniques in which enzymes are immobilized regardless of their 
active site orientation, there are applications where immobilization takes place 
directionally. Such site-specific immobilization studies will also be discussed together (as 
5th method of immobilization) with random immobilization techniques in the following 
sections. 
2.1.2.1 Adsorption: 
Adsorption is the simplest method of immobilization that uses reversible surface 
interactions such as electrostatic (i.e. van der Waals, ionic and hydrogen bonding) and 
hydrophobic (e.g. base stacking) bonding. Although these forces are individually weak for 
effective binding, they are sufficiently large in number within a large protein molecule and 
on a practically infinite surface. In this strategy no activation or modification of the enzyme 
is used; instead, the natural interaction between the enzyme and support results in little or 
no damage to the biological material. The binding efficiency is typically under the 
influence of parameters such as pH and ionic strength of the buffer in which the enzyme 
and surface are incubated together (edited by Bickerstaff, 1997; edited by Mosbach, 1987).  
 
The basic advantages of the technique are (Smith, 1996; edited by Bickerstaff, 1997): 
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- Little if not none damage is given to the biological component of the composite 
system, 
- The technique is easy and cheap as well as the application procedure being fast. 
- Neither the enzymes nor the support materials properties are altered by chemical 
reactions. 
- Provided the appropriate buffer properties, binding is reversible so that the support 
can be reloaded with fresh enzymes. 
 
Possible disadvantages of the technique include (Smith, 1996; edited by Bickerstaff, 
1997): 
- Product contamination by leaked enzymes due to the weak nature of adsorption 
interactions, 
- Nonspecific binding (distinct from orientation), 
- Overloading of the support, 
- Negative effect on enzymatic activity due to steric hindrance, since the enzyme is 
directly stuck on the support. 
 
The most important problem among those is enzyme loss due to desorption. 
Desorption can occur due to several reasons such as pH, temperature, ionic strength, flow 
rate, bubble agitation, particle-caused abrasion and scouring on vessel walls, which are all 
under the topic of environmental circumstances within the reaction medium. These 
problems may be due to binding of substrate or contaminant in substrate, formed product or 
other conditions that cause changes in protein conformation and ionization status of 
exposed amino acids on the protein. 
In case the substrate, the product or any contaminants are charged, non-specific 
binding can be a problem. Non-specific binding can lead to diffusional and reaction 
kinetics problems. In addition, binding of protons (or acids or bases of different definitions) 
can result in alteration of pH microenvironment near the surface resulting in pH shifts of 1-
2 units. Enzymes having strict and narrow pH optima can be affected by the situation 
(edited by Bickerstaff, 1997). Overloading and absence of a spacer in adsorption can result 
in activity problems due to steric hindrance. 
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2.1.2.2 Covalent binding: 
 In this strategy, functional groups on the support and on the amino acids at the 
surface of the enzyme to be immobilized are covalently bound to each other. Commonly 
used surface functional groups of enzymes are amino (NH2) group of lysine or arginine, 
carboxyl (COOH) group of aspartic acid or glutamic acid, the hydroxyl (OH) group of 
serine or threonine, and the sulfydryl (SH) group of cysteine. Although many factors are 
worth consideration in support selection for covalent immobilization, hydrophilicity 
appears to be the most important property, increasing the popularity of polysaccharide 
polymers (e.g. cellulose, dextran, starch and agarose) (edited by Bickerstaff, 1997, edited 
by Mosbach, 1987). Due to the presence of hydroxyl residues on sugar groups, 
polysaccharides are suitable for surface activation by chemical reaction preparative to 
covalent bonding. Another advantage of the presence of hydroxyl groups is increased 
hydrophilicity. Hydroxyl groups interact with water molecules via hydrogen bonding, 
resulting in an aqueous microenvironment on/in the support. However, polysaccharide 
polymers are susceptible to bacterial/fungal attacks. Some alternative materials for use as 
supports are different types of porous silica and porous glass. Physical properties (e.g. pore 
size) of those different types are adjusted by optimizing conditions such as tempering 
parameters, burning or solving the contaminants that are introduced in production in order 
to obtain materials with desired characteristics. Most reactions involving the formation of 
covalent linkage between enzymes and supports can be categorized under the following 
main groups (edited by Bickerstaff, 1997; edited by Mosbach, 1987): 
1) Isourea linkage:  
Support EnzymeO C
NH
N
H  
2) Diazo linkage:  Support N N Enzyme  
3) Peptide bond:  
Support C
O
N
H
Enzyme
 
4) Alkylation reaction: 
Support
H
C
H
N
H
Enzyme
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Basically, covalent bonding is performed by a two-step process. In the first step, 
surface is activated by a specific reagent to form strongly electrophilic (electron-deficient) 
functional groups. In the binding reaction, preformed electrophilic groups readily react with 
nucleophilic (electron-donating) amino groups on the surface of the enzyme to form 
covalent bonds. In order to retain enzymatic activity, it is important to design a coupling 
that does not involve functional groups of aminoacids that are located at the active site and 
critical for biocatalysis.  
Using the possible activation reactions, a large number of polysaccharide derivatives 
such as AE-cellulose (aminoethyl: -C2H4-NH2), CM-cellulose (carboxymethyl: -CH2-
COOH), DEAE-cellulose (diethylaminoethyl: -C2H4-N-(C2H5)2) were developed and 
marketed for various applications (edited by Bickerstaff, 1997; edited by Jakoby et al., 
1974; edited by Mosbach, 1987).  
 
 The most important advantage of the technique is (Smith, 1996; edited by Bickerstaff, 
1997; edited by Mosbach, 1987): 
- The quality of linkage between biomolecule and surface is not affected by 
environmental conditions such as pH or ionic strength. 
 
The main disadvantages of covalent binding strategy are (Smith, 1996; edited by 
Bickerstaff, 1997; edited by Mosbach, 1987): 
- The technique may be destructive in terms of enzymatic activity since the functional 
groups of the enzyme are altered. 
- Should be very well designed in order not to alter functional groups at the active 
site. 
- Irreversibility of the immobilization strategy results in difficulty in replacement of 
exhausted enzyme with fresh enzyme. 
- Expensive, time consuming and risky when compared to adsorptive method. 
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2.1.2.3 Entrapment/Encapsulation: 
In this method of immobilization, enzymes are free in solution and their movement is 
only restricted by the presence of a surrounding network, differing this method from 
adsorption and covalent binding. The pore size of the network is optimized to a value that is 
large enough to allow free substrate and product movement but tight enough to prevent 
leakage of enzymes (edited by Mosbach, 1987). The major methods of entrapment are 
(edited by Bickerstaff, 1997): 
1) Ionotropic gelation of polyionic macromolecules with multivalent cations (e.g. 
alginate) 
2) Temperature induced gelation (e.g. agarose, gelatin) 
3) Organic polymerization by chemical/photochemical reaction (e.g. 
polyacrylamide) 
4) Precipitation from an immiscible solvent (e.g. polystyrene) 
 
Encapsulation is identical to entrapment except that the envelope surrounding the 
enzyme is also free in solution itself. Many materials such as nylon and cellulose nitrate are 
used to construct microcapsules around 10-100 µm in diameter. Use of biological structures 
such as liposomes and even cells as capsules are also reported. As an example where cells 
are used, erythrocytes are swollen in enzyme containing hypotonic solution allowing 
diffusion of enzymes into the erythrocyte, followed by transfer into hypertonic medium, 
thereby trapping enzymes in the cell (edited by Mosbach, 1987; edited by Bickerstaff, 
1997). 
In case of entrapment, the main advantages are (Smith, 1996): 
- The enzyme is not the target of a chemical modification (although it may be 
subjected to). 
- Enzyme is relatively free in motion when compared to adsorption and covalent 
binding. 
- Enzyme is kept away from microbial and proteolytic action (increased enzyme 
stability and half life) 
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While, the disadvantages are (Smith, 1996; edited by Bickerstaff, 1997; edited by 
Mosbach, 1987): 
- Diffusion of substrate to, and product from the active site; thus not effective for 
macromolecular substrates and products. In applications where microcapsules are 
used, this problem may even result in rupture of semipermeable membrane that 
forms the capsule. 
- Preparation is tedious and can result in enzyme inactivation depending on the 
entrapment technique employed. Extensive effort is needed for optimization of pore 
size necessary to allow diffusion of substrates and products but prevent leakage of 
enzymes. 
- Enzymes are kept away from microbial and proteolytic action (replacement of 
exhausted biocatalyst with fresh batch without disintegration of support is not 
feasible) 
- In case of ionotropic gelation, the presence of multivalent cations may affect 
activity of enzymes that are members of protein families using multivalent metal 
cations as cofactors. 
- In case of temperature driven gelation, the gels formed are mostly soft and unstable 
and this method introduces the possibility of enzyme inactivation due to incubation 
in variable temperature environment, which is necessary for gelation. 
- In case of organic (chemical/photochemical) polymerization, although they are not 
main targets of reaction, the enzymes are subject to treatments with harsh chemicals 
that are either highly reactive monomers or strong oxidizing/reducing agents for 
initiation of reaction by free radical formation. Such an exposure can result in 
inactivation of enzymes with considerable possibility. 
- In case of precipitation by phase separation, the enzymes are brought in contact 
with organic solvents. Mostly enzymes are not tolerant to such solvents resulting in 
enzyme inactivation. Thus, usage of this method is limited to highly stable or 
artificially stabilized enzymes. 
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2.1.2.4 Crosslinking: 
Crosslinking does not involve the use of a support of any kind. Instead, enzyme 
movement is restricted by binding enzymes to one another, resulting in a bulk cluster of 
enzymes that are not free in solution. Both chemical and physical methods can be used to 
achieve crosslinking (edited by Bickerstaff, 1997). 
Chemical crosslinking involves the use of bi- or multi-functional reagents such as 
glutaraldehyde and toluene diisocyanate forming a covalent linkage between enzymes 
(edited by Bickerstaff, 1997; edited by Mosbach, 1987). 
Physical crosslinking can be achieved by the use of flocculating agents that introduce 
tangling of macromolecules, meanwhile trapping the enzymes. Polyamines, 
polyethyleneimine, polystyrene sulfonates and various phosphates are reported to be 
successful flocculating agents (edited by Bickerstaff, 1997). 
 Chemical crosslinking is not generally selected as an immobilization strategy alone, 
but mildly used as a supportive tool for enhancement of enzyme retainment in 
entrapment/encapsulation procedures. Main disadvantages resulting in this limited use are 
(edited by Bickerstaff, 1997): 
- Enzymatic activity loss due to highly toxic reagents used in crosslinking strategy. 
- Severe diffusional limitations for the molecules at the core of the enzyme clot 
formed by crosslinking. 
- High levels of enzyme inactivation due to very restricted molecular movement of 
enzymes, which is essential for some enzymes where conformational transformation 
is needed for catalysis. 
- Poor mechanical stability as a result of absence of polymeric support. 
2.1.2.5 Site specific immobilization: 
 A major disadvantage of random immobilization techniques mentioned above is that 
the activity of the immobilized enzyme is often significantly decreased. Reasons for this 
decrease are mainly the blockage of active site, multiple-point binding causing limitations 
to the conformational flexibility of enzyme, or denaturation of the enzyme. These 
disadvantages can be overcome by  employing site-specific immobilization (Figure 2.2).  
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Figure 2. 2 (A) Random immobilization of enzymes. (B) Site-specific immobilization of 
enzymes where an enzyme coated surface with active sites properly oriented for access of 
substrates is achieved (Butterfield et al., 2001). 
 
Strategies employing tools of molecular biology may be used to engineer 
recombinant enzymes which can be oriented with easy access of the active site on surfaces.   
Three approaches to site-specific immobilization of enzymes are:  
a) Gene fusion to incorporate a peptide affinity tag at the N- or C-terminus of the 
enzyme. The enzymes are then attached from this affinity tag to anti-tag antibodies 
on membranes (Figure 2.3); 
 
 
Figure 2. 3 Site-specific immobilization of enzymes using fusion protein technology. The 
DNA sequence specific for the octapeptide FLAG (Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys) is 
added to the target enzyme at N- or C-terminus. After expression and purification, followed 
by addition of the complex to membrane, protein A with a high affinity for IgG antibodies, 
is immobilized. MAb specific to FLAG is added in turn. In the next step, dimethyl 
pimelimidate (DMP) is added to stabilize the anti-FLAG-protein A complex. Addition of 
the FLAG-enzyme fusion complex results in proper orientation of the enzyme with 
accessible active site (Butterfield et al., 2001). 
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b) Post-translational modification to incorporate a single biotin moiety on enzymes. 
Enzymes can be attached to membranes through a (strept)avidin bridge (Figure 
2.4); 
 
Figure 2. 4 Site-specific immobilization of enzymes (in this case -galactosidase) using 
recombinant DNA technology. A biotin ligase recognition sequence is added to the gene of 
target enzyme in the plasmid. Subsequent expression and purification of the enzyme 
containing a N-terminal domain biotin allows specific addition of this complex to 
(strept)avidin previously immobilized onto the membrane (Butterfield et al., 2001). 
 
c) Site-directed mutagenesis to introduce unique cysteines to enzymes: 
Enzymes are attached on thiol-reactive surfaces through the sulfhydryl group on the 
side chain of the introduced cysteine, which is located on the opposite side of the protein 
from the active site (Figure 2.5). 
 
 
Figure 2. 5 Site-specific immobilization of enzymes using site-directed mutagenesis. 
Addition of a cysteine amino acid opposite to the active site results in a functional group 
that is convenient for a subsequent binding reaction with the surface containing a SH 
functional group (Butterfield et al., 2001). 
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In all these methods, the active sites of the immobilized enzymes face away from the 
polymeric surface and resulting in higher activity (Butterfield et al., 2001). 
2.1.3 Applications of Immobilized Enzymes/Proteins/Cells: 
Although all immobilization practices were reviewed from an enzyme-centered 
perspective, above-mentioned strategies are applicable to any protein (e.g. antibodies, 
antigens) or whole-cells (production of biofilms) for applications involving (edited by Cass 
et al., 1998; edited by Mosbach, 1988, edited by Doyle, 1999): 
- synthesis,  
- biosensors,  
- biochips,  
- analysis,  
- diagnosis (like in enzyme based diagnostic kits such as ELISA),  
- arraying and orienting,  
- stabilisation,  
- binding,  
- signal transduction,  
- implant passivation and surface biocompatibilization,  
- surface activation,  
- separation/purification,  
- detoxification and scavenging. 
2.2 Recombinant Vector Construction: Ordering Cells What To Synthesize 
The discovery of standardized method for transformability of bacteria with 
nonchromosomal genetic information (Cohen et al., 1972) followed by convenient, 
successful insertion of target genes into those nonchromosomal information carriers  
plasmids  (Cohen et al. 1973) signaled the birth of recombinant DNA technology and the 
start of genetic engineering era (Lander et al., 2000, Singer, 2003). Since then, a large 
number of plasmids and even artificial chromosomes were constructed in vitro and used to 
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transfer genetic material in order to synthesize recombinant proteins. Plasmid families 
coming from same ancestors were obtained and new families were formed by novel 
combinations of preformed families. First recombinant plasmid mediated transformation 
involved the insertion of ampicillin resistance trait by DNA fragments from p1258 plasmid 
of S. aureus to pSC101 plasmid of E. coli and transformation of E. coli cells with the 
modified pSC101 (Chang et al., 1974). This impressive progress in genetics was followed 
by the successful insertion of a eukaryotic gene fragment from the African clawed toad 
Xenopus laevis into E. coli by using a plasmid construct which was the first eukaryotic-
prokaryotic chimaeric molecule (Morrow et al., 1974), having the name from a beast in 
Greek mythology, with a lion's head and foreparts, a goat's middle, a dragon's rear, and a 
tail in the form of a snake; an apparent hybrid of two or more creatures. After the initiation 
of the use of modified plasmids for gene insertion purposes, some essential properties  
such as recombinant selection  were introduced by modifying the vectors using restriction 
digestion and ligation protocols. Those new assignments started the trend of vector design 
and construction for gene cloning. During those studies the pBR322 plasmid, which is the 
ancestor of a great number of modern plasmids, was constructed by a total of 8 successive 
steps of restriction cut / ligation processes performed on preexisting and process-formed 
plasmids (Bolivar et al., 1977). This plasmid then led to the construction of series of 
modified plasmids, with the following improved functions (Primrose et al., 1994): 
- Vectors to facilitate expression of proteins, 
- Vectors for the identification of regulatory signals, 
- Vectors for the direct selection of recombinants, 
- Vectors with additional restriction sites, 
- Vectors with different, additional or improved selective markers, 
- Vectors with increased stability, 
- Vectors with altered copy numbers, 
- Plasmids for DNA sequencing, 
- Plasmids to permit secretion of proteins, 
- Gene fusion vectors to facilitate protein purification and increase stability of mRNA 
and/or protein of interest, 
- Vectors for use in both E. coli and unrelated organisms (shuttle vectors) 
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- Vector couples for investigation of protein-protein interactions by two-hybrid 
screening. 
The progress on construction of gene delivery and expression vectors continued with 
development of nonplasmid vectors such as (Primrose et al., 1994): 
- Phagemids (having phage and plasmid components) particularly for having single 
stranded DNA for easy dideoxy-sequencing, 
- Phage vectors and in vitro packaging into phages, for facile cDNA library 
construction, 
- Cosmids (having plasmid components and cos viral sequence enabling in vitro 
packaging of plasmids), for increasing the available accommodation for insert to 
32-47 kb, 
- Phasmids (having phage attachment site and plasmid components), especially for 
effectively infinite shelf life of vector and cleaner recombinant screening results 
when compared to bacterial colony selection, 
- Single stranded viral vectors (such as M13 vector), particularly useful for large 
insert accommodation, being continuous DNA source (host is not lysed as in 
phages, growth is retarded), easy dideoxy-sequencing of DNA of interest, being 
ideal for oligonucleotide directed mutagenesis and probe preparation practices. 
As a consequence of specialization in vector designs, gene therapy practices that uses 
even modified retroviruses (such as human immunodeficiency virus, HIV) as gene delivery 
agents have emerged (reviewed by Somia et al., 2000). 
Recombinant vectors are being designed and constructed not only for cloning and 
expression but also for specialty purposes such as easy purification, visual tagging by 
fusion and performing expression in different organisms. In addition to the research 
oriented uses of recombinant vectors, special-purpose vectors are continuously being 
constructed especially for biotechnology and healthcare industries. 
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2.3 Polyhistidine and Similar Affinity Tags: A Sticky Business 
As a result of developments in the fields of recombinant vector construction and 
specialty resin synthesis, a new approach emerged in chromatographic separation 
technology: the use of differences of affinities between molecules as a criterion for 
separation. In affinity chromatography, a molecule, known as ligand, which specifically 
binds to the protein of interest, is covalently attached to an inert and porous matrix (Voet et 
al., 1995). When an impure protein solution is passed through this chromatographic 
material, the desired protein binds to the immobilized ligand, whereas other substances are 
washed through the column with the buffer. The desired protein can then be recovered and 
purified by changing the elution conditions such that the protein is released from the 
chromatographic matrix. As a prerequisite for such a system for either separation or 
isolation of proteins, appropriate fusion vector / specialty resin couples had to be designed 
(e.g. streptavidin/biotin, glutathione-S-transferase/glutathione). Polyhistidine tags, FLAG-
tags, thioredoxin, protein A, maltose-binding protein and cellulose-binding domain can be 
listed as the examples of other most frequently used fusion tags (Dian et al., 2002). In most 
of those systems, since the resin also had biological molecules as ligands, the storing 
conditions are limited and the shelf life is relatively short.  
Within the context of affinity chromatography, a different approach called 
immobilized metal ion affinity chromatography (IMAC) was discovered by Everson and 
Parker in 1974, using the idea of employing immobilized chelating metal ions in order to 
purify metalloproteins (reviewed by Gaberc-Porekar et al., 2001). As with other forms of 
affinity chromatography, IMAC is used in cases where rapid and substantial purification of 
the product are necessary, although compared to other affinity separation technologies it 
cannot be classified as highly specific. However IMAC has the advantages of higher ligand 
stability (longer shelf life of resin material), high protein loading, mild elution conditions, 
simple regeneration and low cost, making the technique an advantageous method especially 
in large-scale purification procedures for industrial applications (reviewed by Gaberc-
Porekar et al., 2001) or a rapid first step of a multi-stepped high purity purification 
procedure. 
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The idea behind the most frequently used IMAC protocol, polyhistidine tag, came 
from the initial use in protein separations with naturally present, exposed histidine residues, 
which are primarily responsible for binding to immobilized metal ions (Figure 2.6.a). 
Improvement of the strategy was pioneered by the study of Hochuli et al. (1987-1988), 
involving recombinant proteins with engineered histidine affinity handles attached to the N- 
or C-terminus, especially in combination with the Ni(II)nitrilotriacetic acid NiNTA 
matrix, which selectively binds adjacent histidines via coordination bonding (Figure 2.6.b, 
2.6.c). Since numerous neighboring histidine residues are uncommon among naturally 
occurring proteins, such oligo-histidine affinity handles form the basis for high selectivity 
and efficiency, often providing a one-step isolation of proteins at over 90% purity 
(reviewed by Gaberc-Porekar et al., 2001). In fusion vector designs for this purpose, a 
specific enzymatic or chemical cleavage site is often positioned between the affinity tag 
and target protein so that the protein can be eventually cleaved off the tag and obtained in 
its native, unaltered form. This purification strategy has attracted the attention of 
biotechnology companies and a number of different resin/fusion vector couples together 
with anti-histidine tag antibodies (shown in Table 2.3 and Table 2.4) were designed and 
marketed. 
In polyhistidine involving purification systems, the affinity should be neither too 
strong (hard to elute under mild conditions) nor too weak (results in sample loss). Studies 
showed that optimum purification conditions are obtained in presence of 6-10 closely 
localized, but not necessarily adjacent (e.g. histidine affinity tag (HAT)) histidines. 
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Figure 2. 6 Schematic illustration of the protein binding to a metal-chelated affinity 
support. Binding of the target protein onto the IMAC matrix is achieved predominantly by: 
(a) multi-point attachment of native or engineered surface histidines; (b) or by histidine tag 
added to the N- or C-terminus of the protein (Figures taken from Gaberc-Porekar et al., 
2001). In figure (c), the possible interaction between neighboring residues in the 6xHis tag 
and Ni-NTA matrix is shown (Figures taken from Qiaexpress ®: Detection and Assay 
Handbook, 2001).  
  29
 
Table 2. 3 Taken from Gaberc-Porekar et al., 2001 
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Table 2. 4 Taken from Gaberc-Porekar et al., 2001 
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2.4 Green Fluorescent Protein as Location and Expression Reporter:  
A Bright Idea 
The green fluorescence of the light producing cells of the jellyfish Aequorea victoria 
under illumination with long-wave ultraviolet light was discovered by Davenport and Nicol 
in 1955. In 1962, Shimomura et al. reported the extraction of the protein responsible for 
this fluorescence. In 1971, the protein was isolated independently by Morin and Hastings. 
The interest in green fluorescent protein (GFP) has grown enormously after its gene was 
reported to be cloned and the protein was expressed by Prasher et al. in 1992 and Chalfie et 
al. in 1994 (edited by Chalfie et al., 1998). As a result of this growing interest, the number 
of scientific publications that have been published with the term GFP in their titles, 
abstracts or keywords increased from at least 500 (edited by Chalfie et al. 1998) to over 
6700 in 2003. The number increases to over 12200 with the addition of results coming from 
the search of articles having the term green fluorescent protein. 
 Since the discovery and cloning of 238 amino acids long wild type A. victoria GFP, 
researchers have gone a long way in understanding and modifying the properties and 
structure of GFP and assigned various uses to the protein. By using the opportunities given 
by modern molecular biology techniques, different GFP mutants with shifts in excitation 
and emission wavelengths (Figure 2.7), increase in fluorescence (Heim et al., 1995, 1996) 
or even humanized versions (Zolotukhin et al., 1996) were produced. Today, certain 
biotechnology companies are producing and marketing genes and proteins of GFP variants 
together with other fluorescent proteins for use in diverse applications from protein 
labeling, quantification (Casey, J.L. et al., 2000) and localization studies to revealing 
protein-protein interactions by fluorescence resonance energy transfer (Heim et al., 1996 
and the references therein). 
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Figure 2. 7 Fluorescence excitation and emission spectra of different GFP mutants. All 
spectra are normalized to a maximal value of 1. (Heim et al., 1996) 
 
2.4.1 Genetic, Physical, and Structural Characteristics of GFP 
In studies of GFP, mainly two source organisms were used and compared, one being 
A. victoria, the other Renilla reniformis (sea pansy) (edited by Chalfie et al., 1998). 
The greenish light emitted by A. victoria is due to the presence of two closely related 
proteins: aequorin (21 kDa) and GFP (27 kDa). Aequorin consists of a Ca2+ binding 
apoprotein (apoaequorin), coelenterazine (organic substrate) and molecular oxygen. In 
presence of Ca2+, coelenterazine is oxidized to coelenteramide resulting in the production of 
CO2 and emission of blue (max = 470 nm) light, where coelenteramide is the emitter center. 
In presence of GFP, due to radiationless energy transfer from the blue fluorescent protein to 
GFP, the wavelength of emitted light shifts from blue (max = 470 nm) to green (max = 508 
nm), identical to in vivo fluorescence of the animal. It is discovered that, GFP is not only a 
helper protein that shifts already occurring fluorescence to a longer wavelength, but also it 
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is a fluorescent protein that emits light at 508 nm wavelength independently from the 
presence of other molecules or ions. (Inouye, S. et al., 1994) 
First cloned A. victoria GFP comprised of 238 amino acids (Figure 2.8). Since then, a 
large number of mutants and fusion peptides of GFP having different amino acid 
compositions and chain lengths are produced by genetic engineering. 
 
Figure 2. 8 DNA and amino acid sequences from the first entirely cloned A. victoria cDNA 
(Gene bank accession number: M62653; Prasher, D.C. et al., 1992). pDraw32 software was 
used to properly present the gene and corresponding amino acid sequence. 
  
All naturally occuring GFPs (20 more GFPs are reported) are acidic, globular 
molecules with a molecular weight of about 27 kDa. A. victoria and recombinant GFPs that 
remain monomeric in dilute solutions being exceptions, GFP is reported to be stable non-
dissociable dimers unless denatured. A. victoria and R. reniformis GFPs and many of the 
mutants of recombinant wild type GFPs have reported isoelectric points between 4.5 and 
5.4 (edited by Chalfie et al., 1998; Narahari, C.R. et al., 2001; Inouye, S. et al., 1994). 
Although there are engineered mutant variants that have shifted values, native GFP has an 
excitation maximum around 395 nm, with a smaller absorbance peak at 475 nm, and an 
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emission maximum around 508 nm when excited at 395nm (Heim, R. et al., 1996; Inouye, 
S. et al., 1994). 
 One important property of GFP, which proves advantageous in applications where 
GFP is used as a reporter of gene expression, is its stability and robust nature against stress 
conditions of pH, heat and presence of denaturants (Philips, G.N.Jr., 1997, edited by 
Chalfie et al., 1998). This stability is thought to be due to its unique three-dimensional 
structure in which the chromophore color causing region of the molecule is in the center 
of a beta-can composed of eleven beta strands at the sides and capped with short loops and 
distorted alpha helices at both ends (Figure 2.9).  
 
 D 
 
Figure 2. 9 Three dimensional beta-can structure of GFP dimer is shown from different 
angles, colored by structural component criteria in A and B; colored by independent chain 
criteria in C. (Protein Data Bank entry: 1GFL [Yang et al., 1996] viewed by RasMol 
molecular renderer software). D shows the resonant forms of the fluorophore with nearby 
crucial amino acids His148, Gln94, and Arg96, and the acid Glu222. Interactions between 
fluorophore and amino acids are shown with dotted lines (Philips, G.N.Jr., 1997).  
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The three dimensional structure protects the chromophore so well that classical quenching 
agents such as acrylamide, halides and molecular oxygen have almost no effect on GFP 
fluorescence (Philips, G.N.Jr., 1997; edited by Chalfie et al., 1998). pH changes between 
pH 4.5 and pH 12 affect the fluorescence properties of GFP (edited by Chalfie et al., 1998). 
Figure 2.10 taken from a study investigating potential use of GFP as an intracellular pH 
indicator (Kneen et al., 1998), shows the pH dependence of some GFP mutants. It can be 
clearly seen that pH changes not only alter the fluorescence intensity but also affect its 
absorption spectrum.  
 
 
Figure 2. 10 pH-dependent spectral properties of GFPs.  (A) Fluorescence excitation and 
emission spectra of GFP-S65T (~20 mg/mL) at indicated pH. (B) Absorbance spectra of 
GFP-S65T (0.25 µg/mL). (C and D) Fluorescence spectra of GFP-Y66H and GFP-T203I as 
in A. (Kneen et al., 1998) 
  
Given the basic information on genetic, physical and structural properties of GFP, 
various applications are discussed in the following section. 
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2.4.2 Use of Green Fluorescent Protein Variants: 
Having the advantage of being autofluorescent (does not need a substrate or 
cofactor), wild type GFP and its mutation-derived variants with increased sensitivity and 
solubility designed and synthesized for in vivo studies are being used in a wide spectrum of 
applications in various model organisms (Chalfie et al., 1994). To name most important 
applications briefly: 
In prokaryotes: 
- Noninvasive, endogenous reporter for gene expression using fusion strategy, 
- Protein localization studies using fusion strategy, 
- Investigations of dynamic processes such as spore formation during bacterial 
development, 
- Tracking of bacteria in complex environments as in the example of bacteria-host 
interactions (reviewed by Naylor, 1999; edited by Chalfie et al., 1998). 
 
In yeast as simple models of eukaryotic organisms: 
- Reporter of gene expression by fusion strategy, within cell cycle of eukaryotes, 
- Tracking intracellular protein transport by using fusion strategy, 
- Investigation of functions related to compartmentalization within the cell (reviewed 
by Naylor, 1999; edited by Chalfie et al., 1998). 
 
In Caenorhabditis elegans, Drosophila, vertebrates, and Arabidopsis as models of 
higher eukaryotic organisms: 
- Reporter of gene delivery and expression by fusion strategy, 
- Following a marked cell population in time during embryologic development, 
- Tracking certain protein molecules (and indirectly their ligands) by fusion strategy 
and visualizing subcellular dynamics, 
- Quantitative analysis of proteins by fusion strategy coupled to flow cytometry, 
- Investigating single molecules and protein interactions by fluorescence resonance 
energy transfer, 
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- Analyzing effects of mutations or other alterations on protein localization by fusion 
strategy (Heim et al., 1996; reviewed by Naylor, 1999; edited by Chalfie et al., 
1998). 
 
In addition to mentioned uses, using site-directed mutagenesis, scientists and 
biotechnology companies develop GFP variants having significantly distinct emissions at 
various wavelengths (Heim et al., 1996). Differential labeling of protein (or indirectly 
protein-interacting) molecules with different color codes became possible with this 
improvement, which provided a visual alternative to yeast two-hybrid protein-protein 
interaction screening. 
Although the established uses of GFP are listed very briefly, the only limitation to the 
variety of applications is the imagination of the scientists, which results in a continuously 
growing number of uses of GFP in various in vivo and in vitro practices. 
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3. MATERIALS & METHODS 
3.1 Materials: 
The materials used in this project are listed below. 
3.1.1 Chemicals 
Chemicals that are used are listed in Appendix A. 
3.1.2 Molecular Biology Kits 
Molecular biology kits that are used for DNA isolation, gel extraction, DNA clean-
up/desalting and protein purification are listed in Appendix B. 
3.1.3 Biological Components (Cells, Plasmids, Oligonucleotides, Molecular Weight 
Markers, Enzymes And Enzyme Buffers) 
Plasmids, DNA and protein molecular weight markers, enzymes and enzyme buffer 
systems that are used for DNA modification (i.e. restriction digestion, ligation) and RNA 
removal are listed in Appendix C. Typical gel electrophoresis photographs carrying 
characteristic band information of molecular weight markers are also provided in Appendix 
C. Plasmid maps of utilized plasmids, pETM-11 (EMBL) and pGFPuv (Clontech) were 
given in Appendix F and Appendix G, respectively. 
3.1.4 Equipments 
Equipments that are used for overall laboratory experiments are listed in Appendix D. 
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3.1.5 Bacterial Strains 
E. coli bacterial strains XL1 Blue, BL21 (DE3) were kindly provided by European 
Molecular Biology Laboratories, Hamburg, Germany. 
3.1.6 Buffers and Solutions 
Standard buffers and solutions used in cloning and molecular manipulations were 
prepared according to the protocols in Sambrook, J. et al., 1989. 
3.1.6.1 Buffer for agarose gel electrophoresis 
1 X TAE (Tris-EDTA-Acetate) buffer was used for preparation of 1% agarose gel 
electrophoresis. 1% agarose gel was used throughout the project. TAE buffer was prepared 
according to the protocols in Sambrook, J. et al., 1989. DNA was visualized by including 
0.005% ethidium bromide in the gel during its preparation. 
3.1.6.2 Buffer for denaturing and urea polyacrylamide gel electrophoresis 
1 X TBE (Tris-Boric acid-Acetate) and 1X Tris-Glycine-SDS (sodium dodecyl 
sulfate) buffer was used for polyacrylamide gel electrophoresis. TBE buffer was prepared 
according to the protocols in Sambrook, J. et al., 1989. 
3.1.7 Culture Media 
Both solid and liquid culture media were used for growing bacteria. In growth media, 
0.1 mg/mL and 0.05 mg/mL antibiotic final concentrations were used for Ampicillin and 
Kanamycin respectively. 
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3.1.7.1 Liquid medium 
LB Broth from Sigma was used as liquid culture of bacteria. This mixture contains 
the tryptone, yeast extract, and sodium chloride mixed in appropriate amounts. 20 g of LB 
Broth was used for preparation of 1 L liquid medium. The liquid medium was autoclaved at 
121o C for 30 min. before using. 
3.1.7.2 Solid medium 
LB Agar from Sigma was used for preparation of solid medium for the growth of 
bacteria. This mixture contains the tryptone, yeast extract, sodium chloride, and agar, which 
are mixed in appropriate amounts. 40 g of LB Agar was used for preparation of 1 L solid 
medium. The appropriate amount of LB Agar is dissolved in correspondent amount 
deionized water for autoclaving at 121o C for 20 min. Autoclaved medium was poured to 
petri plates  (~20 mL/plate) after cooling down to a temperature at which it is still liquid.  
3.1.8 Sequencing 
Sequencing service was commercially provided by MWG-The Genomic Company, 
Germany. 
3.2 Methods 
All molecular biology protocols were applied according to Sambrook et al., 1989 
unless stated otherwise. Enzymatic reactions such as restriction digestion and ligation, and 
applications that were governed by using molecular biology kits were realized by accepting 
the supplier information as the base to our application. 
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3.2.1 Culture Growth  
Cells were grown overnight (12-16 hours) in LB Broth medium prior to any 
application. LB Agar (Millers LB agar) solid medium was used for the growth of bacteria 
on both selective and non-selective media.  
Liquid cultures were grown at 37oC using shaking incubator set to 300 rpm. 
Conventional molecular biology protocols for liquid and solid culture growth and 
other applications including competent cell preparation, transformation, glycerol stocks and 
various gel electrophoresis methods were performed according to procedures in Sambrook 
et al., 1989.  
3.2.2 Directional Cloning 
 Gene cloning steps given below are performed in accordance with protocols in 
Sambrook et al., 1989. Inserts were directly cloned into modified pETM-11 expression 
vector and pETM-Adp-Imm expression vector (pETM-11 derived novel plasmid construct) 
without using a sub-cloning vector. 
3.2.2.1 Restriction digestion 
pETM-11 (EMBL) (Appendix F) was digested with Nco I and Kpn I in order to 
remove MAD (multiple wavelength anomalous dispersion) coding fragment and as a 
preparation to ligation with frame adapter. Frame adapters were also digested with Nco I 
and Kpn I in preparation to ligation with MAD removed pETM-11. pGFPuv (Clontech) 
was in turn digested with Kpn I and Sac I in order to get GFPuv gene from the plasmid.  
All linearized plasmids were obtained by digestions in which the total volume of 
enzyme pairs in double digests was limited to 1/10 of total volume of digestion mixes as 
recommended in Sambrook, et al., 1989, in order to diminish inhibitory activity of glycerol 
in the enzyme solution.  
Sticky end generation at the ends of frame adapters was obtained by double 
digestions which were strictly optimized case specifically. The efficiency of digestion of 
frame adapters was checked by running samples of digested adapters in urea gel 
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electrophoresis with 20% polyacrylamide, 7 M urea concentration in the gel. Parallel-
performed digestions of frame adapters were collected and concentrated at the end of 
digestions. 
3.2.2.2 Gel extraction of linearized plasmids 
Since they largely affect ligation efficiency, small (digestion product) fragments and the 
remaining salts from restriction digestion reaction were removed by gel extraction using 
QIAquick® Gel Extraction Kit. 
3.2.2.3 Desalting of digested frame adapters 
Frame adapters could not be cleaned from unwanted terminal digestion products since both 
the adapters and terminal digests were very small and there was only a few bases length 
difference between them. Despite the failure in removal of terminal digests, salts remained 
from restriction digestion were successfully removed by using Micro-SpinTM G-25 Columns 
(Amersham Biosciences) two times for each sample successively. 
3.2.2.4 Ligation 
Fragments, which were digested to have sticky ends containing Kpn I, Nco I and Sac I 
recognition sequences, were ligated using T4 DNA Ligase (Promega) by incubating at 
room temperature overnight. In ligation reactions, series of vector/insert molar ratios were 
used in order to cover optimum ratio, which was described to be 1:3 (Sambrook et al, 
1989). 
3.2.2.5 Transformation 
Transformations were performed using heat shock protocol described in Sambrook et al., 
1989. Endonuclease deficient E. coli strains XL1-Blue and BL21-DE3 were used as targets 
of transformation. Transformed cells were plated on Luria agar with appropriate antibiotic, 
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which was selected according to the antibiotic marker gene on the transformed plasmids 
and grown overnight at 37oC.  
3.2.2.6 Colony selection 
Positive colonies were selected on appropriate antibiotic containing plates. Selected 
colonies were grown in Luria Broth liquid medium containing the selective antibiotic and 
glycerol stocks were prepared using the liquid cultures. 
3.2.2.7 Plasmid isolation 
Plasmid isolation was performed either with Qiagen-Qiaprep® Spin Miniprep Kit, or Qiagen 
Midi-prep Plasmid Purification Kit. 
3.2.2.8 Analysis of DNA from transformant colonies 
Isolated plasmids were cut with the restriction enzymes specific to the sites located at 
terminal positions of the insert of interest. Uncut and digested plasmids were analyzed by 
agarose gel electrophoresis for verification of the presence of insert within the plasmid. 
Appropriate DNA markers were used for size and concentration determination. In addition, 
concentration and OD260/280 ratio were monitored by absorption measurements. 
3.2.2.9 Frozen stock preparation of transformants 
Frozen stocks of bacteria containing different plasmids with GFPuv and GFPimm were 
prepared in 15% sterilized glycerol containing Luria Broth liquid medium with appropriate 
antibiotics and kept at - 80o C according to the protocol from Sambrook et al, 1989. 
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3.2.2.10 Sequence verification 
Qiagen-Qiaprep® Spin Miniprep Kit, or Qiagen Midi-prep Plasmid Purification Kit purified 
were sent to MWG-The Genomic Company, Germany for sequence analysis. Plasmids 
were also checked by restriction and electrophoretic analysis before sequencing.   
3.2.3 Expression of Target Genes 
Both GFPuv in pGFPuv (Clontech) plasmid and GFPimm in pETM-Adp-Imm plasmid 
were expressed according to the protocol from Sambrook et al., 1989. Different IPTG final 
concentrations were used ranging from 0.7 mM to 1mM for inducing recombinant protein 
expression. In expression series, samples were taken with pre-defined time intervals during 
cellular growth. Sample amount was standardized so that every sample contained same 
amount of cells necessary to give the OD600 absorbance value that was taken at the 
beginning of cellular growth, which was around 0.5 A. For storage and later analysis, cells 
were pelleted and frozen at 20 oC. Pellets were lysed and prepared for SDS-PAGE gel 
analysis according to the protocol from Sambrook et al., 1989. 10 µl of the samples were 
loaded on 5%-15% SDS-PAGE gels together with appropriate protein molecular weight 
marker. 
3.2.4 Purification of Proteins 
3.2.4.1 Purification of GFPuv 
BL-21(DE3) cells transformed with commercial pGFPuv plasmid were grown in 500 
mL liquid cultures (with Ampicillin) overnight at 37oC by shaking. Induction was 
performed using 0.7 mM IPTG as final concentration in liquid medium. Induced protein 
was purified using MonoQ Ion Exchange Chromatography Column (10/10) (Amersham 
Biosciences) installed on ÄKTA FPLC (Amersham Biosciences). Ion exchange buffer pair 
was 30 mM Tris-HCl, pH 7.5 and 30 mM Tris-HCl, pH 7.5 + 1 M NaCl. The gradient used 
for purification is given in Figure 3.1. Total cleared lysate was loaded on the column and 
1mL / min flow rate was used for all purification steps. 
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Figure 3. 1 Buffer gradient used for purification of GFP variants.  %B indicates the 
percentage of buffer with higher salt concentration. 
3.2.4.2 Purification of GFPimm 
BL-21(DE3) cells transformed with constructed pETM-GFP-Imm plasmid were 
grown in 500 mL liquid cultures (with Kanamycin) overnight at 37oC by shaking. Induction 
was performed using 0.7 mM IPTG as final concentration in liquid medium.  
GFPimm protein was isolated using two different methods alternatively during the 
progress of study. 
In the first method, his-tag based purification system component ProBondTM resin 
(Invitrogen) was used according to the protocols supplied by the company. The protocol 
was scaled up so that pellet from 500 mL (OD600: ~ 4A) liquid culture was resuspended in 
40 mL binding buffer and applied on 8 mL 50% ProBondTM resin suspension solution. The 
application was realized in batch type of binding reaction after the resin material is settled 
and packed to 4 mL, solution phase is discarded and washed as described in kit protocols. 
During purification, 1X ProBondTM Native Purification Buffer, pH: 8.0 (50 mM NaH2PO4, 
500 mM NaCl, pH adjusted with NaOH) was used for binding and washing steps while the 
buffer also contained 250 mM imidazole.  
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 In the second method, GFPimm was obtained exactly in the same protocol with 
GFPuv in terms of equipment, solutions and automated method file of FPLC software. 
3.2.4.3 Quantification of GFP variants in solution 
Both GFPuv and GFPimm were quantified relative to a 1 mg/mL rGFPuv protein 
standard (Clontech) by measuring OD280/260 (protein assay) and OD398 (characteristic 
absorption wavelength for GFP) with absorption spectrometry. Relative fluorescence 
values with fluorescence spectrometry and analysis of polyacrylamide gel electrophoresis 
results for serial dilutions were also carried out. 
3.2.5 Surface Binding Preparation 
GFP variants and polystyrene surface was prepared separately for the binding reaction. 
3.2.5.1 Preparation of GFPuv and GFPimm 
Both GFPuv and GFPimm were dialyzed against 0.5X ProBondTM Native Purification 
Buffer at pH 6.0, pH 7.0 and pH 8.0 (25mM NaH2PO4, 250 mM NaCl solutions, pH 
adjusted with NaOH) in order to reduce imidazole (applicable when ProBondTM resin is 
used for GFPimm purification) and excess Na+ ions which may interfere with surface 
binding reaction as competitive inhibitors of charge interaction. Dialysis was performed in 
1 L volumes with 3 changes, each session was at least four hours at 4oC. Dialyzed sample 
volumes ranged from 2 mL to 4 mL throughout the study. 
3.2.5.1.1 Removal of precipitate and requantification of solution phase GFP variants  
Dialyzed samples were transferred into 15 mL Falcon tubes and centrifuged at 2000g for 10 
minutes at 4oC. Supernatants were transferred into new 15 mL Falcon tubes and short-term 
stored in order to be used for the rest of the experiments. Supernatants were quantified 
using the procedure described in section 3.2.4.3. 
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3.2.5.2 Preparation of 96-well plate and characterization of surface modification 
Polystyrene 96-well plates were oxidized using 2M and 3M ammonium persulfate 
solutions. Oxidation setup was prepared by filling wells of plates with 300 µl 2M and 3M 
ammonium persulfate solutions, tightly covering the wells with the aid of parafilm and 
plate cover, applying pressure on the cap. Ammonium persulfate solution loaded plates 
were incubated at 70oC, 24 hours. The cap was pressed in order to prevent evaporation 
caused concentration alterations during incubation period. Preparation of 3M APS solution 
was realized at 45 oC water bath in order to achieve solubilization. Plates were rinsed 
several times with flushing warm water and dried at 70oC for 2 hours. 
 Surface modification was characterized by infrared spectrum analysis of pieces that 
were cut from bottoms of wells of modified plates. 
3.2.6 Surface Binding 
Concentrations of GFPuv and GFPimm solutions were adjusted by diluting GFPuv, 
expression of which is more efficient. Binding reactions were realized by constructing on-
plate matrices. Each surface-binding matrix was planned on 96-well plates so that rows and 
columns represent different GFP variants, different protein concentrations, different 
binding pHs and different plate modification strengths (APS molarities during surface 
modification). Binding was performed at appropriate pH values for each protein sample, 
being the same as pH of the dialysis solutions. During binding studies of GFP variants, 200 
µl concentration-standardized protein solutions were filled in the wells of modified 96 well 
plates and incubated for 2 hours at room temperature. After 2 hours, GFP solutions were 
replaced with the appropriate dialysis buffer at the binding pH of each well individually.  
Final replacement was done after careful and repeated rinsing using appropriate 
buffers having pH value of each wells binding reaction.  
3.2.7 Detection and Quantification of Binding 
Binding was detected and quantified by fluorescence measurements in both 
transparent and opaque (black) 96 well plates. Binding detection was supported by 
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observation of fluorescence in photographs of ultraviolet light transmitted transparent 
plates. Quantification of bound proteins was performed by using rGFPuv (Clontech) 
protein (1mg/mL) as concentration standard both in fluorescence spectrometry and SDS-
PAGE electrophoresis.  
3.2.8 Analysis 
The protein amount was estimated in solution by using OD280/260 absorption and 
fluorescence (398 nm excitation) measurements with respect to rGFPuv standard of known 
concentration. The mentioned estimations were confirmed by SDS-PAGE analysis by 
comparing the same standard. Quantification and analysis of surface-bound GFP was 
performed using fluorescence measurements, standardization of which was done by using 
above-indicated method using rGFPuv standard. The surface-bound-GFP fluorescence 
measurements were performed considering the parameters of GFP type, binding 
concentration, binding pH, measurement pH, measurement state (dry/wet), modification 
strength on polystyrene surface.  
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4. RESULTS 
4.1 Schematic Description of the Immobilization Specialty Plasmid:  
pETM-GFP-Imm 
Immobilization specialty plasmid  pETM-GFP-Imm  was constructed by a series of 
double digestion and ligation reactions. Manipulation of different vectors and resultant 
plasmids after these reactions are given in Figure 4.1. Sequences of vectors pETM-11 and 
pGFPuv are given in Appendix E together with the expected sequences of the vector 
constructs. 
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Figure 4. 1. Plasmid construction scheme showing two source plasmids (pETM-11 and 
pGFPuv), intermediate plasmid (pETM-Adp) and the final immobilization-specialty 
plasmid (pETM-GFP-Imm). 
  
Final plasmid was designed to be modular and upgradeable simply by digestions and 
ligations since each component of the plasmid (i.e. affinity tag, frame adapter, fluorescent 
reporter peptide, multiple cloning site) can be replaced or enhanced with alternatives such 
as different poly-aminoacid tags, fluorescent peptides and additional restriction enzyme 
recognition sites. In order to achieve the modularity and easy further modification, every 
component in the plasmid was inserted by conventional ligation reactions. 
  51
 Steps in construction of final plasmid pETM-GFP-Imm are discussed in the following 
sections. 
4.2 Digestion of pETM-11 and Frame Adapters in Preparation of Intermediate 
Plasmid Construction 
In order to construct a plasmid specialized for expression of immobilization-
facilitated recombinants, poly-histidine tag bearing expression vector  pETM-11 (EMBL) 
 was used as the main-body plasmid (plasmid map, nucleotide sequence of multiple 
cloning site and poly-histidine tag coding regions are given in Appendix F).  
pGFPuv (Clontech) was utilized as the source of GFP for the final immobilization 
specialty plasmid. In order to adjust the frame of GFPuv synchronous to the 5 located 
poly-histidine tag, double stranded frame adapter oligonucleotide was designed in-house 
and synthesized by SeqLab, Germany. 
4.2.1 Modification of pETM-11 in Preparation of Frame Adapter Insertion 
pETM-11 was purified from 250 mL liquid culture (OD600: ~4A) of carrier E. coli 
clones by using Qiagen Midi-prep Plasmid Purification Kit. The plasmid was quantified by 
absorption measurement at 260 nm. Based on the absorption measurement, ~15 µg plasmid 
was double digested with Kpn I and Nco I restriction enzymes in order to excise MAD 
gene, vacancy of which would be used for insertion of GFPuv gene. The quality of double 
digestion and plasmid purification were verified by agarose gel electrophoresis analysis. 
Electrophoresis results showed two major bands that corresponded to MAD-excised 
pETM-11 (~5352 bp*), and MAD gene (~677 bp*)(Figure 4.1.A). Following double 
digestion, linearized plasmid was gel extracted using QIAquick® Gel Extraction Kit (250). 
Gel extracted plasmid was checked for purity, and its concentration was estimated with 
respect to molecular weight marker using agarose gel electrophoresis (Figure 4.2.B). Map 
of linearized plasmid is given in Figure 4.3. 
                                                 
* Number of base pairs is given as approximate values (~) when there are single stranded restriction digestion 
products at the terminal regions of long DNA molecule. The values given are the number of nucleotides 
calculated in case single stranded regions are assumed as double stranded.   
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A   B  
Figure 4. 2 Electrophoretic analysis and preparative digestion of pETM-11 (A-II) and gel 
extracted (B-II) pETM-11 plasmid. Mass Ruler DNA LadderTM, High Range (Fermentas) 
was used as molecular weight marker (A-I, B-I). 
 
 
(MAD removed) 
 
Figure 4. 3. Map of Kpn I and Nco I linearized pETM-11. MAD gene was excised from 
pETM-11 by the mentioned double digestion. Arrows indicate the directions of open 
reading frames for the corresponding genes and colors indicate the GC content of local site 
(showing least GC% to most GC% with blue to red respectively). Map was constructed by 
plasmid drawing software pDraw32.  
 As verified by the gel electrophoretic analysis, MAD gene was properly excised from 
pETM-11 plasmid, leaving a linearized vector bearing Kpn I and Nco I sticky ends for 
subsequent ligation reaction with frame adapter having the same sticky ends. 
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4.2.2 Designing the double stranded frame adapters 
The product to be synthesized using specialty vector which will be properly 
expressed and have GFP and histidine as tags only if the GFP sequence is inserted in frame 
with the start codon of the polyhistidine sequence on pETM-11. This requires insertion of a 
frame adapter with correct number of nucleotides replacing the MAD gene. The 
replacement was achieved using sticky ends generated by removal of MAD gene. For using 
ligation as the strategy, frame adapter was also double digested with Kpn I and Nco I to 
generate the same sticky ends. 
The potential problems with digested oligonucleotides and proposed solutions were 
as follows: 
- Since the oligonucleotides were small targets for restriction enzymes, there was a 
risk of low digestion efficiency even in presence of correct restriction enzyme 
recognition sites. This situation was due to DNA modifying enzymes requirement 
for available space to sit on the DNA in order to perform its function. It is known 
that, to achieve high efficiency in oligonucleotide digestions, oligonucleotides 
should be designed with a number of extra nucleotides at the terminal positions and 
incubation periods should be extended. Although the number of necessary 
nucleotides varies with the restriction enzyme, generally 2-10 extra bases and 
around 20 hours of incubation are recommended (New England Biolabs Technical 
Literature, 2002). 5 extra nucleotides were added at each terminal position on the 
frame adapters in our adapter designs. 
- Digestion products included the fragment that would be inserted into the plasmid 
together with terminal digests. Since these terminal digests had the same sticky ends 
(one in each) they also had the potential to ligate with the plasmid, blocking the 
ligation of frame adapter by competitive inhibition. The wanted and unwanted 
fragments were so similar and both were so small in size that there was no effective 
way of separating them. Since very small amount of adapter was used, recovering 
the DNA from native polyacrylamide gel contained the risk of intolerable sample 
loss. Although the number of terminal digests would also increase with higher 
digestion efficiency, having as much double digested frame adapter as possible in 
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ligation was thought as a potential solution to this problem. Thus, digestion 
efficiency was strictly optimized to be around ideally near 100%. 
 
Three sets of frame adapters were synthesized throughout the project: 
 
Adp# 1) 5  GTACG CCATGG CATGTACT GGTACC TTGTG  3 (30 bp) 
3  CATGC GGTACC GTACATGA CCATGG AACAC  5  
Adp# 2) 5  GTACG CCATGG CATGACT GGTACC TTGTG  3 (29 bp) 
3  CATGC GGTACC GTACTGA CCATGG AACAC  5  
Adp# 3) 5  GTACG CCATGG GAGGCAC GGTACC TTGTG  3 (29 bp) 
3  CATGC GGTACC CTCCGTG CCATGG AACAC  5 
Normal font: Random nucleotide extensions, 
Underlined: Nco I recognition site 
Bold, italic: nucleotide additions to plasmid for frame adjustment,  
Bold, underlined: Kpn I recognition site 
 
First two adapters were defective either in the number of nucleotides (8 instead of 7, 
resulting frameshift) necessary to adjust the frame or due to accidental introduction of a 
premature stop codon (CATGACT) within the frame adapter. Yet, since all three frame 
adapters were optimized for double digestion, remarkable information was gained about the 
effect of non-recognition-site sequence specificity on restriction enzymes efficiency near 
the ends of oligonucleotides.  
4.2.2.1 Digestion of first frame adapter (Adp#1) 
In first double digestion attempts and single digestion controls with Kpn I and Nco I 
at 37oC for 3 hours, Nco I showed inefficient digestion with recommended buffer system 
Multi CoreTM (Promega) (Figure 4.4-A, B). In order to increase efficiency, Y+/TangoTM 
(Fermentas) buffer system was used alternatively by using Multi CoreTM used digestion 
mixes as controls (Figure 4.4-B). Since improvement cannot be achieved by changing the 
buffer system, longer incubation time (overnight) was applied. Finally, by using 
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Y+/TangoTM (Fermentas) buffer with overnight (18 hours) incubation, efficient double 
digestion was obtained. After successful digestion, restriction enzymes and salts in the 
reaction buffer were removed by application of the reaction mixture into Micro-SpinTM G-
25 Columns (Amersham Biosciences). The possibility of DNA loss due to column 
treatment was checked on urea gel by using untreated digestion mix as control (Figure 4.4-
C). Although some sample loss was observed, remaining DNA was decided to be sufficient 
for later experiments.  
A     B  C  
Figure 4. 4 Urea -PAGE analysis of optimization  of Adp#1 double digestion. In A, B and 
C, lane I shows undigested frame adapter. Upper, weaker bands in lanes I in all pictures 
correspond to nondenatured (double stranded) uncut adapter due to the high loading 
concentration. 
(A) Lane II: double digestion. Lanes III and IV: Kpn I and Nco I single digestions, 
respectively.  
(B) Lanes II and III: Kpn I and Nco I with Multi Core (Promega) buffer system, 
respectively. Lanes IV and V: Kpn I and Nco I with Y+/Tango, respectively. 
(C) Lanes II and III: double digests without and with  Micro-SpinTM G-25 Column 
(Amersham Biosciences) treatment, respectively, for removal of restriction enzymes 
and desalting of digestion mix. 
4.2.2.2 Digestion of second frame adapter (Adp#2) 
After realizing the presence of one extra nucleotide which sets incorrect frame for 
GFP expression, the second frame adapter was synthesized by removing one nucleotide 
from the frame adjusting region between the restriction enzyme recognition sites. This 
random removal accidentally led to the formation of a premature stop codon. Until the 
realization of the problem, previously optimized digestion conditions were applied to the 
second adapter and satisfactory results were obtained (Figure 4.5). It was also realized that 
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with the urea gel electrophoresis conditions applied, we were able to distinguish one base 
difference between first and second frame adapter designs (Figure 4.5-B: II-III) 
A   B  
Figure 4. 5 Effect of incubation time on digestion efficiency of Adp#2. Digestion products 
were analysed on Urea-PAGE. A) Results of double digestion of Adp#2. Lane I: undigested 
Adp#2. Lane II: after 4 hours of double digestion. B) Successful digestion after overnight 
(18 hours) incubation. Lane I: undigested Adp#2. Lane II: successfully double digested 
Adp#1. Lane III: successful double digestion of Adp#2. 
4.2.2.3 Design and digestion of third frame adapter (Adp#3) 
Third frame adapter was designed so that not only it adjusts the frame of GFP in 
synchrony with polyhistidine tag, but also connects them flexibly by encoding a freely 
rotating and bending joint peptide. In order to obtain a joint with relatively free motion 
(Voet et al. 1995), adapter was designed to code for glycine rich oligopeptide (GGA-GGC-
ACG: Gly-Gly-Thr). However, the change largely affected digestion efficiency in 
previously optimized conditions (Figure 4.6-A). 
The double digestion conditions were optimized de novo for the final frame adapter 
design. During this optimization, frame adapter and bovine serum albumin (BSA) 
concentrations used for digestion were changed (Figure 4.6-B). In accordance with the 
decreased frame adapter concentration, helper protein BSA concentration was increased 
in order to facilitate temporary binding of the enzymes on DNA for processivity. 
Optimizations revealed that double digestion of Adp#3 is more efficient in dilute 
solutions of the adapter. In order to obtain adequate digested adapter, larger reaction 
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C 
volumes were used with previously standardized amount of adapter. Double digested 
adapter was then concentrated by evaporating solution in speed vacuum and enzymes and 
salts were removed by treatment with Micro-SpinTM G-25 Columns (Amersham 
Biosciences). 
 A    B  
Figure 4. 6 Urea-PAGE analysis of optimization of double digestion of Adp#3.  In A and C, 
Lane I shows undigested frame adapter 
A) Unsatisfactory digestions with previously optimized conditions. Lane I: undigested 
Adp#3. Lane II: KpnI single digestion. Lane III unsatisfactory Nco I single digestion. Lane 
IV: unsatisfactory double digestion with the conditions optimized for preceding adapters. 
Lane V: control showing successfully double digested Adp#2.  
B) Lanes I and II: 0.025 and 0.05 nmols; respectively, of Adp#3 digested with Kpn I. Lanes 
III and IV: 0.025 and 0.05 nmols, respectively, of Adp#3 digested with Nco I. Lane V: 0.05 
nmol Adp#3 digested with doubled Nco I concentration. Lane VI: 0.025 nmol Adp#3 
double digested with Kpn I and Nco I. Lane VII: previous successful digestion as double 
digestion positive control. Lane VIII: 0.025 nmol undigested Adp#3 as negative control. 
The concentrations are calculated using loading volumes of the synthesized adapter 
concentrations, which are reported by Seqlab, Germany. 
C) Optimized conditions for Adp#3. Lane I: undigested Adp#3. Lanes II and III: Kpn I and 
Nco I digested, respectively. Lane IV: Concentrated, double digested sample. The sample is 
double-desalted using Micro-SpinTM G-25 Columns (Amersham Biosciences) after the 
concentration step. 
  58
4.3 Construction of Intermediate Plasmid: pETM-Adp 
pETM-Adp plasmid was constructed twice by using defective second frame adapter 
(Adp#2) and final correct adapter (Adp#3). Results of the correct adapter used experiments 
are presented in this thesis. 
pETM-11 was double digested with Kpn I and Sac I in preparation to ligation with 
Adp#3 (Figure 4.7-A). Gel extracted double digested plasmid was quantified with respect 
to Mass Ruler DNA LadderTM, High Range (Fermentas) molecular weight marker and 
estimated to be 100 ng/µl (Figure 4.7-B).  
   
A   B  
Figure 4. 7 Purification of double digested pETM-11. Lane I: Mass Ruler DNA LadderTM, 
High Range (Fermentas) in both pictures. A) 80 µl pETM-11 double digest (Kpn I, Nco I) 
was run on an agarose gel. B) Double digested pETM-11 was gel extracted and the purified 
fragment was checked and quantified on an agarose gel with respect to the molecular 
weight marker. 
 
In a few unsuccessful ligation attempts, concentrated frame adapter digestion mixes 
were used together with double digested pETM-11. It was later suspected that unsuccessful 
ligations might be due to volume reduction by evaporation resulting in increased salt 
concentration. As later discussed, that could not be removed by single desalting treatment 
with Micro-SpinTM G-25 Columns (Amersham Biosciences). Double digested frame adapter 
was then desalted twice by using Micro-SpinTM G-25 Columns (Amersham Biosciences). 
After double-desalting treatment, ligation was successfully achieved. Ligations were 
carried out in plasmid:insert ratio series as described in Methods section. Transformants 
were spread on Luria Agar plates with Kanamycin selection. After overnight incubation at 
37oC, colonies were picked and grown in 2 mL liquid cultures carrying 0.05 mg/mL 
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Kanamycin. Minipreps of transformed XL1-Blue colonies were checked by digesting with 
Kpn I and Nco I. Results were visualized by agarose gel electrophoresis (Figure 4.8). 
 
Figure 4. 8 Insertion of frame adapter was checked by digestion with Kpn I and Nco I. 
Lanes I and XIII: Mass Ruler DNA LadderTM, High Range (Fermentas) molecular weight 
marker. Lanes II and III: Uncut original pETM-11 and uncut isolated plasmid from colony 
#4. Lanes IV-XI: Kpn I and Nco I digested colonies #1 - #4 in pairs (i.e. Lanes IV, V: 
Col#1 Kpn I, Nco I linearized respectively). Lane XII: Kpn I linearized original pETM-11. 
 
Gel results were consistent with theoretical length of pETM-Adp, 5369 bp. The 
diagram of constructed plasmid is given in Figure 4.9. 
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Figure 4. 9 The map of intermediate plasmid construct pETM-Adp. Small box between Nco 
I and Kpn I recognition sites is the inserted frame adapter. Arrows indicate the directions of 
open reading frames for the corresponding genes and colors indicate the GC content of 
local site (showing least GC% to most GC% with blue to red respectively). Map was 
constructed by plasmid drawing software pDraw32. 
4.4 Construction of Immobilization Specialized Plasmid: pETM-GFP-Imm 
The plasmid designed to facilitate immobilization was constructed by inserting 
GFPuv gene into the intermediate plasmid pETM-Adp. 
pGFPuv and pETM-Adp plasmids were isolated using midi-prep plasmid isolation 
protocols from 250 mL liquid culture grown until OD600 value was ~ 4A. 
pETM-Adp construct was double digested with Kpn I and Sac I in order to generate 
sticky ends necessary for directional insertion of GFPuv gene (Figure 4.10-A, B). DNA 
amount of pETM-Adp was estimated to be around 100 ng/µl. GFPuv was excised from 
pGFPuv (Clontech) plasmid using the same restriction enzymes (Figure 4.10-C, D). 
Molecular weight marker based length analyses were consistent with theoretical values of 
double digestion-linearized pETM-Adp (~5362 bp) and excised GFPuv (~724 bp) 
fragments. 
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A  B  C   D  
Figure 4. 10 Preparation of pETM-Adp and GFPuv fragments for ligation. Lane II in A and 
B: Double digested and gel purified pETM-Adp, respectively. C-II and D-II: Double 
digested pGFPuv and gel purified GFPuv gene, respectively. Lanes A-I and B-I: Mass 
Ruler DNA Ladder, High Range (Fermentas). Lanes C-I and D-I: Mass Ruler DNA Ladder, 
Low Range (Fermentas). 
 
Ligations were carried out in plasmid:insert ratio series as described in Methods 
section. E. coli XL1-Blue cloning strain transformants were spread on Luria Agar plates 
with 0.05 mg/mL Kanamycin selective marker. E. coli BL-21 (DE3) expression strain 
transformants were also spread on Luria Agar with Kanamycin selective marker with the 
exception that half of the plate surface was pre-spread with 0.75 mM IPTG. After overnight 
incubation at 37 oC, colonies were picked and grown in 2 mL liquid cultures carrying 0.05 
mg/mL Kanamycin in preparation for plasmid isolation and screening the presence of insert 
by double digestion with Nco I and Sac I followed by agarose gel electrophoresis (4.11-C). 
Digestion pattern and fragment sizes were consistent with theoretical expectations with the 
exception of XL1-Blue colony #2 (Figure 4.11-C(IV)), which was excluded in the 
subsequent experiments. In addition, positive colonies were already identified in BL-21 
(DE3) spread colonies due to green fluorescence under UV illumination as a result of IPTG 
induced expression of inserted GFPuv gene (Figure 4.11-A). 
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A  B  
C  
Figure 4. 11 Verification of pETM-GFP-Imm construction by fluorescence under UV 
illumination. (A) shows the expression of GFP in transformants on Luria Agar + 
Kanamycin plate. Before inoculation, 0.75 mM IPTG was spread below the dashed line to 
promote GFPuv protein expression. (B) Pellets of bacterial colonies picked from the plate 
shown in A. Left and right tubes in each pair shows liquid cultures without and with IPTG 
respectively. The tube in the middle is the negative control pellet  which does not contain 
GFPuv gene and showing no fluorescence. (C) Electrophoretic analysis of screening 
results. Lanes I and IX: Mass Ruler DNA LadderTM, High Range and Low Range 
(Fermentas) molecular weight markers, respectively. Lanes III, IV and V: Plasmids isolated 
from three different XL1-Blue strain colonies. Lanes VI, VII and VIII: Plasmids isolated 
from three different BL-21 (DE3) strain colonies. Lane II: The unmodified pETM-Adp 
construct. 
 For further verification of the construct, isolated plasmid was sequenced (Seqlab, 
Göttingen) and the adapter and the insert were proved to be 100% identical to the designed 
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Adp#3 and the source GFPuv gene (Appendix H). The immobilization specialty plasmid 
pETM-GFP-Imm was thus constructed as a result of successful ligation and 
transformations, and frozen glycerol stocks were prepared as described in Methods section. 
Figure 4.12 shows the map of the constructed pETM-GFP-Imm plasmid.  
 
Figure 4. 12 The map of immobilization specialty plasmid: pETM-GFP-Imm. Blue 
restriction enzyme recognition sites belong to single cutter enzymes. Arrows indicate the 
directions of open reading frames for the corresponding genes and colors indicate the GC 
content of local site (showing least GC% to most GC% with blue to red respectively). The 
map was constructed by plasmid drawing software pDraw32. 
4.5 Expression and Large Scale Purification of GFP Variants, GFPuv and GFPimm 
BL-21 (DE3) strain colonies containing pGFPuv and pETM-GFP-imm plasmids were 
used for expression of GFPuv and GFPimm proteins, respectively. Expression was carried 
out as described in Methods section. 
 pETM-GFP-Imm containing BL-21(DE3) cells were induced with 0.7 mM IPTG 
together with untransformed BL-21(DE3) and uninduced pETM-GFP-Imm carrying BL-
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21(DE3) as negative controls of expression in terms of transformation and induction, 
respectively. Cells were harvested with sampling amounts as stated in Methods section. 
Time and IPTG concentration dependent expression was followed by analysis of cell lysate 
using PAGE. Presence of GFPimm protein was detected with pETM-GFP-Imm 
transformed uninduced and pETM-GFP-Imm transformed induced cells as shown in lanes 
A-VII, B-IV, B-VII and C-IV of SDS-PAGE analyses (Figure 4.13-A,B,C).  
  
A  B  C  
Figure 4. 13 SDS-PAGE analyses of expression of GFPimm protein. In A, B and C lanes I 
are loaded with Prestained Protein Molecular Weight Marker (Fermentas). A-II, III, IV: t = 
0 min.; A-V, VI, VII: t = 90 min.; B-II, III, IV: t = 180 min.; B-V, VI, VII: t = 240 min.; C-
II, III, IV: t = 990 min. samplings of untransformed, pETM-GFP-Imm transformed 
(uninduced), pETM-GFP-Imm transformed (0.7 mM IPTG induced) BL-21(DE3) E. coli 
colonies, respectively.  
  
Isolation of GFPimm protein was carried out using BL21(DE3) cells grown in 500 
mL LB liquid culture medium with kanamycin and 0.7 mM IPTG. GFPimm was isolated 
using ProBondTM resin (Ni2+-Agarose) (Invitrogen) following basically the protocols given 
with ProBondTM His-tag based protein purification kit. The only exception was that during 
scaling up, 40 mL 1X native buffer was used for resuspension of cells pelleted from 500 
mL liquid culture. Rest of the protocol was applied in accordance with the indicated scale-
up. 
 Figure 4.14-A shows UV illumination of the fractions collected during isolation of 
GFPimm protein using ProBondTM resin. In Figure 4.14-B and C, PAGE analyses of control 
samples taken at different stages of isolation and the isolated protein fractions can be seen, 
respectively. 1 mL fractions were collected during purification of GFPimm. UV 
illumination results showing that fractions V, VI and VII, eluted at 4  10 mL are enriched 
in GFPimm. The result is also confirmed by the SDS-PAGE analyses. First set of GFPimm 
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isolates precipitated during dialysis in preparation to surface binding, which is discussed 
later. 
  
A  
 
B  C  
Figure 4. 14 Analyses of results of GFP-Imm purification. (A) UV illumination of fractions 
collected during isolation of GFPimm protein together with purification buffer filled 
negative control tube. (B) and (C) SDS-PAGE Analysis of fractions and controls. Lanes I 
Prestained Protein MW Marker (Fermentas). (B) Lanes II and III samples taken from 
supernatant and pellet, respectively, after centrifugation of lysed cells. Lane IV the 
discarded buffer after the Ni2+ binding step of histidine tag. Lanes V-VIII wash steps where 
resin bound recombinant protein is cleared from contaminants. (C) Lanes II-IX 
electrophoretic analysis of protein in tubes IV-XI in A. 
 
GFPuv protein was expressed and isolated from ampicillin and 0.7 mM IPTG 
containing 500 mL liquid LB broth medium in parallel to GFPimm to be used as a control 
in surface binding studies. Protein isolation was carried out on a MonoQ (Amersham 
Pharmacia) column connected to an Akta-FPLC system, since GFPuv does not have the 
polyhistidine tag, which is the prerequisite for ProBondTM resin. 0.5 mL fractions were 
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collected during purification of GFPuv. Details of the isolation procedure are given in 
Methods section. Photographs of fractions, SDS-PAGE gel and absorption spectra of most 
concentrated fractions in GFPuv isolation are given in Figure 4.15-A, B, C, D. GFPuv 
expression and purification yielded five to ten times more GFP when compared to GFPimm 
in all isolation attempts. The possible reasons of this difference are mentioned in 
Discussion section. 
A  
B  
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Figure 4. 15 Analyses of results of GFPuv purification.  (A) UV illumination of fractions 
collected during isolation of GFPuv protein.  (B) and (C) SDS-PAGE Analysis of fractions. 
Lanes I: Prestained Protein MW Marker (Fermentas).  (B) Lanes II-IX: fractions X-XVII 
shown in A. (C) Lanes II-IX: fractions XVIII-XXV shown in A. (D) Absorption spectra of 
most concentrated fractions (fractions XI-XIX in A). 
4.6 Surface Binding 
As a preparation for surface binding studies GFPuv and GFPimm were standardized 
in terms of GFP concentration and buffer composition.  
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4.6.1 Preparation of GFPimm 
As the first step of binding preparation for GFPimm, 3 mL total volume was reached 
by combining fractions V  VII in Figure 4.14-A. 
Imidazole and excess Na+ ions coming from the elution buffer, which are potential 
competitive inhibitors of surface binding reaction, remain present in isolated GFPimm 
solution unless removed. GFPimm in 1X ProBondTM Native Purification Buffer, pH: 8.0 (50 
mM NaH2PO4, 500 mM NaCl, pH adjusted with NaOH) was divided into three and 
dialyzed against 0.1X ProBondTM Native Purification Buffer at pH 6.0, pH 7.0 and pH 8.0 
(5 mM NaH2PO4, 50 mM NaCl, pH adjusted with NaOH). Details of the dialysis step are 
given in Methods section. 
Dialysis resulted in sample loss by precipitation (Figure 4.16), thus after the first 
trial, newly isolated GFPimm and GFPuv samples were dialysed against 0.5X ProBondTM 
Native Purification Buffer at pH 6.0, pH 7.0 and pH 8.0 (25 mM NaH2PO4, 250 mM NaCl, 
pH adjusted with NaOH). 
 
Figure 4. 16 Figure shows the sample loss due to precipitation during dialysis. 
4.6.2 Preparation of GFPuv 
As the first step of binding preparation for GFPuv, 4 mL total volume was reached by 
combining fractions XII  XIX in Figure 4.15-A. 
GFPuv protein was also dialyzed against 0.5X ProBondTM Native Purification Buffer 
at pH 6.0, pH 7.0 and pH 8.0 in order to equalize binding parameters for GFPuv and 
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GFPimm even though the former does not have imidazole coming from the purification 
buffer. 
4.6.3 Modification of Polystyrene Surface in Preparation for Binding Reaction 
For binding studies, polystyrene 96-well plates were treated with 2 M and 3 M APS 
as described in Methods section, and characterized by FT-IR. By using the strong oxidizing 
agent, ammonium persulfate (APS), achievement of a heterogeneous pool of functional 
groups (containing carboxylic acids, alcohols and ketones on the surface of polystyrene 
material) was aimed. Fourier transform infrared (FT-IR) spectroscopy results revealed the 
presence of these groups in the surface-most 1µm layer of polystyrene material (Figure 
4.17). Details of the preparation of surface modification are given in Methods section. 
 
Figure 4. 17 FT-IR spectrum of unmodified, 2M and 3M APS modified polystyrene 
samples. Black, blue and red lines represent unmodified, 2M and 3M APS modified 
polystyrene samples respectively. The functional groups and the regions that corresponds to 
them are shown in the legend at the lower left corner. X-axis and y-axis show wavenumber 
(cm-1) and transmittance ratio (over 1.0 perfect transmittance), respectively. 
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4.6.4 Surface Binding 
Since first large scale GFPimm isolates were lost due to unwanted precipitation 
during dialysis, a second isolation was carried out. SDS-PAGE analysis of the most 
concentrated GFPimm fractions of the second isolation are given in Figure 4.18-A. After 
dialyzing both GFPuv and GFPimm as stated in Methods, amount and purity of previously 
isolated GFPuv was compared to that of isolated GFPimm by running GFPimm on SDS-
PAGE gel together with different dilutions of GFPuv (Figure 4.18-B). The absorption 
values at the characteristic wavelength of GFP, which is 398 nm, were taken into 
consideration while comparing concentrations of GFPuv and GFPimm. Based on the fact 
that concentration is directly proportional to absorbance at the molecule-specific absorption 
wavelength, GFPuv was estimated to be three times concentrated in comparison to 
GFPimm. 
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A  B  
C  
Figure 4. 18 Analysis of GFPimm fractions and GFPimm-GFPuv equalization check. Lane 
I: Protein Molecular Weight Marker (Fermentas) in both A and B. (A) Lanes II-VII: 
GFPimm fractions. (B) Lane II: combined and dialyzed GFPimm fractions. Lanes III, IV 
and V: GFPuv in ratios of 3:1, 2:1 and 1:1 (v:v) when compared to GFPimm loaded on lane 
II. (C) Absorption spectra of GFPuv (green) and GFPimm (red). Absorption measurements 
were carried out at 398 nm, the characteristic wavelength for GFP. 
 
 Based on the comparison of absorption measurements of GFPuv and GFPimm, 
GFPuv was loaded three times diluted and GFPimm was applied undiluted into the wells of 
modified 96 well plate for binding studies. After incubating the plate with protein solutions 
for 2 hours, wells were emptied and rinsed repeatedly with appropriate buffers as indicated 
in Methods section. Chemical (APS) and biological (GFP) modification scheme for the 96 
well plate and legends for color codes used in the scheme are given in Figure 4.19-A. After 
rinsing, UV transmitted photographs of plates were taken with and without buffer in the 
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wells where binding had occurred (Figure 4.19-B and C). Similarly fluorescence 
measurements were carried out on dry and 100 µl appropriate buffer filled plates. Results of 
fluorescence measurements on dry and buffer filled wells are given in Figure 4.19-D, E as 
histograms, while actual values are supplied in Appendix I. Histograms given in Figure 
4.19-D, E show a summary of fluorescence measurements from dry and 100 µl appropriate 
buffer filled wells respectively. It can be seen that GFPimm binds to the modified 
polystyrene with higher efficiency in comparison to binding of GFPuv. The results also 
show that modification efficiency of 3M APS is higher than that of 2M APS. Fluorescence 
measurements of wells filled with buffer (Figure 4.19-E) still yield higher values for 
GFPimm, however, the difference between binding efficiencies of GFP variants was 
measured to be less. The reason for the inconsistency between dry and wet measurements 
may be optical phenomena affecting beam path and detected intensity due to 
presence/absence of buffer and shape of meniscus it formed within the well as a result of 
altered hydrophilicity of the wells after APS treatment. 
In the histograms and Appendix I, measurements from a column of unmodified wells 
adjacent to the modified ones are also included. These reflect the level of noise coming 
from neighboring GFP-bound wells of the transparent plate. Such high level of background 
prompted the use of black 96-well plates in further experiments.  
  
A   
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Figure 4. 19 (A) Modification scheme mapping the 96 well plate in terms of chemical and 
biological modification. Legends and color codes are indicated in order to display the 
nature of modifications in each well. (B) and (C) Photographs of UV transmitted dry and 
100 µl appropriate buffer (for each well) filled plates respectively. (D) and (E) 
Measurement of fluorescence from GFP bound 96 well dry and 100 µl appropriate buffer 
(for each well) filled plates. One additional (empty) column was included in D and E to 
reveal the effect of neighboring well on fluorescence measurement. 
 
4.6.4.1 Repeating the surface binding experiment using black 96-well plates 
Since scattering from adjacent cells seemed to affect fluorescence measurements in 
transparent polystyrene 96 well plates, black polystyrene 96 well plates were used instead, 
in a second surface binding experiment. Black 96 well plates were modified with APS as 
previously stated and nature of modification was checked using FT-IR spectroscopy 
(Figure 4.20). 
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Figure 4. 20 FT-IR spectrum of black polystyrene 96 well plates. Black PS plates were 
modified using 2 M and 3 M APS solutions and showed the same pattern with previously 
modified transparent plates. Black, blue and red lines represent unmodified, 2 M and 3 M 
APS modified samples. X-axis and y-axis show wavenumber (cm-1) and transmittance ratio 
(over 1.0 perfect transmittance), respectively. 
  
 Expression of GFPuv and GFPimm was performed once again in order to prepare 
samples for black 96-well plate binding measurements. For this set of GFPuv and GFPimm 
isolations, protocols given in Methods section 3.2.4.1 are applied for both GFP variants. 
Elution profiles of GFPuv and GFPimm are given in Figure 4.21-A, B. Both GFP variants 
showed similar elution properties but GFPimm separation was not as successful as GFPuv 
as seen in peak separations in Figure 4.21-A, B. By combining the fractions with highest 
GFP concentration, a total of 4 mL of both GFPuv and GFPimm protein solutions were 
pooled and dialysed against 0.5X Probond Native Purification Buffer as described in 
Methods section. 
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A  
B  
Figure 4. 21 Elution profiles of GFP variants from the Mono Q column. UV absorption at 
280 nm (blue) and percentage gradient for buffer pairs (green,100% Buffer A to 100% 
Buffer B from left to right), during elution are shown. Both GFPuv and GFPimm were 
eluted the peaks between 90 and 120 minutes on the profiles. (A) Elution profile of GFPuv. 
(B) Elution profile of GFPimm.  
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Before binding studies, dilutions of rGFPuv protein (Clontech), which was purchased 
as a standard, were applied to an unmodified plate in order to find the correlation between 
the GFP concentration and the relative fluorescence intensity measurement. Figure 4.22-A 
shows fluorescence intensity measurement results of dilutions of rGFPuv protein. 1/100 
dilutions at pH 6, 7 and 8 were compared to the theoretical values based on the 
fluorescence of 1/20 diluted rGFPuv protein. 1/20 diluted sample loaded well contained 10 
µg rGFPuv while 1/100 diluted sample loaded well contained 2 µg of the protein. 
Fluorescence of isolated GFPuv and GFPimm proteins were also measured and values for 
serial dilutions of isolated GFPuv and GFPimm proteins are given in Figure 4.22-B. The 
measurements were found to be meaningful at 0.005x and 0.0005x dilutions region by 
comparing with expected values calculated using the applied dilution factors. Fluorescence 
values measured in this region were considered within the linear range of concentration
fluorescence correlation while very low intensity measurements at higher dilution factors 
were found to be within the noise level. The inconsistency between fluorescence values of 
0.05x and 0.005x diluted GFP samples may be due to the potentially lower pipetting 
accuracy as a result of significantly high viscosity of concentrated protein solutions.  
In order to complement estimates on the GFPuv/GFPimm concentration ratio, 
absorption measurements were also performed in parallel to fluorescence spectroscopy. For 
these samples absorption values for GFPuv and GFPimm at characteristic wavelength of 
GFP (398 nm) were measured to be 1.850 and 0.470, respectively. Thus, their 
concentration ratio was calculated to be approximately 4, which was consistent with 
fluorescence intensity ratios of 0.005x diluted GFPuv and GFPimm (~ 5) given in Figure 
4.22-B. Standardization of GFPuv and GFPimm amounts (with respect to rGFPuv standard) 
in preparation of surface loading, concentrations were thus estimated using absorption, 
fluorescence measurements and SDS-PAGE results (Figure 4.22-B, C, D). As mentioned in 
in detail in the Discussion section, by quantification of GFP variants with two independent 
methods, it was also shown that the fluorescence yield of GFPimm was unaltered by the 
addition of poly-histidine tag. This standardization was done with the assumption that 
surface bound GFP variants have the same fluorescence characteristics with rGFPuv in 
solution, which is also discussed in the Discussion section. Based on the measurements of 
fluorescence intensity of dilutions of rGFPuv standard and 0.005x diluted purified proteins, 
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purified GFPuv and GFPimm were used at around 400 ng/µl and 40-50 ng/µl, respectively. 
According to the estimated ratio of GFPuv and GFPimm, same amount of GFP was loaded 
in wells by 5 times diluting GFPuv. 
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C  D  
Figure 4. 22 (A) Histogram showing fluorescence values for rGFPuv standard protein. 1/20 
dilution well: 10 µg. 1/100 dilution wells: 2 µg of rGFPuv standard. (B) Histogram 
showing fluorescence values for serial dilutions of isolated GFPuv and GFPimm proteins 
starting from 20x diluted and ending at 2000000x diluted from right to left. (C) SDS-PAGE 
analysis of isolated GFPuv protein for checking the purity and quantification. Lanes IV, V 
and VI: 1, 3 and 5 µl (2x diluted) isolates loaded on the gel. (D) SDS-PAGE analysis of 
isolated GFPimm protein for checking the purity and quantification.  Lanes IV, V, VI and 
VII: 3, 5, 7 and 9 µl (2x diluted) isolates loaded on the gel. Lane I: Protein MW Marker 
(Fermentas) in C and D. Lanes II and III were loaded with 500 ng and 1µg rGFPuv protein 
in both gels shown in C and D. 
  
After equalizing the amount of GFPuv and GFPimm by diluting the former, binding 
reactions were carried out using the modified black 96 well plate according to the 
configuration given in Figure 4.23-A. GFP loaded plates were incubated at room 
temperature for 2 hours. After 2 hours, fluorescence values were measured from both dry 
and 200 µl appropriate buffer filled 96 well plates (Figure 4.23- B, C, D, E, F, G).  
In order to check the possibility to have different fluorescence values with same 
amount of GFP due to different pH values, the buffer in wells of plate was replaced with 
pH 7 buffer solution and the plate was incubated at 4 oC, overnight. Bound GFP 
fluorescence was re-measured after pH 7 buffer treatment with 200 µl pH 7 buffer loaded in 
the wells. Fluorescence results of the whole plate at individual binding pHs and pH 7 are 
given in Figure 4.24-A, B, respectively. All fluorescence intensity measurements presented 
in Figures 4.22, 4.23 and 4.24 are given as tables in Appendix I. 
 The most meaningful data set was obtained with 2x diluted GFPimm and the 
equivalent GFPuv, which showed a higher binding of GFPimm at all pH values (the highest 
being at pH 7) and an increasing binding trend from unmodified to 3M modified wells. In 
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all measurements, samples with highest dilution factor gave too small fluorescence 
intensity values that were within the noise range and thus could not be meaningfully 
interpreted. The figures clearly indicate the difference in binding efficiencies of GFPimm 
and GFPuv. In general, the highest differential binding occurs at pH 7 while GFPuv seemed 
to have equal or higher binding efficiency at pH 8 in some of the measurements. Further 
comments on some unexpected results are included in Discussion section. 
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Figure 4. 23 (A) 96 well plate modification and loading configuration is mapped and given 
with color codes used in the map. (B)-(G) Fluorescence measurements are given in 
diagrams. B, C, D, E, F and G shows 2x diluted (dry), 2x diluted (appropriate buffer filled); 
20x diluted (dry), 20x diluted (appropriate buffer filled); 200x diluted (dry), 200x diluted 
(appropriate buffer filled) GFP loads, respectively. Numerical values of the measurements 
are given in Appendix I.
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Figure 4. 24 A and B shows measurements of all modified wells together, performed at binding pH and at pH 7 (after overnight pH 7 
treatment) respectively. C summarizes the effect of binding pH, loading concentration and strength of surface modification in one 
histogram by showing GFPimm/GFPuv binding ratios. 
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5. DISCUSSION 
As described in the introduction, the immobilization system is composed of a 
modular and flexible recombinant vector and a modified surface. On the way to the 
construction of components of the system, some instructive difficulties were experienced. 
The inferences from each step of construction of the system are compiled in this section. 
5.1 Adapter Design and Preparation 
Although last one of the three frame adapters was used for construction of pETM-
Adp, three adapters were designed throughout the study (described in 4.1.2). Since all three 
adapters were optimized for double digestion with Nco I and Kpn I, important observations 
were made on mechanisms of action of the restriction enzymes. 
As recommended in technical reports of restriction enzyme suppliers, 5 bp length 
extensions after restriction enzyme recognition sites were introduced into the frame 
adapters design. However, since two restriction enzyme recognition sites were only 8 and 
7 bases away from each other (in Adp#1 and Adp#2/Adp#3, respectively), in addition to 
the extensions, incubation time was also increased from 4 hours to overnight (16-18 hours). 
Since there was one nucleotide difference between Adp#1 and Adp#2, the 
optimization conditions set for the former also worked with the latter (Figures 4.4, 4.5). 
The third frame adapter was designed de novo changing all the sequence written for 
Adp#1 and Adp#2. In this design, the adapter was constructed so that it will code a highly 
flexible (Voet et al., 1995), glycine-rich joint between attachment site and fluorescent 
reporter in order to achieve kinetics similar to solution phase when bound on the surface. 
Although the length of Adp#3 was equal to Adp#2, the digestion efficiency decreased 
significantly due to the changed sequence between the two restriction enzyme recognition 
sites as explained in Results section (4.2.2.3). The reason for the decrease in efficiency is 
thought to be as a result of higher GC content of middle part of Adp#3 (5/7: 71.4%) when 
compared to Adp#2 (3/7: 42.9%). Considering the general reaction mechanisms of type II 
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restriction enzymes (Voet et al., 1995; reviewed by Perona, 2002), it can be speculated that 
the local stability increase due to significantly higher GC content may prevent (or make 
difficult) the bending of DNA by the enzyme. A possibility may be the physical 
displacement of the enzyme during its bending action. Stress formed on the enzyme during 
the resistance of local site to bending may result in the displacement from the binding site 
in accordance with the mechanical equality of acting and reacting forces.  
The double digestion reaction was re-optimized to achieve high efficiency digestion. 
Together with long incubation times, BSA concentration was also increased. BSA is 
thought to increase enzymatic activity by interacting with both DNA and proteins, thus 
changing the kinetics from intermolecular to intramolecular reaction by bringing the 
enzyme and substrate in closer proximity than they are in solution. In order to increase 
enzyme processivity and stability on DNA, excess (50% higher than recommended 
concentration) BSA was used to act as molecular glue bringing DNA and the enzyme 
together. Lower DNA concentration, higher BSA concentration and longer incubation time 
resulted in an efficiency approaching 100% in double digestion. Since DNA was diluted in 
optimized reactions, high volumes of digestion mixes were concentrated after the reaction 
was completed and results were monitored by Urea-PAGE (Figure 4.6). 
It was important to have digestion efficiency close to 100% since we were not able to 
isolate double digested frame adapter from the terminal (unwanted) digests which had the 
potential to interfere with the ligation reaction in construction of pETM-Adp. The problem 
is mentioned in more details in Results section (4.2.2). 
It was seen that by using Urea-PAGE (20%) gels 1 nucleotide base difference in 
length of the fragments could be detected, however since the fragment of interest was very 
small, there was diffusional loss of the fragment from the gel during staining with ethidium 
bromide containing solution. To avoid the loss of double digested frame adapter for better 
quantification of the adapter with respect to fragments of known concentration staining 
time was decreased while ethidium bromide concentration of staining solution was 
increased. As a result, the fragment concentration and purity were estimated using Urea-
PAGE results. Amount estimation was performed by Urea-PAGE analysis instead of 
absorption measurements due to the small sample volume and its low concentration (Figure 
4.6). 
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5.2 Construction of pETM-Adp and pETM-GFP-Imm 
During construction of pETM-Adp by joining Adp#3 and the modified pETM-11, 
ligation problems were experienced. Since T4 DNA ligase activity is reported to be very 
sensitive to salt concentration, the source of the problems were likely to be salts remaining 
from the restriction digestion buffer. The problem is thought to be magnified as a result of 
concentrating the large volume (dilute DNA containing) digestion mixes to have sufficient 
amount of digested frame adapter for ligation since salts of the buffer are also concentrated. 
For desalting process, the digestion mixes of Adp#1 and Adp#2 were passed through 
Micro-SpinTM G-25 Columns (Amersham Biosciences). Since Adp#3 digestion mix was 
concentrated after the reaction, it was passed twice through the mentioned column in order 
to desalt the solution. The first ligation after the double-desalting process resulted in 27 
transformant colonies. 
During vector constructions, attention was paid not to change distances between 
functional elements of the backbone plasmid since relative positions of signal sequences 
and genes on the vector are important in gene expression efficiencies (Primrose et al., 
1994). As a result, final plasmid pETM-GFP-Imm was designed to have the same relative 
positions of fusion genes with original pETM-11 plasmid with the only exception of GFP 
gene being exactly in place of excised MAD gene (Figure 4.12). 
5.3 Expression, Purification and Quantification of GFP 
During expression of GFP variants, significant difference was observed between the 
expression levels of GFPuv and GFPimm. The reason of this difference is thought to be the 
local abundance of histidine coding sequence in poly-histidine tag in a substrate 
concentration dependent manner similar to the ribosome stalling example in attenuation 
in tryptophan operon (Klug et al., 1997). The copy numbers of vectors and the relative 
positions of promoters with respect to GFP may also be the reason for the difference in the 
level of expression of the two proteins. 
In GFP expression attempts, it was seen that the expression level was largely 
dependent on aeration. There was significant difference (visually detectable in terms of 
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fluorescence) in expression levels between the same volume of cultures grown in 500 mL 
and 1000 mL flasks. 
In the second set of purification of GFP variants, which is performed for binding to 
black 96-well plates, GFPuv and GFPimm showed similar elution behavior in ion exchange 
column although their ionic properties are very different due to the poly-histidine tag. The 
reason for this unexpected similarity is the usage of anion exchange column instead of 
cation exchange while GFPimm is rich in positive charges. The expression and purification 
steps are not strictly optimized since our focus was mainly on surface binding reaction and 
detection of its efficiency under the influence of a number of parameters discussed in 
section 5.4.  
Fluorescence intensity and absorbance measurements as well as SDS-PAGE results 
were used to complement one another to obtain reliable results for quantification of the two 
GFP variants. Since GFPimm was suspected to have altered fluorescence yield when 
compared to GFPuv, concentration ratios obtained by absorption and fluorescence 
measurements were compared. The concentration ratio of GFPuv and GFPimm gave 
similar results in both techniques, verifying that the fluorescence characteristic of GFPuv 
was retained after the addition of poly-histidine tag.  
In our experiments rGFPuv in solution was assumed to have the same fluorescence 
characteristics with the surface bound GFP variants. This assumption was based on the 
position of GFP fluorophore, which is in the core of the protein, away from the surface 
interactions. 
In addition to quantification of GFP variants, the purity of preparations was also 
monitored by SDS-PAGE analysis (Figures 4.15, 4.18). In purifications of GFPimm, two 
different methods, poly-histidine tag based Ni2+ column and standard ion exchange 
chromatography were used. GFPimm could not be isolated with high degree of 
homogeneity with either method. Since in the second method GFPuv and GFPimm were 
purified under exactly the same conditions, it appears that GFPimm elutes either as homo- 
or hetero-complexes due to intermolecular interactions in the solution. A similar result is 
obtained by SDS-PAGE analysis where samples are incubated at 95oC in presence of 2-
mercaptoethanol. Here a series of high molecular weight bands which may be GFPimm 
homo-complexes or impurities were visualised. This result complicated the use of 
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electrophoretic analysis in quantification, thus fluorescence measurement was used as 
alternative quantification method (Figure 4.22). Another possibility may be the interaction 
of the relatively reactive charged tag with a number of proteins in the cell lysate so that 
they are eluted together from the column. In any case, seemingly lower level of purity of 
GFPimm was not considered as a problem in comparing surface binding of GFPuv and 
GFPimm, since this would not cause an artifact that would work in favor of GFPimm. 
Thus, GFPimm was assumed to be either disadvantageous or equal to GFPuv, which did 
not cause problem in evaluation of our system. 
Another possible effect of poly-histidine tag is activity alterations in recombinant 
enzymes due to the localized charge density of the tag. Since the tag forms an unusually 
reactive site on the protein it is fused, it may alter the three-dimensional conformation (thus 
activity in the case of enzymes) reacting with the protein to which it is tagged. Separation 
of highly charged tag and the enzyme of interest (which is cloned into the multiple cloning 
site of pETM-GFP-Imm for immobilization) by a linker such as adapter coded joint and 
GFP is assumed to protect the enzyme from intermolecular poly-histidine tag effect on 
activity. GFP is thought to be resistant to attacks by poly-histidine tag since the fluorophore 
is located in the core of the protein with poor accessibility, as in the assumption argument 
of retaining fluorescence characteristics after binding to surfaces given above.  
5.4 Surface Preparation and Binding 
In the first round of surface modification experiments, transparent, polystyrene 96-
well plates were used. In the fluorescence measurements of GFP bound transparent plates, 
significant fluorescence was observed in the biologically unmodified (treated with distilled 
water) wells adjacent to GFP bound wells. Since the GFP fluorescence from neighboring 
wells were observed to affect each other during quantification in transparent plates, black 
(opaque) polystyrene 96-well plates were used as alternative. 
FT-IR measurements showed that, although both transparent and opaque plates were 
modified with 2 M and 3 M ammonium persulfate, the difference in surface properties 
between 2 M and 3 M modified wells of transparent plates is insignificant, while significant 
in opaque plates. The possible reason may be the concentration loss as a result of APS 
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crystal formation in 3M solution at room temperature. After recognition of the problem, 3M 
APS solution was continuously heated in order to be kept over 45oC (at which it is soluble 
in water) during loading in opaque plates so that the true 3 M concentration could be 
maintained. By doing so, FT-IR spectra showed that better chemical modification results 
were obtained. Although the surface modification was assumed to be heterogenous and not 
fully characterized, a possible reaction scheme with persulfate-modified polymers is given 
in Table 5.1. The reaction mechanisms were predicted using the information from the 
literature that used polypropylene as the model system (Gugumus, 2002; Kocsis-Karger, 
1999; Bamford et al., 1996; Tidjani et al., 1995; Broska et al., 1999; Vaillant et al., 1994; 
Achimsky et al., 1997; Gugumus, 1998; Rabello et al., 1997; Gijsman et al., 1996), 
however they may be also applied to polystyrene with the same reactions but different 
kinetic parameters. Some basic reactions and structures of important intermediates are 
given in Figure 5.1. 
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Figure 5. 1 Proposed models for persulfate oxidation of polymers (shown with polystyrene 
example): some important reactions, structures of intermediate and final products of the 
proposed reactions. Free radicals are shown with dots. In the reactions, unshown H sources 
are mainly neighbouring chains and water. In box D, the polymers were drawn without ring 
structures for simplicity. (A) Initial formation of free radicals; (B) Formation of hydroxyl 
radical; (C) Formation of tertiary carbon and peroxyl radical; (D) Proposed product 
formation starting from hydroperoxide containing polymer molecule. 
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Table 5. 1 Reaction model illustrating alcohol, ketone, carboxylic acid, ester and ether 
formation in polystyrene (bold, reactions 9-21). Carbon centers (eg. HR, R·) are generally 
depicted as tertiary but they may also be secondary, particularly with radical backbiting 
mechanisms, and primary on occasion. The HR-OOH group specifically depicts a 
secondary carbon center. An abstractable hydrogen beta to an active center, -HROO·, is 
depicted in reaction 20. While reactions 3-5 depict two modes of carbon radical formation, 
hydroxyl attack (reaction 5) is presumed to dominate. Processes leading to bond breakage 
and eventual mesopatterning are outlined with italics. 
¯O3SO-OSO3¯    2SO4·¯ (1) initiation 
SO4·¯  + H2O  HSO4¯ + ·OH (2) propagation in aqueous-phase 
RH + SO4·¯  R· + HSO4¯ (3) propagation via surface H-
abstraction 
RH + SO4·¯   RH·+ + SO42-     R· + H+ +  SO42- (4) propagation via surface e- 
abstraction 
RH + ·OH  R· + H2O (5) propagation via surface H-
abstraction 
R· + O2  R-OO· (+ HR)  R-OOH + ·R (6) propagation in matrix 
R-OOH  R-O· + ·OH (7) thermal decomposition of 
peroxy groups 
R-OOH + HOO-R  R-O· + ·OO-R + H2O (8) thermal decomposition of 
peroxy groups 
R-O·  R=O + ·R  (9) propagation via scission 
R-OOH + H+ i R=O + HO-R + H+ (10) acid catalyzed decomposition 
HR-OOH + H+  R=O + H2O + H+  (11) acid catalyzed decomposition  
HR-OOH + ·OOR  R=O + ·OH + HOO-R (12) radical decomposition 
HR-OOH + ·OH  R=O + ·OH + H2O (13) radical decomposition 
R=O + ·OH  R(=O)OH + ·R (14) propagation via transfer  
R=O + ·OR  R(=O)OR + ·R (15) propagation via transfer  
RH + ·O-R  R· + HO-R (16) propagation via transfer 
R· + ·O-R  R-O-R  (17) radical termination 
R· + ·OH  R-OH (18) radical termination 
R-OO· + ·OO-RH  R-OH + O=R + O2 (19) radical termination 
RO· + HROO·  R-OH + O=R + O=R (20) radical termination 
HR-O· + ·OH  R=O + H2O (21) radical termination 
2 HO·  ½ O2 + H2O (22) radical termination 
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 It was characterized by FT-IR that the products of the reactions proposed above are 
consistent with the functional groups formed by APS oxidation of polystyrene. The 
formation of ketone, alcohol and more importantly carboxylic acid groups are shown in 
detail in the series of proposed reactions in Table 5.1. 
Unmodified black polystyrene plates gave the same fingerprint as the unmodified 
transparent plates when monitored by measuring the FT-IR spectrum. The possible reasons 
for this are: 
- The dye may be an intercalating agent instead of surface coating material and may 
be effective at very small concentrations that cannot be detected by FT-IR. 
- Black dye may be a chemical that is invisible within the IR radiation range. 
- Being a weaker possibility, the dye may give weak peaks that are superimposed on 
the characteristic peaks of polystyrene material, which would make it hard to 
recognize in the spectra. 
As the FT-IR results of the second modification (opaque plate) indicate, differential 
modification is successfully achieved using 2 M and 3 M APS solutions. In principle, the 
modification resulted in a heterogeneous population of functional groups on the surface, 
most significant of which are matrix-residing carboxylic acid residues. It should be noted 
that the detection penetration limit of the instrument is approximately 1µm resulting in the 
measurement of bulk properties rather than a surface layer, but it does provide insight on 
the surface characteristics. 
The imidazole and positively charged ions that have the potential to competitively 
interfere with the surface binding reaction were reduced in the protein solutions by dialysis. 
The complications that were experienced during dialysis and their solutions were 
mentioned in Sections 3.2.5.1 and 4.6.1. It was observed that an optimum concentration of 
ions is necessary at which there would be no interference with surface binding while 
protein precipitation is also avoided.  
Concentrations of GFPuv and GFPimm were estimated using absorption, 
fluorescence and electrophoretic analysis data. Based on the estimate, GFPuv was diluted 
to have approximately equal concentrations of both proteins for binding studies. The 
purities of proteins were not considered as a source of artifact as explained in Section 5.3. 
Binding characteristics were checked considering the following parameters: 
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- GFP type 
- Binding concentration 
- Binding pH 
- Measurement pH 
- Measurement state (dry/wet) 
- Modification strength on polystyrene surface 
The indicated parameters were checked on separate rows and columns of 96-well 
plates, forming an experimental matrix. 
It was seen that in overall, the most efficient binding was achieved at pH 7 although 
pKa of histidine is near 6. In order to verify that the higher value at pH 7 was not an artifact 
due to higher fluorescence of GFP at this pH, binding buffers at pH values of 6, 7 and 8 
were exchanged with pH 7 buffer and the plate was incubated overnight. pH 7 incubated 
plates also showed highest fluorescence at pH 7 bound GFPimm. This situation may be 
explained with the following model. Since around pH 6, a significant percentage of 
histidine population is ionized, they are in a more reactive state. In their charged state, they 
might be interacting with charged amino acids on the surface of GFPimm, which 
competitively inhibits surface binding reaction by blocking the charged histidine residues. 
Another unexpected observation was the high affinity of GFPuv (in some cases 
superior to GFPimm) to modified polystyrene surface at pH 8. This may be a result of a pH 
dependent alteration in reactivities of amino acids that are naturally located on the surface 
of GFPuv, such as the one expected at pH 6 for GFPimm (Figure 4.23-B). 
The difference in 2x and 20x diluted sample loaded wells indicated that the surface is 
not saturated within this range. 
Overnight incubation at pH 7 yielded lower fluorescence values which may be due to 
protein leakage or denaturation as a result of pH dependent conformational change. 
Immobilized peptides may be more susceptible to such pH changes after they are bound 
due to the restricted ability to change into a stable alternative conformation. During the 
conformational change, they may lose activity or leak into solution due to the stress formed 
near the bound site. 
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Modification inhomogeneities on polystyrene plates may be another reason for 
measurement inconsistencies, especially when the difference of GFPimm and GFPuv is 
small. 
As a summary of binding efficiency comparison, it can be clearly seen that GFPimm 
has a significantly higher surface binding property when compared to GFPuv (Figure 4.24-
C). Up to 17 fold difference was achieved between GFPimm and GFPuv by performing the 
binding reaction at pH 7 with highest surface loading concentration pf proteins on 2M APS 
modified wells. The error bars indicated in the histogram shown in Figure 4.24-C are due 
to the standard deviation obtained from the measurements at different conditions (dry, 
binding pH buffer-filled, pH 7 buffer-filled). 
The possible interactions between poly-histidine tags and oxidized polystyrene 
surfaces are summarized in Figure 5.2-A. GFPimm was also observed to interact with 
unmodified polystyrene better than GFPuv. Figure 5.2-B explains the model for interaction 
of GFPimm with unmodified polystyrene. In the case of hydrophobic interaction between 
imidazole groups of histidines and phenyl groups of unmodified polystyrene, quadripolar 
interactions are assumed to play an important role. In addition to those interactions, protein 
molecules have the advantage of being large molecules, thus having the possibility to be 
effectively immobilized by their own inertia. Since they are large and composed of a large 
number of reactive groups on surface, they may interact with one group while another one 
loses interaction with the surface. 
 
Figure 5. 2 (A) Charge based interaction possibilities between histidines of the poly-histine 
tag and the functional groups formed on the surface as a result of APS oxidation of 
polystyrene. (B) Non-covalent, hydrophobic interaction possibility between the electron 
clouds of imidazole groups of poly-histidine tag and phenyl groups of unmodified 
polystyrene. 
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 Since the charges formed on the surface increase hydrophilicity of polystyrene 
surface, the surface is coated with a film of water molecules. In enzyme immobilization 
practices such an interaction provides an aqueous environment for the immobilized 
enzyme to work as in its natural environment. However, the charges on the surface form an 
artificial local pH which may negatively affect the enzyme activity (edited by Bickerstaff, 
1997; edited by Mosbach, 1987). By using both a hydrophilic surface and a linker peptide, 
any protein immobilized by using GFPimm based immobilization system will avoid the 
problem of local pH while being attached to an aqueous environment. 
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6. CONCLUSION 
Although similar studies are present, the immobilization system developed in this 
study is novel and has a number of advantages over similar systems. The novelties and 
advantages are described in introduction section.  
In this study we have developed a functional two-component immobilization system 
composed of an activated surface and a recombinant vector encoding a fluorescent 
immobilization adapter. This immobilization strategy is an alternative to the classical 
surface linking methods wherein the enzyme is bound to the surface following chemical 
treatment. By preparing the surface and enzyme to be immobilized separately and 
encouraging binding in a subsequent step, biological function is likely to be retained. In 
addition to avoiding the disadvantages of chemical immobilization strategies, our method 
intrinsically features some benefits associated with classical covalent immobilization such 
as the preservation of native-like traits by incorporating linker molecules, and improved 
surface retention in comparison to adsorptive modes of immobilization.  
By virtue that the linker contains a fluorescent marker, the system allows for easy 
visualization and quantification of immobilized target proteins. Although similar studies 
incorporating affinity tags and GFP markers were performed, this work is novel in the 
sense that ready-to-immobilize protein is prepared at the DNA level. More importantly, the 
design allows for expression, immobilization, visualization and quantification of any target 
protein (Figure 6.1-A). 
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A 
 
B 
 
Figure 6. 1 (A) Scheme showing the mechanism of immobilization of any enzyme which is 
cloned into the multiple cloning site of immobilization specialty vector: pETM-GFP-Imm. 
(B) The immobilization system is flexible in the sense that every component can be easily 
changed by single step modifications on pETM-GFP-Imm plasmid. E indicates enzyme / 
effector peptide (e.g. attachment signal peptides, antibiotics), VM represents visual 
marker, FA stands for flexible arm, T indicates tag of appropriate amino acids and S 
stands for surface in the figure. 
 
The immobilization system can be used in a wide variety of applications due to its 
flexible design. Expression of different enzymes or signal peptides, use of different 
fluorescent proteins instead of GFP, and immobilization via different affinity tags in place 
of the common His-tag are all possible by manipulating the vector (Figure 6.1-B).  
The use of different support materials specific to each affinity tag gives the 
opportunity to develop a large combination of immobilized proteins for application in 
analysis, enzyme based diagnostic kits, sensing, arraying and orienting, catalysis, 
stabilisation, binding, signal transduction, chemical transformation, implant 
biocompatibilization, surface activation, purification, detoxification and scavenging. A 
provisional patent for the immobilization strategy and its elements has been approved 
(Application number: PCT/TR03/00019). 
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APPENDICES 
APPENDIX A 
CHEMICALS 
(in alphabetical order) 
 
Name of Chemical Supplier Company Catalog 
Number 
Acetic Acid Riedel-de Haén, Germany 27225 
Acrylamide/Bis-acrylamide Sigma, Germany A3699 
Agarose Sigma, Germany A-6138 
Ammonium persulfate Carlo-Erba, Italy  420627 
Ampicillin Sigma, Germany  A9518 
Boric Acid Riedel-de Haén, Germany 11607 
Distilled water, sterile, MilliQ 
filtered 
Millipore, France   
EDTA (Ethylenediaminetetraacetic 
acid) 
Riedel-de Haén, Germany 27248 
Ethanol Riedel-de Haén, Germany 32221 
Ethidium Bromide Merck, Germany OCO28942 
Glycerol Riedel-de Haén, Germany 15523 
HCl Merck, Germany 100314 
Imidazole Sigma, Germany I-2399 
IPTG Promega, Germany V39517 
Isopropanol Riedel-de Haén, Germany 24137 
Kanamycin Sigma, Germany K4000 
Liquid nitrogen Karbogaz, Turkey  
Luria Agar Sigma, Germany L-3147 
Luria Broth Sigma, Germany L-3022 
2-Mercaptoethanol Aldrich Chemical Company, M370-1 
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Germany 
NaCl Riedel-de Haén, Germany 13423 
NaH2PO4 Merck, Germany 106370 
NaOH Merck, Germany 106462 
Nickel Chloride Merck, Germany 806722 
Polystyrene 96-well plate TPP, SWITZERLAND TP92696 
Polystyrene culture plate TPP, SWITZERLAND TP93100 
Sodium Dodecyl Sulphate Sigma, Germany L-4390 
TEMED Sigma, Germany T-7029 
Tris Fluka, Switzerland 93349 
Urea Merck, Germany 1.12007.2500 
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APPENDIX B 
MOLECULAR BIOLOGY KITS 
(in alphabetical order) 
 
Name of Kit Supplier 
Company 
Catalog Number 
Micro-SpinTM G-25 Columns Amersham 
Biosciences 
27-5325-01 
ProBondTM resin Invitrogen, 
Germany 
46-0019 
Qiagen Midi-prep Plasmid 
Purification Kit (100) 
Qiagen, Germany 
 
12145 (All buffers in protocols 
are included) 
Qiaprep® Mini-prep plasmid 
isolation kit (250) 
Qiagen, Germany  27106 (All buffers in protocols 
are included) 
QIAquick® Gel Extraction Kit 
(250) 
Qiagen, Germany 28706 (All buffers in protocols 
are included) 
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APPENDIX C  
BIOLOGICAL COMPONENTS:CELLS, PLASMIDS, OLIGONUCLEOTIDES, 
ENZYMES AND ENZYME BUFFERS  
(in alphabetical order) 
 
NAME OF ENZYME / BUFFER 
SYSTEM Supplier Company Catalog Number 
BSA (Bovine Serum Albumin) 
(acetylated, 10X concentrated) 
Promega, Germany Supplied with Kpn I, 
Nco I and Sac I 
Kpn I Promega, Germany R634A 
Multi-CoreTM Buffer (10X) Promega, Germany  supplied with Kpn I, 
Nco I and Sac I 
Lysozyme Merck, Germany 1.05281 
Mass Ruler DNA Ladder, High Range 
(Agarose gel photograph and MW 
values of bands are provided below) 
Fermentas, Germany #SM0393 
Mass Ruler DNA Ladder, Low Range 
(Agarose gel photograph and MW 
values of bands are provided below) 
Fermentas, Germany #SM0383 
Nco I Promega, Germany R651F 
pETM-11 European Molecular 
Biology Laboratories, 
Germany 
 
pETM-Adp Designed and 
constructed in-house 
 
E. coli strains  
(XL1-Blue, BL21-DE3) 
Kindly provided by 
EMBL, Hamburg, 
Germany 
 
Frame Adapters  Designed in-house, 
synthesized by Seqlab, 
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PGFPuv Clontech, Germany #6079-1 
rGFPuv protein standard Clontech, Germany #8366-1 
RNAase Qiagen, Germany supplied with Qiagen 
Plasmid Isolation Kits 
Sac I Promega, Germany R606A 
T4 DNA Ligase Promega, Germany M180B 
T4 DNA Ligase Buffer (10X) Promega, Germany Supplied with T4 DNA 
Ligase 
Protein MW Marker (gel photograph 
and MW values of bands are provided 
below) 
Fermentas, Germany #SM0431 
Prestained Protein MW Marker (gel 
photograph and MW values of bands 
are provided below) 
Fermentas, Germany #SM0441 
Y+/Tango Fermentas, Germany Supplied with 
restriction enzymes 
purchased from 
Fermentas. 
 
 
 
 
 
 
Prestained 
Protein MW 
Marker 
Protein MW 
Marker 
Mass Ruler 
DNA Ladder, 
Low Range 
Mass Ruler 
DNA Ladder, 
High Range 
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APPENDIX D 
EQUIPMENTS 
 
Type of instrument Supplier Company 
Hirayama, Hiclave HV-110, JAPAN Autoclave: 
Certoclav, Table Top Autoclave CV-EL-12L, AUSTRIA 
Sartorius, BP221S, GERMANY Balance: 
Schimadzu, Libror EB-3200 HU, JAPAN 
Eppendorf, 5415D, GERMANY Centrifuge: 
Hitachi, Sorvall RC5C Plus, USA 
-80o C, Kendro Lab. Prod.  
Heraeus Hfu486 Basic, GERMANY 
Deepfreeze: 
-20o C, Bosch, TÜRKYE 
Dialysis tubes CelluSep T3,  
Membrane Filtration Products Inc., USA 
Millipore, Elix-S, FRANCE Distilled Water: 
Millipore, MilliQ Academic, FRANCE 
Biogen Inc., USA Electrophoresis: 
Biorad Inc., USA 
0.2 µm filter: Millipore, 
Catalog# GNWP04700, USA 
Filter membranes: 
0.45 µm filter: Millipore,  
Catalog# HNWP04700, USA 
Fluorometer: SPECTRAmax GEMINI XS, Molecular Devices 
Corporation, USA 
FPLC ÄKTA FPLC, Amersham Biosciences 
FPLC Column MonoQ Ion Exchange Chromatography Column (10/10), 
Amersham Biosciences 
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UVITEC, UVIdoc Gel Documentation System, UK Gel Documentation: 
Biorad, UV-Transilluminator 2000, USA 
Heater Block: Bioblock Scientific, FRANCE 
Ice Machine: Scotsman Inc., AF20, USA 
Memmert, Modell 300, GERMANY Incubator: 
Memmert, Modell 600, GERMANY 
FT Infrared 
Spectrophotometer with 
Attenuated Total 
Reflectance Accessory: 
Equinox 55 TGA-IR, Bruker Optics Inc. 
Laminar Flow: Kendro Lab. Prod., Heraeus, HeraSafe HS12, 
GERMANY 
VELP Scientifica, ARE Heating Magnetic Stirrer, 
ITALY 
Magnetic Stirrer: 
VELP Scientifica, Microstirrer, ITALY 
Gilson, Pipetman, FRANCE Microliter Pipette: 
Mettler Toledo, Volumate, USA 
Microwave Oven: Bosch, TÜRKYE 
pH meter: WTW, pH540 GLP MultiCal®, GERMANY 
Polystyrene 96-well plate: TPP, SWITZERLAND 
Biorad, PowerPac 300, USA Power Supply: 
Wealtec, Elite 300, USA 
Refrigerator: +4o C, Bosch, TÜRKYE 
Forma Scientific, Orbital Shaker 4520, USA 
GFL, Shaker 3011, USA 
Shaker: 
New Brunswick Sci., Innova 4330, USA 
Sonicator: Vibracell 75043, Bioblock Scientific, FRANCE 
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Schimadzu, UV-1208, JAPAN 
Schimadzu, UV-3150, JAPAN 
Spectrophotometer: 
Secoman, Anthelie Advanced, ITALY 
Savant, Speed Vac® Plus Sc100A, USA Speed Vacuum: 
Savant, Refrigerated Vapor Trap RVT 400, USA 
Thermocycler: Eppendorf, Mastercycler Gradient, GERMANY 
Vacuum: Heto, MasterJet Sue 300Q, DENMARK 
Vortex: Velp Scientifica, ITALY 
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APPENDIX E:  
Plasmid sequences: pETM-11, pGFPuv, pETM-Adp, pETM-GFP-Imm 
Sequence of pETM-11 
 
    1 CATCACCATC ACCATCACCC CATGAGCGAT TACGACATCC CCACTACTGA 
   51 GAATCTTTAT TTTCAGGGCG CCATGGCGGC GGCGGTTCGG ATGAACATCC 
  101 AGATGCTGCT GGAGGCGGCC GACTATCTGG AGCGGCGGGA GAGAGAAGCT 
  151 GAACATGGTT ATGCCTCCAT GTTACCATAC AAAAACAAGG ACAGAGATGC 
  201 CTTAAAACGG AGGAACAAAT CCAAAAAGAA TAACAGCAGT AGCAGATCAA 
  251 CTCACAATGA AATGGAGAAG AATAGACGGG CTCATCTTCG CTTGTGCCTG 
  301 GAGAAGTTGA AGGGGCTGGT GCCACTGGGA CCCGAATCAA GTCGACACAC 
  351 TACGTTGAGT TTATTAACAA AAGCCAAATT GCACATAAAG AAACTTGAAG 
  401 ATTGTGACAG AAAAGCCGTT CACCAAATCG ACCAGCTTCA GCGAGAGCAG 
  451 CGACACCTGA AGAGGCAGCT GGAGAAGCTG GGCATTGAGA GGATCCGGAT 
  501 GGACAGCATC GGCTCCACCG TCTCCTCGGA GCGCTCCGAC TCCGACAGGG 
  551 AAGAAATCGA CGTTGACGTG GAGAGCACGG ACTATCTCAC AGGTGATCTG 
  601 GACTGGAGCA GCAGCAGTGT GAGCGACTCT GACGAGCGGG GCAGCATGCA 
  651 GAGCCTCGGC AGTGATGAGG GCTATTCCAG CACCAGCATC AAGAGAATAA 
  701 AGCTGCAGGA CAGTCACAAG GCGTGTCTTG GTCTCTAACT AGTGGTACCG 
  751 GATCCGAATT CGAGCTCCGT CGACAAGCTT GCGGCCGCAC TCGAGCACCA 
  801 CCACCACCAC CACTGAGATC CGGCTGCTAA CAAAGCCCGA AAGGAAGCTG 
  851 AGTTGGCTGC TGCCACCGCT GAGCAATAAC TAGCATAACC CCTTGGGGCC 
  901 TCTAAACGGG TCTTGAGGGG TTTTTTGCTG AAAGGAGGAA CTATATCCGG 
  951 ATTGGCGAAT GGGACGCGCC CTGTAGCGGC GCATTAAGCG CGGCGGGTGT 
 1001 GGTGGTTACG CGCAGCGTGA CCGCTACACT TGCCAGCGCC CTAGCGCCCG 
 1051 CTCCTTTCGC TTTCTTCCCT TCCTTTCTCG CCACGTTCGC CGGCTTTCCC 
 1101 CGTCAAGCTC TAAATCGGGG GCTCCCTTTA GGGTTCCGAT TTAGTGCTTT 
 1151 ACGGCACCTC GACCCCAAAA AACTTGATTA GGGTGATGGT TCACGTAGTG 
 1201 GGCCATCGCC CTGATAGACG GTTTTTCGCC CTTTGACGTT GGAGTCCACG 
 1251 TTCTTTAATA GTGGACTCTT GTTCCAAACT GGAACAACAC TCAACCCTAT 
 1301 CTCGGTCTAT TCTTTTGATT TATAAGGGAT TTTGCCGATT TCGGCCTATT 
 1351 GGTTAAAAAA TGAGCTGATT TAACAAAAAT TTAACGCGAA TTTTAACAAA 
 1401 ATATTAACGT TTACAATTTC AGGTGGCACT TTTCGGGGAA ATGTGCGCGG 
 1451 AACCCCTATT TGTTTATTTT TCTAAATACA TTCAAATATG TATCCGCTCA 
 1501 TGAATTAATT CTTAGAAAAA CTCATCGAGC ATCAAATGAA ACTGCAATTT 
 1551 ATTCATATCA GGATTATCAA TACCATATTT TTGAAAAAGC CGTTTCTGTA 
 1601 ATGAAGGAGA AAACTCACCG AGGCAGTTCC ATAGGATGGC AAGATCCTGG 
 1651 TATCGGTCTG CGATTCCGAC TCGTCCAACA TCAATACAAC CTATTAATTT 
 1701 CCCCTCGTCA AAAATAAGGT TATCAAGTGA GAAATCACCA TGAGTGACGA 
 1751 CTGAATCCGG TGAGAATGGC AAAAGTTTAT GCATTTCTTT CCAGACTTGT 
 1801 TCAACAGGCC AGCCATTACG CTCGTCATCA AAATCACTCG CATCAACCAA 
 1851 ACCGTTATTC ATTCGTGATT GCGCCTGAGC GAGACGAAAT ACGCGATCGC 
 1901 TGTTAAAAGG ACAATTACAA ACAGGAATCG AATGCAACCG GCGCAGGAAC 
 1951 ACTGCCAGCG CATCAACAAT ATTTTCACCT GAATCAGGAT ATTCTTCTAA 
 2001 TACCTGGAAT GCTGTTTTCC CGGGGATCGC AGTGGTGAGT AACCATGCAT 
 2051 CATCAGGAGT ACGGATAAAA TGCTTGATGG TCGGAAGAGG CATAAATTCC 
 2101 GTCAGCCAGT TTAGTCTGAC CATCTCATCT GTAACATCAT TGGCAACGCT 
 2151 ACCTTTGCCA TGTTTCAGAA ACAACTCTGG CGCATCGGGC TTCCCATACA 
 2201 ATCGATAGAT TGTCGCACCT GATTGCCCGA CATTATCGCG AGCCCATTTA 
 2251 TACCCATATA AATCAGCATC CATGTTGGAA TTTAATCGCG GCCTAGAGCA 
 2301 AGACGTTTCC CGTTGAATAT GGCTCATAAC ACCCCTTGTA TTACTGTTTA 
 2351 TGTAAGCAGA CAGTTTTATT GTTCATGACC AAAATCCCTT AACGTGAGTT 
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 2401 TTCGTTCCAC TGAGCGTCAG ACCCCGTAGA AAAGATCAAA GGATCTTCTT 
 2451 GAGATCCTTT TTTTCTGCGC GTAATCTGCT GCTTGCAAAC AAAAAAACCA 
 2501 CCGCTACCAG CGGTGGTTTG TTTGCCGGAT CAAGAGCTAC CAACTCTTTT 
 2551 TCCGAAGGTA ACTGGCTTCA GCAGAGCGCA GATACCAAAT ACTGTCCTTC 
 2601 TAGTGTAGCC GTAGTTAGGC CACCACTTCA AGAACTCTGT AGCACCGCCT 
 2651 ACATACCTCG CTCTGCTAAT CCTGTTACCA GTGGCTGCTG CCAGTGGCGA 
 2701 TAAGTCGTGT CTTACCGGGT TGGACTCAAG ACGATAGTTA CCGGATAAGG 
 2751 CGCAGCGGTC GGGCTGAACG GGGGGTTCGT GCACACAGCC CAGCTTGGAG 
 2801 CGAACGACCT ACACCGAACT GAGATACCTA CAGCGTGAGC TATGAGAAAG 
 2851 CGCCACGCTT CCCGAAGGGA GAAAGGCGGA CAGGTATCCG GTAAGCGGCA 
 2901 GGGTCGGAAC AGGAGAGCGC ACGAGGGAGC TTCCAGGGGG AAACGCCTGG 
 2951 TATCTTTATA GTCCTGTCGG GTTTCGCCAC CTCTGACTTG AGCGTCGATT 
 3001 TTTGTGATGC TCGTCAGGGG GGCGGAGCCT ATGGAAAAAC GCCAGCAACG 
 3051 CGGCCTTTTT ACGGTTCCTG GCCTTTTGCT GGCCTTTTGC TCACATGTTC 
 3101 TTTCCTGCGT TATCCCCTGA TTCTGTGGAT AACCGTATTA CCGCCTTTGA 
 3151 GTGAGCTGAT ACCGCTCGCC GCAGCCGAAC GACCGAGCGC AGCGAGTCAG 
 3201 TGAGCGAGGA AGCGGAAGAG CGCCTGATGC GGTATTTTCT CCTTACGCAT 
 3251 CTGTGCGGTA TTTCACACCG CATATATGGT GCACTCTCAG TACAATCTGC 
 3301 TCTGATGCCG CATAGTTAAG CCAGTATACA CTCCGCTATC GCTACGTGAC 
 3351 TGGGTCATGG CTGCGCCCCG ACACCCGCCA ACACCCGCTG ACGCGCCCTG 
 3401 ACGGGCTTGT CTGCTCCCGG CATCCGCTTA CAGACAAGCT GTGACCGTCT 
 3451 CCGGGAGCTG CATGTGTCAG AGGTTTTCAC CGTCATCACC GAAACGCGCG 
 3501 AGGCAGCTGC GGTAAAGCTC ATCAGCGTGG TCGTGAAGCG ATTCACAGAT 
 3551 GTCTGCCTGT TCATCCGCGT CCAGCTCGTT GAGTTTCTCC AGAAGCGTTA 
 3601 ATGTCTGGCT TCTGATAAAG CGGGCCATGT TAAGGGCGGT TTTTTCCTGT 
 3651 TTGGTCACTG ATGCCTCCGT GTAAGGGGGA TTTCTGTTCA TGGGGGTAAT 
 3701 GATACCGATG AAACGAGAGA GGATGCTCAC GATACGGGTT ACTGATGATG 
 3751 AACATGCCCG GTTACTGGAA CGTTGTGAGG GTAAACAACT GGCGGTATGG 
 3801 ATGCGGCGGG ACCAGAGAAA AATCACTCAG GGTCAATGCC AGCGCTTCGT 
 3851 TAATACAGAT GTAGGTGTTC CACAGGGTAG CCAGCAGCAT CCTGCGATGC 
 3901 AGATCCGGAA CATAATGGTG CAGGGCGCTG ACTTCCGCGT TTCCAGACTT 
 3951 TACGAAACAC GGAAACCGAA GACCATTCAT GTTGTTGCTC AGGTCGCAGA 
 4001 CGTTTTGCAG CAGCAGTCGC TTCACGTTCG CTCGCGTATC GGTGATTCAT 
 4051 TCTGCTAACC AGTAAGGCAA CCCCGCCAGC CTAGCCGGGT CCTCAACGAC 
 4101 AGGAGCACGA TCATGCGCAC CCGTGGGGCC GCCATGCCGG CGATAATGGC 
 4151 CTGCTTCTCG CCGAAACGTT TGGTGGCGGG ACCAGTGACG AAGGCTTGAG 
 4201 CGAGGGCGTG CAAGATTCCG AATACCGCAA GCGACAGGCC GATCATCGTC 
 4251 GCGCTCCAGC GAAAGCGGTC CTCGCCGAAA ATGACCCAGA GCGCTGCCGG 
 4301 CACCTGTCCT ACGAGTTGCA TGATAAAGAA GACAGTCATA AGTGCGGCGA 
 4351 CGATAGTCAT GCCCCGCGCC CACCGGAAGG AGCTGACTGG GTTGAAGGCT 
 4401 CTCAAGGGCA TCGGTCGAGA TCCCGGTGCC TAATGAGTGA GCTAACTTAC 
 4451 ATTAATTGCG TTGCGCTCAC TGCCCGCTTT CCAGTCGGGA AACCTGTCGT 
 4501 GCCAGCTGCA TTAATGAATC GGCCAACGCG CGGGGAGAGG CGGTTTGCGT 
 4551 ATTGGGCGCC AGGGTGGTTT TTCTTTTCAC CAGTGAGACG GGCAACAGCT 
 4601 GATTGCCCTT CACCGCCTGG CCCTGAGAGA GTTGCAGCAA GCGGTCCACG 
 4651 CTGGTTTGCC CCAGCAGGCG AAAATCCTGT TTGATGGTGG TTAACGGCGG 
 4701 GATATAACAT GAGCTGTCTT CGGTATCGTC GTATCCCACT ACCGAGATAT 
 4751 CCGCACCAAC GCGCAGCCCG GACTCGGTAA TGGCGCGCAT TGCGCCCAGC 
 4801 GCCATCTGAT CGTTGGCAAC CAGCATCGCA GTGGGAACGA TGCCCTCATT 
 4851 CAGCATTTGC ATGGTTTGTT GAAAACCGGA CATGGCACTC CAGTCGCCTT 
 4901 CCCGTTCCGC TATCGGCTGA ATTTGATTGC GAGTGAGATA TTTATGCCAG 
 4951 CCAGCCAGAC GCAGACGCGC CGAGACAGAA CTTAATGGGC CCGCTAACAG 
 5001 CGCGATTTGC TGGTGACCCA ATGCGACCAG ATGCTCCACG CCCAGTCGCG 
 5051 TACCGTCTTC ATGGGAGAAA ATAATACTGT TGATGGGTGT CTGGTCAGAG 
 5101 ACATCAAGAA ATAACGCCGG AACATTAGTG CAGGCAGCTT CCACAGCAAT 
 5151 GGCATCCTGG TCATCCAGCG GATAGTTAAT GATCAGCCCA CTGACGCGTT 
 5201 GCGCGAGAAG ATTGTGCACC GCCGCTTTAC AGGCTTCGAC GCCGCTTCGT 
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 5251 TCTACCATCG ACACCACCAC GCTGGCACCC AGTTGATCGG CGCGAGATTT 
 5301 AATCGCCGCG ACAATTTGCG ACGGCGCGTG CAGGGCCAGA CTGGAGGTGG 
 5351 CAACGCCAAT CAGCAACGAC TGTTTGCCCG CCAGTTGTTG TGCCACGCGG 
 5401 TTGGGAATGT AATTCAGCTC CGCCATCGCC GCTTCCACTT TTTCCCGCGT 
 5451 TTTCGCAGAA ACGTGGCTGG CCTGGTTCAC CACGCGGGAA ACGGTCTGAT 
 5501 AAGAGACACC GGCATACTCT GCGACATCGT ATAACGTTAC TGGTTTCACA 
 5551 TTCACCACCC TGAATTGACT CTCTTCCGGG CGCTATCATG CCATACCGCG 
 5601 AAAGGTTTTG CGCCATTCGA TGGTGTCCGG GATCTCGACG CTCTCCCTTA 
 5651 TGCGACTCCT GCATTAGGAA GCAGCCCAGT AGTAGGTTGA GGCCGTTGAG 
 5701 CACCGCCGCC GCAAGGAATG GTGCATGCAA GGAGATGGCG CCCAACAGTC 
 5751 CCCCGGCCAC GGGGCCTGCC ACCATACCCA CGCCGAAACA AGCGCTCATG 
 5801 AGCCCGAAGT GGCGAGCCCG ATCTTCCCCA TCGGTGATGT CGGCGATATA 
 5851 GGCGCCAGCA ACCGCACCTG TGGCGCCGGT GATGCCGGCC ACGATGCGTC 
 5901 CGGCGTAGAG GATCGAGATC TCGATCCCGC GAAATTAATA CGACTCACTA 
 5951 TAGGGGAATT GTGAGCGGAT AACAATTCCC CTCTAGAAAT AATTTTGATT 
 6001 TAACTTTAAG AAGGAGATAT ACCATGAAA 
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Sequence of pGFPuv (Clontech) 
    1 AGCGCCCAAT ACGCAAACCG CCTCTCCCCG CGCGTTGGCC GATTCATTAA 
   51 TGCAGCTGGC ACGACAGGTT TCCCGACTGG AAAGCGGGCA GTGAGCGCAA 
  101 CGCAATTAAT GTGAGTTAGC TCACTCATTA GGCACCCCAG GCTTTACACT 
  151 TTATGCTTCC GGCTCGTATG TTGTGTGGAA TTGTGAGCGG ATAACAATTT 
  201 CACACAGGAA ACAGCTATGA CCATGATTAC GCCAAGCTTG CATGCCTGCA 
  251 GGTCGACTCT AGAGGATCCC CGGGTACCGG TAGAAAAAAT GAGTAAAGGA 
  301 GAAGAACTTT TCACTGGAGT TGTCCCAATT CTTGTTGAAT TAGATGGTGA 
  351 TGTTAATGGG CACAAATTTT CTGTCAGTGG AGAGGGTGAA GGTGATGCAA 
  401 CATACGGAAA ACTTACCCTT AAATTTATTT GCACTACTGG AAAACTACCT 
  451 GTTCCATGGC CAACACTTGT CACTACTTTC TCTTATGGTG TTCAATGCTT 
  501 TTCCCGTTAT CCGGATCATA TGAAACGGCA TGACTTTTTC AAGAGTGCCA 
  551 TGCCCGAAGG TTATGTACAG GAACGCACTA TATCTTTCAA AGATGACGGG 
  601 AACTACAAGA CGCGTGCTGA AGTCAAGTTT GAAGGTGATA CCCTTGTTAA 
  651 TCGTATCGAG TTAAAAGGTA TTGATTTTAA AGAAGATGGA AACATTCTCG 
  701 GACACAAACT CGAGTACAAC TATAACTCAC ACAATGTATA CATCACGGCA 
  751 GACAAACAAA AGAATGGAAT CAAAGCTAAC TTCAAAATTC GCCACAACAT 
  801 TGAAGATGGA TCCGTTCAAC TAGCAGACCA TTATCAACAA AATACTCCAA 
  851 TTGGCGATGG CCCTGTCCTT TTACCAGACA ACCATTACCT GTCGACACAA 
  901 TCTGCCCTTT CGAAAGATCC CAACGAAAAG CGTGACCACA TGGTCCTTCT 
  951 TGAGTTTGTA ACTGCTGCTG GGATTACACA TGGCATGGAT GAGCTCTACA 
 1001 AATAATGAAT TCCAACTGAG CGCCGGTCGC TACCATTACC AACTTGTCTG 
 1051 GTGTCAAAAA TAATAGGCCT ACTAGTCGGC CGTACGGGCC CTTTCGTCTC 
 1101 GCGCGTTTCG GTGATGACGG TGAAAACCTC TGACACATGC AGCTCCCGGA 
 1151 GACGGTCACA GCTTGTCTGT AAGCGGATGC CGGGAGCAGA CAAGCCCGTC 
 1201 AGGGCGCGTC AGCGGGTGTT GGCGGGTGTC GGGGCTGGCT TAACTATGCG 
 1251 GCATCAGAGC AGATTGTACT GAGAGTGCAC CATATGCGGT GTGAAATACC 
 1301 GCACAGATGC GTAAGGAGAA AATACCGCAT CAGGCGGCCT TAAGGGCCTC 
 1351 GTGATACGCC TATTTTTATA GGTTAATGTC ATGATAATAA TGGTTTCTTA 
 1401 GACGTCAGGT GGCACTTTTC GGGGAAATGT GCGCGGAACC CCTATTTGTT 
 1451 TATTTTTCTA AATACATTCA AATATGTATC CGCTCATGAG ACAATAACCC 
 1501 TGATAAATGC TTCAATAATA TTGAAAAAGG AAGAGTATGA GTATTCAACA 
 1551 TTTCCGTGTC GCCCTTATTC CCTTTTTTGC GGCATTTTGC CTTCCTGTTT 
 1601 TTGCTCACCC AGAAACGCTG GTGAAAGTAA AAGATGCTGA AGATCAGTTG 
 1651 GGTGCACGAG TGGGTTACAT CGAACTGGAT CTCAACAGCG GTAAGATCCT 
 1701 TGAGAGTTTT CGCCCCGAAG AACGTTTTCC AATGATGAGC ACTTTTAAAG 
 1751 TTCTGCTATG TGGCGCGGTA TTATCCCGTA TTGACGCCGG GCAAGAGCAA 
 1801 CTCGGTCGCC GCATACACTA TTCTCAGAAT GACTTGGTTG AGTACTCACC 
 1851 AGTCACAGAA AAGCATCTTA CGGATGGCAT GACAGTAAGA GAATTATGCA 
 1901 GTGCTGCCAT AACCATGAGT GATAACACTG CGGCCAACTT ACTTCTGACA 
 1951 ACGATCGGAG GACCGAAGGA GCTAACCGCT TTTTTGCACA ACATGGGGGA 
 2001 TCATGTAACT CGCCTTGATC GTTGGGAACC GGAGCTGAAT GAAGCCATAC 
 2051 CAAACGACGA GCGTGACACC ACGATGCCTG TAGCAATGGC AACAACGTTG 
 2101 CGCAAACTAT TAACTGGCGA ACTACTTACT CTAGCTTCCC GGCAACAATT 
 2151 AATAGACTGG ATGGAGGCGG ATAAAGTTGC AGGACCACTT CTGCGCTCGG 
 2201 CCCTTCCGGC TGGCTGGTTT ATTGCTGATA AATCTGGAGC CGGTGAGCGT 
 2251 GGGTCTCGCG GTATCATTGC AGCACTGGGG CCAGATGGTA AGCCCTCCCG 
 2301 TATCGTAGTT ATCTACACGA CGGGGAGTCA GGCAACTATG GATGAACGAA 
 2351 ATAGACAGAT CGCTGAGATA GGTGCCTCAC TGATTAAGCA TTGGTAACTG 
 2401 TCAGACCAAG TTTACTCATA TATACTTTAG ATTGATTTAA AACTTCATTT 
 2451 TTAATTTAAA AGGATCTAGG TGAAGATCCT TTTTGATAAT CTCATGACCA 
 2501 AAATCCCTTA ACGTGAGTTT TCGTTCCACT GAGCGTCAGA CCCCGTAGAA 
 2551 AAGATCAAAG GATCTTCTTG AGATCCTTTT TTTCTGCGCG TAATCTGCTG 
 2601 CTTGCAAACA AAAAAACCAC CGCTACCAGC GGTGGTTTGT TTGCCGGATC 
 2651 AAGAGCTACC AACTCTTTTT CCGAAGGTAA CTGGCTTCAG CAGAGCGCAG 
 2701 ATACCAAATA CTGTCCTTCT AGTGTAGCCG TAGTTAGGCC ACCACTTCAA 
 2751 GAACTCTGTA GCACCGCCTA CATACCTCGC TCTGCTAATC CTGTTACCAG 
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 2801 TGGCTGCTGC CAGTGGCGAT AAGTCGTGTC TTACCGGGTT GGACTCAAGA 
 2851 CGATAGTTAC CGGATAAGGC GCAGCGGTCG GGCTGAACGG GGGGTTCGTG 
 2901 CACACAGCCC AGCTTGGAGC GAACGACCTA CACCGAACTG AGATACCTAC 
 2951 AGCGTGAGCT ATGAGAAAGC GCCACGCTTC CCGAAGGGAG AAAGGCGGAC 
 3001 AGGTATCCGG TAAGCGGCAG GGTCGGAACA GGAGAGCGCA CGAGGGAGCT 
 3051 TCCAGGGGGA AACGCCTGGT ATCTTTATAG TCCTGTCGGG TTTCGCCACC 
 3101 TCTGACTTGA GCGTCGATTT TTGTGATGCT CGTCAGGGGG GCGGAGCCTA 
 3151 TGGAAAAACG CCAGCAACGC GGCCTTTTTA CGGTTCCTGG CCTTTTGCTG 
 3201 GCCTTTTGCT CACATGTTCT TTCCTGCGTT ATCCCCTGAT TCTGTGGATA 
 3251 ACCGTATTAC CGCCTTTGAG TGAGCTGATA CCGCTCGCCG CAGCCGAACG 
 3301 ACCGAGCGCA GCGAGTCAGT GAGCGAGGAA GCGGAAG 
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Sequence of pETM-Adp (intermediate plasmid) 
 
    1 CATCACCATC ACCATCACCC CATGAGCGAT TACGACATCC CCACTACTGA 
   51 GAATCTTTAT TTTCAGGGCG CCATGGGAGG CACGGTACCG GATCCGAATT 
  101 CGAGCTCCGT CGACAAGCTT GCGGCCGCAC TCGAGCACCA CCACCACCAC 
  151 CACTGAGATC CGGCTGCTAA CAAAGCCCGA AAGGAAGCTG AGTTGGCTGC 
  201 TGCCACCGCT GAGCAATAAC TAGCATAACC CCTTGGGGCC TCTAAACGGG 
  251 TCTTGAGGGG TTTTTTGCTG AAAGGAGGAA CTATATCCGG ATTGGCGAAT 
  301 GGGACGCGCC CTGTAGCGGC GCATTAAGCG CGGCGGGTGT GGTGGTTACG 
  351 CGCAGCGTGA CCGCTACACT TGCCAGCGCC CTAGCGCCCG CTCCTTTCGC 
  401 TTTCTTCCCT TCCTTTCTCG CCACGTTCGC CGGCTTTCCC CGTCAAGCTC 
  451 TAAATCGGGG GCTCCCTTTA GGGTTCCGAT TTAGTGCTTT ACGGCACCTC 
  501 GACCCCAAAA AACTTGATTA GGGTGATGGT TCACGTAGTG GGCCATCGCC 
  551 CTGATAGACG GTTTTTCGCC CTTTGACGTT GGAGTCCACG TTCTTTAATA 
  601 GTGGACTCTT GTTCCAAACT GGAACAACAC TCAACCCTAT CTCGGTCTAT 
  651 TCTTTTGATT TATAAGGGAT TTTGCCGATT TCGGCCTATT GGTTAAAAAA 
  701 TGAGCTGATT TAACAAAAAT TTAACGCGAA TTTTAACAAA ATATTAACGT 
  751 TTACAATTTC AGGTGGCACT TTTCGGGGAA ATGTGCGCGG AACCCCTATT 
  801 TGTTTATTTT TCTAAATACA TTCAAATATG TATCCGCTCA TGAATTAATT 
  851 CTTAGAAAAA CTCATCGAGC ATCAAATGAA ACTGCAATTT ATTCATATCA 
  901 GGATTATCAA TACCATATTT TTGAAAAAGC CGTTTCTGTA ATGAAGGAGA 
  951 AAACTCACCG AGGCAGTTCC ATAGGATGGC AAGATCCTGG TATCGGTCTG 
 1001 CGATTCCGAC TCGTCCAACA TCAATACAAC CTATTAATTT CCCCTCGTCA 
 1051 AAAATAAGGT TATCAAGTGA GAAATCACCA TGAGTGACGA CTGAATCCGG 
 1101 TGAGAATGGC AAAAGTTTAT GCATTTCTTT CCAGACTTGT TCAACAGGCC 
 1151 AGCCATTACG CTCGTCATCA AAATCACTCG CATCAACCAA ACCGTTATTC 
 1201 ATTCGTGATT GCGCCTGAGC GAGACGAAAT ACGCGATCGC TGTTAAAAGG 
 1251 ACAATTACAA ACAGGAATCG AATGCAACCG GCGCAGGAAC ACTGCCAGCG 
 1301 CATCAACAAT ATTTTCACCT GAATCAGGAT ATTCTTCTAA TACCTGGAAT 
 1351 GCTGTTTTCC CGGGGATCGC AGTGGTGAGT AACCATGCAT CATCAGGAGT 
 1401 ACGGATAAAA TGCTTGATGG TCGGAAGAGG CATAAATTCC GTCAGCCAGT 
 1451 TTAGTCTGAC CATCTCATCT GTAACATCAT TGGCAACGCT ACCTTTGCCA 
 1501 TGTTTCAGAA ACAACTCTGG CGCATCGGGC TTCCCATACA ATCGATAGAT 
 1551 TGTCGCACCT GATTGCCCGA CATTATCGCG AGCCCATTTA TACCCATATA 
 1601 AATCAGCATC CATGTTGGAA TTTAATCGCG GCCTAGAGCA AGACGTTTCC 
 1651 CGTTGAATAT GGCTCATAAC ACCCCTTGTA TTACTGTTTA TGTAAGCAGA 
 1701 CAGTTTTATT GTTCATGACC AAAATCCCTT AACGTGAGTT TTCGTTCCAC 
 1751 TGAGCGTCAG ACCCCGTAGA AAAGATCAAA GGATCTTCTT GAGATCCTTT 
 1801 TTTTCTGCGC GTAATCTGCT GCTTGCAAAC AAAAAAACCA CCGCTACCAG 
 1851 CGGTGGTTTG TTTGCCGGAT CAAGAGCTAC CAACTCTTTT TCCGAAGGTA 
 1901 ACTGGCTTCA GCAGAGCGCA GATACCAAAT ACTGTCCTTC TAGTGTAGCC 
 1951 GTAGTTAGGC CACCACTTCA AGAACTCTGT AGCACCGCCT ACATACCTCG 
 2001 CTCTGCTAAT CCTGTTACCA GTGGCTGCTG CCAGTGGCGA TAAGTCGTGT 
 2051 CTTACCGGGT TGGACTCAAG ACGATAGTTA CCGGATAAGG CGCAGCGGTC 
 2101 GGGCTGAACG GGGGGTTCGT GCACACAGCC CAGCTTGGAG CGAACGACCT 
 2151 ACACCGAACT GAGATACCTA CAGCGTGAGC TATGAGAAAG CGCCACGCTT 
 2201 CCCGAAGGGA GAAAGGCGGA CAGGTATCCG GTAAGCGGCA GGGTCGGAAC 
 2251 AGGAGAGCGC ACGAGGGAGC TTCCAGGGGG AAACGCCTGG TATCTTTATA 
 2301 GTCCTGTCGG GTTTCGCCAC CTCTGACTTG AGCGTCGATT TTTGTGATGC 
 2351 TCGTCAGGGG GGCGGAGCCT ATGGAAAAAC GCCAGCAACG CGGCCTTTTT 
 2401 ACGGTTCCTG GCCTTTTGCT GGCCTTTTGC TCACATGTTC TTTCCTGCGT 
 2451 TATCCCCTGA TTCTGTGGAT AACCGTATTA CCGCCTTTGA GTGAGCTGAT 
 2501 ACCGCTCGCC GCAGCCGAAC GACCGAGCGC AGCGAGTCAG TGAGCGAGGA 
 2551 AGCGGAAGAG CGCCTGATGC GGTATTTTCT CCTTACGCAT CTGTGCGGTA 
 2601 TTTCACACCG CATATATGGT GCACTCTCAG TACAATCTGC TCTGATGCCG 
 2651 CATAGTTAAG CCAGTATACA CTCCGCTATC GCTACGTGAC TGGGTCATGG 
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 2701 CTGCGCCCCG ACACCCGCCA ACACCCGCTG ACGCGCCCTG ACGGGCTTGT 
 2751 CTGCTCCCGG CATCCGCTTA CAGACAAGCT GTGACCGTCT CCGGGAGCTG 
 2801 CATGTGTCAG AGGTTTTCAC CGTCATCACC GAAACGCGCG AGGCAGCTGC 
 2851 GGTAAAGCTC ATCAGCGTGG TCGTGAAGCG ATTCACAGAT GTCTGCCTGT 
 2901 TCATCCGCGT CCAGCTCGTT GAGTTTCTCC AGAAGCGTTA ATGTCTGGCT 
 2951 TCTGATAAAG CGGGCCATGT TAAGGGCGGT TTTTTCCTGT TTGGTCACTG 
 3001 ATGCCTCCGT GTAAGGGGGA TTTCTGTTCA TGGGGGTAAT GATACCGATG 
 3051 AAACGAGAGA GGATGCTCAC GATACGGGTT ACTGATGATG AACATGCCCG 
 3101 GTTACTGGAA CGTTGTGAGG GTAAACAACT GGCGGTATGG ATGCGGCGGG 
 3151 ACCAGAGAAA AATCACTCAG GGTCAATGCC AGCGCTTCGT TAATACAGAT 
 3201 GTAGGTGTTC CACAGGGTAG CCAGCAGCAT CCTGCGATGC AGATCCGGAA 
 3251 CATAATGGTG CAGGGCGCTG ACTTCCGCGT TTCCAGACTT TACGAAACAC 
 3301 GGAAACCGAA GACCATTCAT GTTGTTGCTC AGGTCGCAGA CGTTTTGCAG 
 3351 CAGCAGTCGC TTCACGTTCG CTCGCGTATC GGTGATTCAT TCTGCTAACC 
 3401 AGTAAGGCAA CCCCGCCAGC CTAGCCGGGT CCTCAACGAC AGGAGCACGA 
 3451 TCATGCGCAC CCGTGGGGCC GCCATGCCGG CGATAATGGC CTGCTTCTCG 
 3501 CCGAAACGTT TGGTGGCGGG ACCAGTGACG AAGGCTTGAG CGAGGGCGTG 
 3551 CAAGATTCCG AATACCGCAA GCGACAGGCC GATCATCGTC GCGCTCCAGC 
 3601 GAAAGCGGTC CTCGCCGAAA ATGACCCAGA GCGCTGCCGG CACCTGTCCT 
 3651 ACGAGTTGCA TGATAAAGAA GACAGTCATA AGTGCGGCGA CGATAGTCAT 
 3701 GCCCCGCGCC CACCGGAAGG AGCTGACTGG GTTGAAGGCT CTCAAGGGCA 
 3751 TCGGTCGAGA TCCCGGTGCC TAATGAGTGA GCTAACTTAC ATTAATTGCG 
 3801 TTGCGCTCAC TGCCCGCTTT CCAGTCGGGA AACCTGTCGT GCCAGCTGCA 
 3851 TTAATGAATC GGCCAACGCG CGGGGAGAGG CGGTTTGCGT ATTGGGCGCC 
 3901 AGGGTGGTTT TTCTTTTCAC CAGTGAGACG GGCAACAGCT GATTGCCCTT 
 3951 CACCGCCTGG CCCTGAGAGA GTTGCAGCAA GCGGTCCACG CTGGTTTGCC 
 4001 CCAGCAGGCG AAAATCCTGT TTGATGGTGG TTAACGGCGG GATATAACAT 
 4051 GAGCTGTCTT CGGTATCGTC GTATCCCACT ACCGAGATAT CCGCACCAAC 
 4101 GCGCAGCCCG GACTCGGTAA TGGCGCGCAT TGCGCCCAGC GCCATCTGAT 
 4151 CGTTGGCAAC CAGCATCGCA GTGGGAACGA TGCCCTCATT CAGCATTTGC 
 4201 ATGGTTTGTT GAAAACCGGA CATGGCACTC CAGTCGCCTT CCCGTTCCGC 
 4251 TATCGGCTGA ATTTGATTGC GAGTGAGATA TTTATGCCAG CCAGCCAGAC 
 4301 GCAGACGCGC CGAGACAGAA CTTAATGGGC CCGCTAACAG CGCGATTTGC 
 4351 TGGTGACCCA ATGCGACCAG ATGCTCCACG CCCAGTCGCG TACCGTCTTC 
 4401 ATGGGAGAAA ATAATACTGT TGATGGGTGT CTGGTCAGAG ACATCAAGAA 
 4451 ATAACGCCGG AACATTAGTG CAGGCAGCTT CCACAGCAAT GGCATCCTGG 
 4501 TCATCCAGCG GATAGTTAAT GATCAGCCCA CTGACGCGTT GCGCGAGAAG 
 4551 ATTGTGCACC GCCGCTTTAC AGGCTTCGAC GCCGCTTCGT TCTACCATCG 
 4601 ACACCACCAC GCTGGCACCC AGTTGATCGG CGCGAGATTT AATCGCCGCG 
 4651 ACAATTTGCG ACGGCGCGTG CAGGGCCAGA CTGGAGGTGG CAACGCCAAT 
 4701 CAGCAACGAC TGTTTGCCCG CCAGTTGTTG TGCCACGCGG TTGGGAATGT 
 4751 AATTCAGCTC CGCCATCGCC GCTTCCACTT TTTCCCGCGT TTTCGCAGAA 
 4801 ACGTGGCTGG CCTGGTTCAC CACGCGGGAA ACGGTCTGAT AAGAGACACC 
 4851 GGCATACTCT GCGACATCGT ATAACGTTAC TGGTTTCACA TTCACCACCC 
 4901 TGAATTGACT CTCTTCCGGG CGCTATCATG CCATACCGCG AAAGGTTTTG 
 4951 CGCCATTCGA TGGTGTCCGG GATCTCGACG CTCTCCCTTA TGCGACTCCT 
 5001 GCATTAGGAA GCAGCCCAGT AGTAGGTTGA GGCCGTTGAG CACCGCCGCC 
 5051 GCAAGGAATG GTGCATGCAA GGAGATGGCG CCCAACAGTC CCCCGGCCAC 
 5101 GGGGCCTGCC ACCATACCCA CGCCGAAACA AGCGCTCATG AGCCCGAAGT 
 5151 GGCGAGCCCG ATCTTCCCCA TCGGTGATGT CGGCGATATA GGCGCCAGCA 
 5201 ACCGCACCTG TGGCGCCGGT GATGCCGGCC ACGATGCGTC CGGCGTAGAG 
 5251 GATCGAGATC TCGATCCCGC GAAATTAATA CGACTCACTA TAGGGGAATT 
 5301 GTGAGCGGAT AACAATTCCC CTCTAGAAAT AATTTTGATT TAACTTTAAG 
 5351 AAGGAGATAT ACCATGAAA 
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Sequence of pETM-GFP-Imm (immobilization specialty plasmid) 
 
    1 ATGAAACATC ACCATCACCA TCACCCCATG AGCGATTACG ACATCCCCAC 
   51 TACTGAGAAT CTTTATTTTC AGGGCGCCAT GGGAGGCACG GTACCGGTAG 
  101 AAAAAATGAG TAAAGGAGAA GAACTTTTCA CTGGAGTTGT CCCAATTCTT 
  151 GTTGAATTAG ATGGTGATGT TAATGGGCAC AAATTTTCTG TCAGTGGAGA 
  201 GGGTGAAGGT GATGCAACAT ACGGAAAACT TACCCTTAAA TTTATTTGCA 
  251 CTACTGGAAA ACTACCTGTT CCATGGCCAA CACTTGTCAC TACTTTCTCT 
  301 TATGGTGTTC AATGCTTTTC CCGTTATCCG GATCATATGA AACGGCATGA 
  351 CTTTTTCAAG AGTGCCATGC CCGAAGGTTA TGTACAGGAA CGCACTATAT 
  401 CTTTCAAAGA TGACGGGAAC TACAAGACGC GTGCTGAAGT CAAGTTTGAA 
  451 GGTGATACCC TTGTTAATCG TATCGAGTTA AAAGGTATTG ATTTTAAAGA 
  501 AGATGGAAAC ATTCTCGGAC ACAAACTCGA GTACAACTAT AACTCACACA 
  551 ATGTATACAT CACGGCAGAC AAACAAAAGA ATGGAATCAA AGCTAACTTC 
  601 AAAATTCGCC ACAACATTGA AGATGGATCC GTTCAACTAG CAGACCATTA 
  651 TCAACAAAAT ACTCCAATTG GCGATGGCCC TGTCCTTTTA CCAGACAACC 
  701 ATTACCTGTC GACACAATCT GCCCTTTCGA AAGATCCCAA CGAAAAGCGT 
  751 GACCACATGG TCCTTCTTGA GTTTGTAACT GCTGCTGGGA TTACACATGG 
  801 CATGGATGAG CTCCGTCGAC AAGCTTGCGG CCGCACTCGA GCACCACCAC 
  851 CACCACCACT GAGATCCGGC TGCTAACAAA GCCCGAAAGG AAGCTGAGTT 
  901 GGCTGCTGCC ACCGCTGAGC AATAACTAGC ATAACCCCTT GGGGCCTCTA 
  951 AACGGGTCTT GAGGGGTTTT TTGCTGAAAG GAGGAACTAT ATCCGGATTG 
 1001 GCGAATGGGA CGCGCCCTGT AGCGGCGCAT TAAGCGCGGC GGGTGTGGTG 
 1051 GTTACGCGCA GCGTGACCGC TACACTTGCC AGCGCCCTAG CGCCCGCTCC 
 1101 TTTCGCTTTC TTCCCTTCCT TTCTCGCCAC GTTCGCCGGC TTTCCCCGTC 
 1151 AAGCTCTAAA TCGGGGGCTC CCTTTAGGGT TCCGATTTAG TGCTTTACGG 
 1201 CACCTCGACC CCAAAAAACT TGATTAGGGT GATGGTTCAC GTAGTGGGCC 
 1251 ATCGCCCTGA TAGACGGTTT TTCGCCCTTT GACGTTGGAG TCCACGTTCT 
 1301 TTAATAGTGG ACTCTTGTTC CAAACTGGAA CAACACTCAA CCCTATCTCG 
 1351 GTCTATTCTT TTGATTTATA AGGGATTTTG CCGATTTCGG CCTATTGGTT 
 1401 AAAAAATGAG CTGATTTAAC AAAAATTTAA CGCGAATTTT AACAAAATAT 
 1451 TAACGTTTAC AATTTCAGGT GGCACTTTTC GGGGAAATGT GCGCGGAACC 
 1501 CCTATTTGTT TATTTTTCTA AATACATTCA AATATGTATC CGCTCATGAA 
 1551 TTAATTCTTA GAAAAACTCA TCGAGCATCA AATGAAACTG CAATTTATTC 
 1601 ATATCAGGAT TATCAATACC ATATTTTTGA AAAAGCCGTT TCTGTAATGA 
 1651 AGGAGAAAAC TCACCGAGGC AGTTCCATAG GATGGCAAGA TCCTGGTATC 
 1701 GGTCTGCGAT TCCGACTCGT CCAACATCAA TACAACCTAT TAATTTCCCC 
 1751 TCGTCAAAAA TAAGGTTATC AAGTGAGAAA TCACCATGAG TGACGACTGA 
 1801 ATCCGGTGAG AATGGCAAAA GTTTATGCAT TTCTTTCCAG ACTTGTTCAA 
 1851 CAGGCCAGCC ATTACGCTCG TCATCAAAAT CACTCGCATC AACCAAACCG 
 1901 TTATTCATTC GTGATTGCGC CTGAGCGAGA CGAAATACGC GATCGCTGTT 
 1951 AAAAGGACAA TTACAAACAG GAATCGAATG CAACCGGCGC AGGAACACTG 
 2001 CCAGCGCATC AACAATATTT TCACCTGAAT CAGGATATTC TTCTAATACC 
 2051 TGGAATGCTG TTTTCCCGGG GATCGCAGTG GTGAGTAACC ATGCATCATC 
 2101 AGGAGTACGG ATAAAATGCT TGATGGTCGG AAGAGGCATA AATTCCGTCA 
 2151 GCCAGTTTAG TCTGACCATC TCATCTGTAA CATCATTGGC AACGCTACCT 
 2201 TTGCCATGTT TCAGAAACAA CTCTGGCGCA TCGGGCTTCC CATACAATCG 
 2251 ATAGATTGTC GCACCTGATT GCCCGACATT ATCGCGAGCC CATTTATACC 
 2301 CATATAAATC AGCATCCATG TTGGAATTTA ATCGCGGCCT AGAGCAAGAC 
 2351 GTTTCCCGTT GAATATGGCT CATAACACCC CTTGTATTAC TGTTTATGTA 
 2401 AGCAGACAGT TTTATTGTTC ATGACCAAAA TCCCTTAACG TGAGTTTTCG 
 2451 TTCCACTGAG CGTCAGACCC CGTAGAAAAG ATCAAAGGAT CTTCTTGAGA 
 2501 TCCTTTTTTT CTGCGCGTAA TCTGCTGCTT GCAAACAAAA AAACCACCGC 
 2551 TACCAGCGGT GGTTTGTTTG CCGGATCAAG AGCTACCAAC TCTTTTTCCG 
 2601 AAGGTAACTG GCTTCAGCAG AGCGCAGATA CCAAATACTG TCCTTCTAGT 
 2651 GTAGCCGTAG TTAGGCCACC ACTTCAAGAA CTCTGTAGCA CCGCCTACAT 
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 2701 ACCTCGCTCT GCTAATCCTG TTACCAGTGG CTGCTGCCAG TGGCGATAAG 
 2751 TCGTGTCTTA CCGGGTTGGA CTCAAGACGA TAGTTACCGG ATAAGGCGCA 
 2801 GCGGTCGGGC TGAACGGGGG GTTCGTGCAC ACAGCCCAGC TTGGAGCGAA 
 2851 CGACCTACAC CGAACTGAGA TACCTACAGC GTGAGCTATG AGAAAGCGCC 
 2901 ACGCTTCCCG AAGGGAGAAA GGCGGACAGG TATCCGGTAA GCGGCAGGGT 
 2951 CGGAACAGGA GAGCGCACGA GGGAGCTTCC AGGGGGAAAC GCCTGGTATC 
 3001 TTTATAGTCC TGTCGGGTTT CGCCACCTCT GACTTGAGCG TCGATTTTTG 
 3051 TGATGCTCGT CAGGGGGGCG GAGCCTATGG AAAAACGCCA GCAACGCGGC 
 3101 CTTTTTACGG TTCCTGGCCT TTTGCTGGCC TTTTGCTCAC ATGTTCTTTC 
 3151 CTGCGTTATC CCCTGATTCT GTGGATAACC GTATTACCGC CTTTGAGTGA 
 3201 GCTGATACCG CTCGCCGCAG CCGAACGACC GAGCGCAGCG AGTCAGTGAG 
 3251 CGAGGAAGCG GAAGAGCGCC TGATGCGGTA TTTTCTCCTT ACGCATCTGT 
 3301 GCGGTATTTC ACACCGCATA TATGGTGCAC TCTCAGTACA ATCTGCTCTG 
 3351 ATGCCGCATA GTTAAGCCAG TATACACTCC GCTATCGCTA CGTGACTGGG 
 3401 TCATGGCTGC GCCCCGACAC CCGCCAACAC CCGCTGACGC GCCCTGACGG 
 3451 GCTTGTCTGC TCCCGGCATC CGCTTACAGA CAAGCTGTGA CCGTCTCCGG 
 3501 GAGCTGCATG TGTCAGAGGT TTTCACCGTC ATCACCGAAA CGCGCGAGGC 
 3551 AGCTGCGGTA AAGCTCATCA GCGTGGTCGT GAAGCGATTC ACAGATGTCT 
 3601 GCCTGTTCAT CCGCGTCCAG CTCGTTGAGT TTCTCCAGAA GCGTTAATGT 
 3651 CTGGCTTCTG ATAAAGCGGG CCATGTTAAG GGCGGTTTTT TCCTGTTTGG 
 3701 TCACTGATGC CTCCGTGTAA GGGGGATTTC TGTTCATGGG GGTAATGATA 
 3751 CCGATGAAAC GAGAGAGGAT GCTCACGATA CGGGTTACTG ATGATGAACA 
 3801 TGCCCGGTTA CTGGAACGTT GTGAGGGTAA ACAACTGGCG GTATGGATGC 
 3851 GGCGGGACCA GAGAAAAATC ACTCAGGGTC AATGCCAGCG CTTCGTTAAT 
 3901 ACAGATGTAG GTGTTCCACA GGGTAGCCAG CAGCATCCTG CGATGCAGAT 
 3951 CCGGAACATA ATGGTGCAGG GCGCTGACTT CCGCGTTTCC AGACTTTACG 
 4001 AAACACGGAA ACCGAAGACC ATTCATGTTG TTGCTCAGGT CGCAGACGTT 
 4051 TTGCAGCAGC AGTCGCTTCA CGTTCGCTCG CGTATCGGTG ATTCATTCTG 
 4101 CTAACCAGTA AGGCAACCCC GCCAGCCTAG CCGGGTCCTC AACGACAGGA 
 4151 GCACGATCAT GCGCACCCGT GGGGCCGCCA TGCCGGCGAT AATGGCCTGC 
 4201 TTCTCGCCGA AACGTTTGGT GGCGGGACCA GTGACGAAGG CTTGAGCGAG 
 4251 GGCGTGCAAG ATTCCGAATA CCGCAAGCGA CAGGCCGATC ATCGTCGCGC 
 4301 TCCAGCGAAA GCGGTCCTCG CCGAAAATGA CCCAGAGCGC TGCCGGCACC 
 4351 TGTCCTACGA GTTGCATGAT AAAGAAGACA GTCATAAGTG CGGCGACGAT 
 4401 AGTCATGCCC CGCGCCCACC GGAAGGAGCT GACTGGGTTG AAGGCTCTCA 
 4451 AGGGCATCGG TCGAGATCCC GGTGCCTAAT GAGTGAGCTA ACTTACATTA 
 4501 ATTGCGTTGC GCTCACTGCC CGCTTTCCAG TCGGGAAACC TGTCGTGCCA 
 4551 GCTGCATTAA TGAATCGGCC AACGCGCGGG GAGAGGCGGT TTGCGTATTG 
 4601 GGCGCCAGGG TGGTTTTTCT TTTCACCAGT GAGACGGGCA ACAGCTGATT 
 4651 GCCCTTCACC GCCTGGCCCT GAGAGAGTTG CAGCAAGCGG TCCACGCTGG 
 4701 TTTGCCCCAG CAGGCGAAAA TCCTGTTTGA TGGTGGTTAA CGGCGGGATA 
 4751 TAACATGAGC TGTCTTCGGT ATCGTCGTAT CCCACTACCG AGATATCCGC 
 4801 ACCAACGCGC AGCCCGGACT CGGTAATGGC GCGCATTGCG CCCAGCGCCA 
 4851 TCTGATCGTT GGCAACCAGC ATCGCAGTGG GAACGATGCC CTCATTCAGC 
 4901 ATTTGCATGG TTTGTTGAAA ACCGGACATG GCACTCCAGT CGCCTTCCCG 
 4951 TTCCGCTATC GGCTGAATTT GATTGCGAGT GAGATATTTA TGCCAGCCAG 
 5001 CCAGACGCAG ACGCGCCGAG ACAGAACTTA ATGGGCCCGC TAACAGCGCG 
 5051 ATTTGCTGGT GACCCAATGC GACCAGATGC TCCACGCCCA GTCGCGTACC 
 5101 GTCTTCATGG GAGAAAATAA TACTGTTGAT GGGTGTCTGG TCAGAGACAT 
 5151 CAAGAAATAA CGCCGGAACA TTAGTGCAGG CAGCTTCCAC AGCAATGGCA 
 5201 TCCTGGTCAT CCAGCGGATA GTTAATGATC AGCCCACTGA CGCGTTGCGC 
 5251 GAGAAGATTG TGCACCGCCG CTTTACAGGC TTCGACGCCG CTTCGTTCTA 
 5301 CCATCGACAC CACCACGCTG GCACCCAGTT GATCGGCGCG AGATTTAATC 
 5351 GCCGCGACAA TTTGCGACGG CGCGTGCAGG GCCAGACTGG AGGTGGCAAC 
 5401 GCCAATCAGC AACGACTGTT TGCCCGCCAG TTGTTGTGCC ACGCGGTTGG 
 5451 GAATGTAATT CAGCTCCGCC ATCGCCGCTT CCACTTTTTC CCGCGTTTTC 
 5501 GCAGAAACGT GGCTGGCCTG GTTCACCACG CGGGAAACGG TCTGATAAGA 
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 5551 GACACCGGCA TACTCTGCGA CATCGTATAA CGTTACTGGT TTCACATTCA 
 5601 CCACCCTGAA TTGACTCTCT TCCGGGCGCT ATCATGCCAT ACCGCGAAAG 
 5651 GTTTTGCGCC ATTCGATGGT GTCCGGGATC TCGACGCTCT CCCTTATGCG 
 5701 ACTCCTGCAT TAGGAAGCAG CCCAGTAGTA GGTTGAGGCC GTTGAGCACC 
 5751 GCCGCCGCAA GGAATGGTGC ATGCAAGGAG ATGGCGCCCA ACAGTCCCCC 
 5801 GGCCACGGGG CCTGCCACCA TACCCACGCC GAAACAAGCG CTCATGAGCC 
 5851 CGAAGTGGCG AGCCCGATCT TCCCCATCGG TGATGTCGGC GATATAGGCG 
 5901 CCAGCAACCG CACCTGTGGC GCCGGTGATG CCGGCCACGA TGCGTCCGGC 
 5951 GTAGAGGATC GAGATCTCGA TCCCGCGAAA TTAATACGAC TCACTATAGG 
 6001 GGAATTGTGA GCGGATAACA ATTCCCCTCT AGAAATAATT TTGATTTAAC 
 6051 TTTAAGAAGG AGATATACC 
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APPENDIX F 
pETM-11 (EMBL) Plasmid Map 
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APPENDIX G: 
pGFPuv (Clontech) Plasmid Map 
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APPENDIX H: 
Sequencing result: 
Alignment of insertion region of theoretical pETM-GFP-Imm plasmid (BWB8373) 
with sequenced pETM-GFP-Imm (BWB8207) and GFPuv gene (pGFPuv[GFP]) 
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APPENDIX I: 
TABLES OF RELATIVE FLUORESCENCE INTENSITY VALUES 
GFP bound transparent polystyrene 96 well plate, dry measurement 
 No modification (dH2O treated) 2M APS modified 3M APS modified Empty 
Blank (No GFP) 12.02 19.511 17.073 13.635 
GFPuv at pH 6.0 23.96 64.387 62.106 20.444 
GFPimm at pH 6.0 63.792 274.97 443.267 76.069 
GFPuv at pH 7.0 15.509 67.949 85.149 22.401 
GFPimm at pH 7.0 233.672 690.85 888.078 145.186 
GFPuv at pH 8.0 16.176 78.776 89.982 23.807 
GFPimm at pH 8.0 99.532 250.865 344.894 50.509 
No treatment 12.462 13.748 13.114 13.251 
 
GFP bound transparent polystyrene 96 well plate, filled with 100 µl appropriate 
buffer  
 No modification (dH2O treated) 
2M 
APS 
modified 
3M 
APS 
modified 
Empty 
Blank (No GFP) 19.273 14.676 14.076 11.229 
GFPuv at pH 6.0 39.267 61.197 51.422 16.242 
GFPimm at pH 6.0 135.422 393.247 514.398 39.453 
GFPuv at pH 7.0 34.918 65.44 76.862 18.412 
GFPimm at pH 7.0 685.664 787.917 896.646 71.299 
GFPuv at pH 8.0 41.757 86.718 87.015 16.624 
GFPimm at pH 8.0 226.244 327.216 407.67 26.861 
No treatment 12.546 13.605 13.388 12.236 
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Fluorescence measurements of rGFPuv standard, GFPuv and GFPimm dilutions 
rGFPuv dilutions  
20X diluted 4368.524 
100X diluted, pH 6 695.942 
100X diluted, pH 7 826.601 
100X diluted, pH 8 899.446 
 
GFPuv,  
pH 6 
GFPuv,  
pH 7 
GFPuv,  
pH 8 
GFPimm,  
pH 6 
GFPimm,  
pH 7 
GFPimm,  
pH 8 
0.05X diluted 1724.876 1655.763 1673.424 165.37 212.375 198.868 
0.005X 
diluted 56.292 50.916 48.299 5.116 10.824 11.604 
0.0005X 
diluted 5.848 5.563 6.72 0.991 1.615 1.421 
0.00005X 
diluted 0.59 0.985 0.993 0.107 0.378 0.572 
0.000005X 
diluted 0.195 0.121 -0.023 0.132 0.266 0.001 
0.0000005X 
diluted 0.166 0.011 0.017 0.113 0.037 0.2 
 
GFP bound black polystyrene 96 well plate, dry measurement 
 unmodified, pH 6 
2M 
APS, 
pH 6 
3M 
APS, 
pH 6 
unmodified, 
pH 7 
2M 
APS, 
pH 7 
3M 
APS, 
pH 7 
unmodified, 
pH 8 
2M 
APS, 
pH 8 
3M 
APS, 
pH 8 
GFPuv 0.737 1.285 0.984 1.268 3.446 6.053 2.902 20.136 22.884 
GFPimm; 
2X dil. 0.073 3.153 2.752 3.92 63.677 59.241 1.426 40.607 44.747 
GFPuv 0.934 1.652 3.442 2.964 8.249 8.091 2.744 5.575 7.121 
GFPimm; 
20X dil. 0.413 4.338 3.866 1.343 12.888 17.029 0.969 9.55 12.343 
GFPuv 0.443 0.663 0.372 1.857 0.711 0.402 1.9 0.608 0.622 
GFPimm; 
200X dil. 0.228 0.644 0.429 0.821 0.99 1.379 0.829 1.22 2.064 
 
  131
GFP bound black polystyrene 96 well plate, filled with 200 µl appropriate buffer 
 unmodified, pH 6 
2M 
APS, 
pH 6 
3M 
APS, 
pH 6 
unmodified, 
pH 7 
2M 
APS, 
pH 7 
3M 
APS, 
pH 7 
unmodified, 
pH 8 
2M 
APS, 
pH 8 
3M 
APS, 
pH 8 
GFPuv 2.923 27.515 18.204 3.793 14.376 21.479 5.447 81.404 114.264 
GFPimm; 
2X dil. 13.034 
105.35
2 
124.34
1 33.965 
190.00
5 
251.15
5 9.557 91.957 
149.16
6 
GFPuv 1.826 30.881 23.015 6.105 26.934 34.636 5.956 22.719 17.315 
GFPimm; 
20X dil. 1.784 36.629 35.803 3.232 30.403 33.177 1.8 26.103 29.028 
GFPuv 2.312 1.452 1.073 4.79 1.217 1.107 3.837 1.106 0.97 
GFPimm; 
200X dil. 0.729 3.301 3.469 2.894 3.211 4.517 2.004 2.501 2.774 
 
GFP bound black polystyrene 96 well plate, filled with 200 µl pH 7.0 buffer (after pH 
7.0, overnight incubation) 
 unmodified, pH 6 
2M 
APS, 
pH 6 
3M 
APS, 
pH 6 
unmodified, 
pH 7 
2M 
APS, 
pH 7 
3M 
APS, 
pH 7 
unmodified, 
pH 8 
2M 
APS, 
pH 8 
3M 
APS, 
pH 8 
GFPuv 1.357 4.451 12.903 2.023 7.731 13.528 3.518 26.412 32.21 
GFPimm; 
2X dil. 4.221 63.007 58.607 5.857 
154.13
4 
109.85
2 1.46 57.278 60.377 
GFPuv 1.494 6.774 14.18 3.096 15.028 21.287 3.517 6.654 7.884 
GFPimm; 
20X dil. 0.974 19.021 22.753 2.324 34.483 20.422 1.198 14.832 14.949 
GFPuv 1.688 1.487 0.903 2.154 0.93 0.975 2.676 0.808 0.502 
GFPimm; 
200X dil. 0.65 1.368 3.034 1.408 2.518 4.717 1.236 1.342 1.973 
 
